A	O
transcriptional	B-DNA
regulatory	I-DNA
element	I-DNA
is	O
associated	O
with	O
a	O
nuclease-hypersensitive	B-DNA
site	I-DNA
in	O
the	O
pol	B-DNA
gene	I-DNA
of	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
.	O

Analysis	O
of	O
the	O
chromatin	O
organization	O
of	O
the	O
integrated	O
human	B-DNA
immunodeficiency	I-DNA
virus	I-DNA
type	I-DNA
1	I-DNA
(	I-DNA
HIV-1	I-DNA
)	I-DNA
genome	I-DNA
has	O
previously	O
revealed	O
a	O
major	B-DNA
constitutive	I-DNA
DNase	I-DNA
I-hypersensitive	I-DNA
site	I-DNA
associated	O
with	O
the	O
pol	B-DNA
gene	I-DNA
(	O
E.	O
Verdin	O
,	O
J.	O
Virol.	O
65	O
:	O
6790-6799	O
,	O
1991	O
)	O
.	O

In	O
the	O
present	O
report	O
,	O
high-resolution	O
mapping	O
of	O
this	O
site	O
with	O
DNase	B-protein
I	I-protein
and	O
micrococcal	B-protein
nuclease	I-protein
identified	O
a	O
nucleosome-free	B-DNA
region	I-DNA
centered	O
around	O
nucleotides	B-DNA
(	I-DNA
nt	I-DNA
)	I-DNA
4490	I-DNA
to	I-DNA
4766	I-DNA
.	O

A	O
500-bp	B-DNA
fragment	I-DNA
encompassing	O
this	O
hypersensitive	B-DNA
site	I-DNA
(	O
nt	B-DNA
4481	I-DNA
to	I-DNA
4982	I-DNA
)	O
exhibited	O
transcription-enhancing	O
activity	O
(	O
two-	O
to	O
threefold	O
)	O
when	O
it	O
was	O
cloned	O
in	O
its	O
natural	O
position	O
with	O
respect	O
to	O
the	O
HIV-1	B-DNA
promoter	I-DNA
after	O
transient	O
transfection	O
in	O
U937	B-cell_line
and	O
CEM	B-cell_line
cells	I-cell_line
.	O

Using	O
in	O
vitro	O
footprinting	O
and	O
gel	O
shift	O
assays	O
,	O
we	O
have	O
identified	O
four	O
distinct	O
binding	B-DNA
sites	I-DNA
for	O
nuclear	B-protein
proteins	I-protein
within	O
this	O
positive	B-DNA
regulatory	I-DNA
element	I-DNA
.	O

Site	B-DNA
B	I-DNA
(	O
nt	B-DNA
4519	I-DNA
to	I-DNA
4545	I-DNA
)	O
specifically	O
bound	O
four	O
distinct	O
nuclear	B-protein
protein	I-protein
complexes	I-protein
:	O
a	O
ubiquitous	B-protein
factor	I-protein
,	O
a	O
T-cell-specific	B-protein
factor	I-protein
,	O
a	O
B-cell-specific	B-protein
factor	I-protein
,	O
and	O
the	O
monocyte/macrophage-	B-protein
and	I-protein
B-cell-specific	I-protein
transcription	I-protein
factor	I-protein
PU.1/Spi-1	B-protein
.	O

In	O
most	O
HIV-1	O
isolates	O
in	O
which	O
this	O
PU	B-DNA
box	I-DNA
was	O
not	O
conserved	O
,	O
it	O
was	O
replaced	O
by	O
a	O
binding	B-DNA
site	I-DNA
for	O
the	O
related	O
factor	O
Ets1	B-protein
.	O

Factors	O
binding	O
to	O
site	B-DNA
C	I-DNA
(	O
nt	B-DNA
4681	I-DNA
to	I-DNA
4701	I-DNA
)	O
had	O
a	O
DNA-binding	O
specificity	O
similar	O
to	O
that	O
of	O
factors	O
binding	O
to	O
site	B-DNA
B	I-DNA
,	O
except	O
for	O
PU.1/Spi-1	B-protein
.	O

A	O
GC	B-DNA
box	I-DNA
containing	O
a	O
binding	B-DNA
site	I-DNA
for	O
Sp1	B-protein
was	O
identified	O
(	O
nt	B-DNA
4623	I-DNA
to	I-DNA
4631	I-DNA
)	O
.	O

Site	B-DNA
D	I-DNA
(	O
nt	B-DNA
4816	I-DNA
to	I-DNA
4851	I-DNA
)	O
specifically	O
bound	O
a	O
ubiquitously	B-protein
expressed	I-protein
factor	I-protein
.	O

These	O
results	O
identify	O
a	O
transcriptional	B-DNA
regulatory	I-DNA
element	I-DNA
associated	O
with	O
a	O
nuclease-hypersensitive	B-DNA
site	I-DNA
in	O
the	O
pol	B-DNA
gene	I-DNA
of	O
HIV-1	O
and	O
suggest	O
that	O
its	O
activity	O
may	O
be	O
controlled	O
by	O
a	O
complex	O
interplay	O
of	O
cis-	O
regulatory	B-DNA
elements	I-DNA
.	O

JournaL	NULL
or	NULL
ViroLocy	NULL
,	NULL
Apr	NULL
.	NULL

1994	NULL
,	NULL
p.	NULL
2632-2648	NULL
0022-538	NULL
X	NULL
,	NULL
/94/	NULL
$	NULL
04.00+0	NULL
Copyright	NULL
©	NULL
1994	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

68	NULL
,	NULL
No	NULL
.	NULL

4	NULL
A	NULL
Transcriptional	NULL
Regulatory	NULL
Element	NULL
Is	NULL
Associated	NULL
with	NULL
a	NULL
Nuclease-Hypersensitive	NULL
Site	NULL
in	NULL
the	NULL
pol	NULL
Gene	NULL
of	NULL
Human	NULL
Immunodeficiency	NULL
Virus	NULL
Type	NULL
1	NULL
CARINE	NULL
VAN	NULL
LIN:1	NULL
“	NULL
,	NULL
l	NULL
JACQUES	NULL
GHYSDAEL	NULL
,	NULL
``	NULL
PETER	NULL
PARAS	NULL
,	NULL
JR.	NULL
,	NULL
``	NULL
ARSENE	NULL
BURNY	NULL
,	NULL
*	NULL
anp	NULL
ERIC	NULL
VERDIN'*	NULL
Laboratory	NULL
of	NULL
Viral	NULL
and	NULL
Molecular	NULL
Pathogenesis	NULL
,	NULL
National	NULL
Institute	NULL
of	NULL
Neurological	NULL
Disorders	NULL
and	NULL
Stroke	NULL
,	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
Bethesda	NULL
,	NULL
Maryland	NULL
20892	NULL
``	NULL
;	NULL
Section	NULL
de	NULL
Biologie	NULL
,	NULL
Institut	NULL
Curie	NULL
,	NULL
91405	NULL
Orsay	NULL
Cédex	NULL
,	NULL
France	NULL
``	NULL
;	NULL
and	NULL
Département	NULL
de	NULL
Biologie	NULL
Moléculaire	NULL
,	NULL
Université	NULL
Libre	NULL
de	NULL
Bruxelles	NULL
,	NULL
1640	NULL
Rhode-St-Genése	NULL
,	NULL
Belgium	NULL
``	NULL
Received	NULL
15	NULL
November	NULL
1993/Accepted	NULL
7	NULL
January	NULL
1994	NULL
Analysis	NULL
of	NULL
the	NULL
chromatin	NULL
organization	NULL
of	NULL
the	NULL
integrated	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HIV-1	NULL
)	NULL
genome	NULL
has	NULL
previously	NULL
revealed	NULL
a	NULL
major	NULL
constitutive	NULL
DNase	NULL
I-hypersensitive	NULL
site	NULL
associated	NULL
with	NULL
the	NULL
pol	NULL
gene	NULL
(	NULL
E.	NULL
Verdin	NULL
,	NULL
J.	NULL
Virol	NULL
.	NULL

65:6790-6799	NULL
,	NULL
1991	NULL
)	NULL
.	NULL

In	NULL
the	NULL
present	NULL
report	NULL
,	NULL
high-resolution	NULL
mapping	NULL
of	NULL
this	NULL
site	NULL
with	NULL
DNase	NULL
I	NULL
and	NULL
micrococcal	NULL
nuclease	NULL
identified	NULL
a	NULL
nucleosome-free	NULL
region	NULL
centered	NULL
around	NULL
nucleotides	NULL
(	NULL
nt	NULL
)	NULL
4490	NULL
to	NULL
4766	NULL
.	NULL

A	NULL
500-bp	NULL
fragment	NULL
encompassing	NULL
this	NULL
hypersensitive	NULL
site	NULL
(	NULL
nt	NULL
4481	NULL
to	NULL
4982	NULL
)	NULL
exhibited	NULL
transcription-enhancing	NULL
activity	NULL
(	NULL
two-	NULL
to	NULL
threefold	NULL
)	NULL
when	NULL
it	NULL
was	NULL
cloned	NULL
in	NULL
its	NULL
natural	NULL
position	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
HIV-1	NULL
promoter	NULL
after	NULL
transient	NULL
transfection	NULL
in	NULL
U937	NULL
and	NULL
CEM	NULL
cells	NULL
.	NULL

Using	NULL
in	NULL
vitro	NULL
footprinting	NULL
and	NULL
gel	NULL
shift	NULL
assays	NULL
,	NULL
we	NULL
have	NULL
identified	NULL
four	NULL
distinct	NULL
binding	NULL
sites	NULL
for	NULL
nuclear	NULL
proteins	NULL
within	NULL
this	NULL
positive	NULL
regulatory	NULL
element	NULL
.	NULL

Site	NULL
B	NULL
(	NULL
nt	NULL
4519	NULL
to	NULL
4545	NULL
)	NULL
specifically	NULL
bound	NULL
four	NULL
distinct	NULL
nuclear	NULL
protein	NULL
complexes	NULL
:	NULL
a	NULL
ubiquitous	NULL
factor	NULL
,	NULL
a	NULL
T-cell-specific	NULL
factor	NULL
,	NULL
a	NULL
B-cell-specific	NULL
factor	NULL
,	NULL
and	NULL
the	NULL
monocyte/macrophage-	NULL
and	NULL
B-cell-specific	NULL
transcription	NULL
factor	NULL
PU.1/Spi-1	NULL
.	NULL

In	NULL
most	NULL
HIV-1	NULL
isolates	NULL
in	NULL
which	NULL
this	NULL
PU	NULL
box	NULL
was	NULL
not	NULL
conserved	NULL
,	NULL
it	NULL
was	NULL
replaced	NULL
by	NULL
a	NULL
binding	NULL
site	NULL
for	NULL
the	NULL
related	NULL
factor	NULL
Ets1	NULL
.	NULL

Factors	NULL
binding	NULL
to	NULL
site	NULL
C	NULL
(	NULL
nt	NULL
4681	NULL
to	NULL
4701	NULL
)	NULL
had	NULL
a	NULL
DNA-binding	NULL
specificity	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
factors	NULL
binding	NULL
to	NULL
site	NULL
B	NULL
,	NULL
except	NULL
for	NULL
PU.1/Spi-1	NULL
.	NULL

A	NULL
GC	NULL
box	NULL
containing	NULL
a	NULL
binding	NULL
site	NULL
for	NULL
Spl	NULL
was	NULL
identified	NULL
(	NULL
nt	NULL
4623	NULL
to	NULL
4631	NULL
)	NULL
.	NULL

Site	NULL
D	NULL
(	NULL
nt	NULL
4816	NULL
to	NULL
4851	NULL
)	NULL
specifically	NULL
bound	NULL
a	NULL
ubiquitously	NULL
expressed	NULL
factor	NULL
.	NULL

These	NULL
results	NULL
identify	NULL
a	NULL
transcriptional	NULL
regulatory	NULL
element	NULL
associated	NULL
with	NULL
a	NULL
nuclease-hypersensitive	NULL
site	NULL
in	NULL
the	NULL
po/	NULL
gene	NULL
of	NULL
HIV-1	NULL
and	NULL
suggest	NULL
that	NULL
its	NULL
activity	NULL
may	NULL
be	NULL
controlled	NULL
by	NULL
a	NULL
complex	NULL
interplay	NULL
of	NULL
cis-regulatory	NULL
elements	NULL
.	NULL

Human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HIV-1	NULL
)	NULL
is	NULL
a	NULL
lentivirus	NULL
that	NULL
is	NULL
etiologically	NULL
associated	NULL
with	NULL
AIDS	NULL
,	NULL
a	NULL
slowly	NULL
progressive	NULL
degenerative	NULL
disease	NULL
affecting	NULL
the	NULL
immune	NULL
and	NULL
central	NULL
nervous	NULL
systems	NULL
in	NULL
humans	NULL
(	NULL
for	NULL
reviews	NULL
,	NULL
see	NULL
references	NULL
18	NULL
,	NULL
24	NULL
,	NULL
35	NULL
,	NULL
52	NULL
,	NULL
and	NULL
79	NULL
)	NULL
.	NULL

Regulation	NULL
of	NULL
HIV-1	NULL
gene	NULL
expression	NULL
is	NULL
controlled	NULL
by	NULL
the	NULL
combined	NULL
action	NULL
of	NULL
trans-acting	NULL
cellular	NULL
and	NULL
viral	NULL
regulatory	NULL
factors	NULL
(	NULL
for	NULL
a	NULL
review	NULL
,	NULL
see	NULL
references	NULL
18	NULL
,	NULL
31	NULL
,	NULL
35	NULL
,	NULL
40	NULL
,	NULL
64	NULL
,	NULL
and	NULL
79	NULL
)	NULL
.	NULL

The	NULL
protein	NULL
factors	NULL
exert	NULL
their	NULL
regulatory	NULL
functions	NULL
by	NULL
interacting	NULL
with	NULL
viral	NULL
cis-acting	NULL
elements	NULL
,	NULL
at	NULL
both	NULL
the	NULL
DNA	NULL
and	NULL
the	NULL
RNA	NULL
levels	NULL
.	NULL

At	NULL
the	NULL
transcriptional	NULL
level	NULL
,	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
,	NULL
which	NULL
is	NULL
present	NULL
at	NULL
both	NULL
extremities	NULL
of	NULL
the	NULL
integrated	NULL
viral	NULL
genome	NULL
,	NULL
contains	NULL
cis-acting	NULL
elements	NULL
necessary	NULL
for	NULL
transcription	NULL
initiation	NULL
(	NULL
5'-LTR	NULL
)	NULL
and	NULL
for	NULL
polyadenylation	NULL
of	NULL
the	NULL
viral	NULL
transcripts	NULL
(	NULL
3'-LTR	NULL
)	NULL
.	NULL

Several	NULL
inducible	NULL
or	NULL
constitutive	NULL
transcription	NULL
factors	NULL
bind	NULL
in	NULL
vitro	NULL
to	NULL
each	NULL
of	NULL
the	NULL
four	NULL
functionally	NULL
defined	NULL
regions	NULL
of	NULL
the	NULL
5'-LTR	NULL
:	NULL
first	NULL
,	NULL
the	NULL
negative	NULL
regulatory	NULL
element	NULL
,	NULL
a	NULL
silencer	NULL
,	NULL
containing	NULL
binding	NULL
sites	NULL
for	NULL
the	NULL
cellular	NULL
factors	NULL
AP-1	NULL
,	NULL
COUP	NULL
,	NULL
NF-AT1	NULL
,	NULL
USF	NULL
,	NULL
glucocorticoid	NULL
receptor	NULL
,	NULL
and	NULL
NF-IL6	NULL
;	NULL
second	NULL
,	NULL
the	NULL
TCF-1a	NULL
site	NULL
and	NULL
the	NULL
enhancer	NULL
region	NULL
,	NULL
which	NULL
interacts	NULL
with	NULL
NF-kB	NULL
,	NULL
HIVEN86A	NULL
,	NULL
and	NULL
EBP-1	NULL
;	NULL
third	NULL
,	NULL
the	NULL
basal	NULL
promoter	NULL
containing	NULL
three	NULL
Spl-binding	NULL
sites	NULL
,	NULL
a	NULL
TATA	NULL
box	NULL
,	NULL
and	NULL
an	NULL
initiator	NULL
element	NULL
close	NULL
to	NULL
the	NULL
transcription	NULL
initiation	NULL
site	NULL
;	NULL
and	NULL
fourth	NULL
,	NULL
the	NULL
5°	NULL
untranslated	NULL
leader	NULL
region	NULL
containing	NULL
binding	NULL
sites	NULL
for	NULL
UBP-1/LBP-1	NULL
,	NULL
UBP-2	NULL
,	NULL
and	NULL
CTF/NF1	NULL
(	NULL
for	NULL
reviews	NULL
,	NULL
see	NULL
references	NULL
18	NULL
,	NULL
31	NULL
,	NULL
35	NULL
,	NULL
40	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
last	NULL
region	NULL
corresponds	NULL
to	NULL
the	NULL
frans-activation	NULL
response	NULL
(	NULL
TAR	NULL
)	NULL
element	NULL
whose	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
The	NULL
Picower	NULL
Institute	NULL
for	NULL
Medical	NULL
Research	NULL
,	NULL
350	NULL
Community	NULL
Dr.	NULL
,	NULL
Manhasset	NULL
,	NULL
NY	NULL
11030	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
516	NULL
)	NULL
562-9495	NULL
.	NULL

Fax	NULL
:	NULL
(	NULL
516	NULL
)	NULL
365-5090	NULL
.	NULL

2632	NULL
RNA	NULL
forms	NULL
a	NULL
stable	NULL
stem-loop	NULL
structure	NULL
interacting	NULL
with	NULL
the	NULL
viral	NULL
transactivator	NULL
Tat	NULL
in	NULL
a	NULL
manner	NULL
critical	NULL
for	NULL
high	NULL
activity	NULL
of	NULL
the	NULL
HIV-1	NULL
promoter	NULL
(	NULL
for	NULL
reviews	NULL
,	NULL
see	NULL
references	NULL
17	NULL
,	NULL
29	NULL
,	NULL
43	NULL
,	NULL
and	NULL
69	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
these	NULL
elements	NULL
,	NULL
a	NULL
12-O-tetradecanoylphorbol-13-acetate	NULL
(	NULL
TPA	NULL
)	NULL
-inducible	NULL
intragenic	NULL
enhancer	NULL
was	NULL
identified	NULL
in	NULL
the	NULL
pol	NULL
!	NULL

gene	NULL
of	NULL
HIV-1	NULL
(	NULL
83	NULL
)	NULL
.	NULL

This	NULL
element	NULL
is	NULL
composed	NULL
of	NULL
two	NULL
functional	NULL
subdomains	NULL
encompassing	NULL
nucleotides	NULL
(	NULL
nt	NULL
)	NULL
4079	NULL
to	NULL
4342	NULL
and	NULL
nt	NULL
4781	NULL
to	NULL
6026	NULL
,	NULL
both	NULL
exhibiting	NULL
TPA-inducible	NULL
enhancing	NULL
activity	NULL
,	NULL
on	NULL
the	NULL
herpes	NULL
simplex	NULL
virus	NULL
thymidine	NULL
kinase	NULL
promoter	NULL
in	NULL
HeLa	NULL
cells	NULL
(	NULL
83	NULL
)	NULL
.	NULL

However	NULL
,	NULL
when	NULL
these	NULL
elements	NULL
were	NULL
tested	NULL
in	NULL
T-lymphoid	NULL
and	NULL
monocyte/macrophage	NULL
cell	NULL
lines	NULL
,	NULL
they	NULL
exhibited	NULL
no	NULL
significant	NULL
activity	NULL
in	NULL
the	NULL
context	NULL
of	NULL
either	NULL
the	NULL
heterologous	NULL
thymidine	NULL
kinase	NULL
promoter	NULL
or	NULL
the	NULL
homologous	NULL
HIV-1	NULL
promoter	NULL
(	NULL
8	NULL
)	NULL
.	NULL

Nevertheless	NULL
,	NULL
analysis	NULL
of	NULL
the	NULL
chromatin	NULL
organization	NULL
of	NULL
integrated	NULL
HIV-1	NULL
identified	NULL
a	NULL
single	NULL
major	NULL
DNase	NULL
I-hypersensitive	NULL
site	NULL
in	NULL
the	NULL
8-kb	NULL
region	NULL
located	NULL
between	NULL
the	NULL
two	NULL
LTRs	NULL
(	NULL
82	NULL
)	NULL
.	NULL

This	NULL
site	NULL
maps	NULL
to	NULL
the	NULL
pol	NULL
gene	NULL
precisely	NULL
between	NULL
the	NULL
two	NULL
functional	NULL
domains	NULL
of	NULL
the	NULL
intragenic	NULL
enhancer	NULL
identified	NULL
in	NULL
HeLa	NULL
cells	NULL
(	NULL
82	NULL
)	NULL
.	NULL

This	NULL
constitutive	NULL
hypersensitive	NULL
site	NULL
is	NULL
present	NULL
only	NULL
in	NULL
a	NULL
cell	NULL
line	NULL
of	NULL
monocytic	NULL
origin	NULL
and	NULL
not	NULL
in	NULL
two	NULL
cell	NULL
lines	NULL
of	NULL
lymphoid	NULL
origin	NULL
,	NULL
suggesting	NULL
a	NULL
cellular	NULL
specificity	NULL
associated	NULL
with	NULL
this	NULL
intragenic	NULL
element	NULL
(	NULL
82	NULL
)	NULL
.	NULL

Since	NULL
DNase	NULL
I-hypersensitive	NULL
sites	NULL
are	NULL
frequently	NULL
associated	NULL
with	NULL
regulatory	NULL
regions	NULL
of	NULL
genes	NULL
such	NULL
as	NULL
promoters	NULL
and	NULL
enhancers	NULL
(	NULL
36	NULL
)	NULL
,	NULL
the	NULL
presence	NULL
of	NULL
this	NULL
open	NULL
chromatin	NULL
configuration	NULL
in	NULL
vivo	NULL
prompted	NULL
us	NULL
to	NULL
examine	NULL
the	NULL
potential	NULL
regulatory	NULL
role	NULL
of	NULL
the	NULL
underlying	NULL
DNA	NULL
element	NULL
in	NULL
HIV-1	NULL
transcription	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
have	NULL
characterized	NULL
the	NULL
intragenic	NULL
hypersensitive	NULL
site	NULL
and	NULL
found	NULL
that	NULL
a	NULL
region	NULL
of	NULL
the	NULL
po	NULL
!	NULL

gene	NULL
centered	NULL
around	NULL
nt	NULL
Vor	NULL
.	NULL

68	NULL
,	NULL
1994	NULL
4490	NULL
to	NULL
4766	NULL
is	NULL
nucleosome	NULL
free	NULL
in	NULL
vivo	NULL
.	NULL

When	NULL
cloned	NULL
downstream	NULL
and	NULL
in	NULL
the	NULL
sense	NULL
orientation	NULL
relative	NULL
to	NULL
the	NULL
HIV-1	NULL
promoter	NULL
,	NULL
the	NULL
po	NULL
!	NULL

gene-hypersensitive	NULL
site	NULL
region	NULL
reproducibly	NULL
increases	NULL
transcription	NULL
mediated	NULL
by	NULL
the	NULL
HIV-1	NULL
5'-LTR	NULL
in	NULL
U937	NULL
and	NULL
CEM	NULL
cells	NULL
.	NULL

This	NULL
positive	NULL
regulatory	NULL
element	NULL
contains	NULL
several	NULL
recognition	NULL
sites	NULL
for	NULL
ubiquitous	NULL
and	NULL
cell-type-specific	NULL
DNA-binding	NULL
factors	NULL
,	NULL
suggesting	NULL
their	NULL
involvement	NULL
in	NULL
the	NULL
control	NULL
of	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
region	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
culture	NULL
.	NULL

Human	NULL
cell	NULL
lines	NULL
were	NULL
obtained	NULL
from	NULL
the	NULL
AIDS	NULL
Research	NULL
and	NULL
Reference	NULL
Reagent	NULL
Program	NULL
(	NULL
National	NULL
Institute	NULL
of	NULL
Allergy	NULL
and	NULL
Infectious	NULL
Diseases	NULL
[	NULL
NIAID	NULL
]	NULL
,	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
Bethesda	NULL
,	NULL
Md	NULL
.	NULL
)	NULL

.	NULL

All	NULL
cell	NULL
lines	NULL
,	NULL
except	NULL
HeLaS3	NULL
and	NULL
HeLa	NULL
,	NULL
were	NULL
grown	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
(	NULL
GIBCO-BRL	NULL
}	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
(	NULL
HyClone	NULL
)	NULL
,	NULL
50	NULL
U	NULL
of	NULL
penicillin	NULL
and	NULL
50	NULL
pg	NULL
of	NULL
streptomycin	NULL
per	NULL
ml	NULL
,	NULL
and	NULL
2	NULL
mM	NULL
glutamine	NULL
at	NULL
37°C	NULL
in	NULL
a	NULL
95	NULL
%	NULL
air-5	NULL
%	NULL
CO	NULL
;	NULL
atmosphere	NULL
and	NULL
were	NULL
maintained	NULL
at	NULL
a	NULL
density	NULL
of	NULL
0.25	NULL
x	NULL
10°	NULL
to	NULL
1	NULL
x	NULL
10°	NULL
cells	NULL
per	NULL
ml	NULL
(	NULL
exponential	NULL
growth	NULL
phase	NULL
)	NULL
.	NULL

HeLa	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
Dulbecco	NULL
modified	NULL
Eagle	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
and	NULL
HeLaS3	NULL
cells	NULL
in	NULL
minimal	NULL
essential	NULL
medium	NULL
supplemented	NULL
with	NULL
5	NULL
%	NULL
horse	NULL
serum	NULL
.	NULL

When	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
spinner	NULL
flasks	NULL
,	NULL
medium	NULL
was	NULL
supplemented	NULL
with	NULL
15	NULL
mM	NULL
HEPES	NULL
(	NULL
N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic	NULL
acid	NULL
;	NULL
pH	NULL
7.3	NULL
)	NULL
.	NULL

When	NULL
indicated	NULL
,	NULL
cells	NULL
were	NULL
treated	NULL
for	NULL
12	NULL
h	NULL
with	NULL
10	NULL
nM	NULL
TPA	NULL
dissolved	NULL
in	NULL
dimethyl	NULL
sulfoxide	NULL
(	NULL
final	NULL
concentra-tion	NULL
,	NULL
0.01	NULL
%	NULL
)	NULL
or	NULL
with	NULL
dimethyl	NULL
sulfoxide	NULL
alone	NULL
(	NULL
final	NULL
concentra-tion	NULL
,	NULL
0.01	NULL
%	NULL
)	NULL
as	NULL
a	NULL
control	NULL
.	NULL

Indirect	NULL
end-labeling	NULL
technique	NULL
.	NULL

The	NULL
indirect	NULL
end-labeling	NULL
technique	NULL
was	NULL
performed	NULL
essentially	NULL
as	NULL
previously	NULL
described	NULL
by	NULL
our	NULL
laboratory	NULL
(	NULL
82	NULL
,	NULL
84	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
nuclei	NULL
were	NULL
purified	NULL
from	NULL
exponentially	NULL
growing	NULL
cells	NULL
.	NULL

DNase	NULL
I	NULL
and	NULL
micrococcal	NULL
nuclease	NULL
digestions	NULL
were	NULL
performed	NULL
in	NULL
situ	NULL
on	NULL
intact	NULL
nuclei	NULL
,	NULL
and	NULL
DNA	NULL
was	NULL
extracted	NULL
and	NULL
purified	NULL
.	NULL

Control	NULL
genomic	NULL
DNA	NULL
was	NULL
purified	NULL
,	NULL
and	NULL
nuclease	NULL
treatment	NULL
of	NULL
naked	NULL
DNA	NULL
was	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
82	NULL
,	NULL
84	NULL
)	NULL
.	NULL

Southern	NULL
blotting	NULL
was	NULL
carried	NULL
out	NULL
as	NULL
described	NULL
elsewhere	NULL
(	NULL
82	NULL
,	NULL
84	NULL
)	NULL
,	NULL
with	NULL
the	NULL
following	NULL
modifications	NULL
.	NULL

Purified	NULL
DNA	NULL
(	NULL
30	NULL
mg	NULL
)	NULL
was	NULL
digested	NULL
with	NULL
EcoRI	NULL
,	NULL
and	NULL
the	NULL
fragments	NULL
generated	NULL
were	NULL
separated	NULL
by	NULL
electrophoresis	NULL
in	NULL
1.5	NULL
%	NULL
agarose	NULL
gels	NULL
in	NULL
1	NULL
X	NULL
TBE	NULL
buffer	NULL
(	NULL
90	NULL
mM	NULL
Tris-HCI	NULL
,	NULL
90	NULL
mM	NULL
boric	NULL
acid	NULL
,	NULL
2	NULL
mM	NULL
EDTA	NULL
[	NULL
pH	NULL
8.3	NULL
]	NULL
)	NULL
at	NULL
1.5	NULL
V/cm	NULL
.	NULL

Size	NULL
markers	NULL
were	NULL
electrophoresed	NULL
along	NULL
with	NULL
the	NULL
samples	NULL
.	NULL

Each	NULL
size	NULL
marker	NULL
was	NULL
generated	NULL
by	NULL
digesting	NULL
HIV-1	NULL
,	NULL
;	NULL
,	NULL
.	NULL

,	NULL
;	NULL
DNA	NULL
(	NULL
cloned	NULL
in	NULL
plasmid	NULL
pNL4-3	NULL
[	NULL
1	NULL
]	NULL
)	NULL
with	NULL
EcoRI	NULL
and	NULL
another	NULL
enzyme	NULL
chosen	NULL
to	NULL
generate	NULL
a	NULL
fragment	NULL
of	NULL
defined	NULL
size	NULL
and	NULL
location	NULL
in	NULL
the	NULL
region	NULL
under	NULL
study	NULL
.	NULL

Several	NULL
of	NULL
these	NULL
markers	NULL
were	NULL
mixed	NULL
together	NULL
,	NULL
added	NULL
to	NULL
30	NULL
ug	NULL
of	NULL
cellular	NULL
DNA	NULL
,	NULL
and	NULL
coelectropho-resed	NULL
with	NULL
the	NULL
samples	NULL
.	NULL

After	NULL
electrophoresis	NULL
,	NULL
gels	NULL
were	NULL
incubated	NULL
in	NULL
denaturing	NULL
solution	NULL
and	NULL
then	NULL
in	NULL
neutralizing	NULL
solution	NULL
and	NULL
were	NULL
transferred	NULL
by	NULL
capillarity	NULL
to	NULL
a	NULL
nylon	NULL
membrane	NULL
.	NULL

DNA	NULL
was	NULL
cross-linked	NULL
to	NULL
nylon	NULL
membranes	NULL
by	NULL
exposure	NULL
to	NULL
UV	NULL
light	NULL
.	NULL

The	NULL
membranes	NULL
were	NULL
washed	NULL
and	NULL
prehybridized	NULL
.	NULL

A	NULL
probe	NULL
spanning	NULL
nt	NULL
5063	NULL
to	NULL
5743	NULL
(	NULL
coordinates	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
NYS5	NULL
provirus	NULL
,	NULL
where	NULL
nt	NULL
+1	NULL
is	NULL
the	NULL
first	NULL
nucleotide	NULL
in	NULL
the	NULL
5-LTR	NULL
U3	NULL
region	NULL
)	NULL
was	NULL
synthesized	NULL
by	NULL
15	NULL
cycles	NULL
(	NULL
95°C	NULL
for	NULL
2	NULL
min	NULL
,	NULL
55°C	NULL
for	NULL
2	NULL
min	NULL
,	NULL
and	NULL
72°C	NULL
for	NULL
3	NULL
min	NULL
)	NULL
of	NULL
PCR	NULL
using	NULL
1	NULL
ng	NULL
of	NULL
a	NULL
plasmid	NULL
containing	NULL
a	NULL
complete	NULL
molecular	NULL
clone	NULL
of	NULL
HIV-1	NULL
(	NULL
pBRU2	NULL
)	NULL
as	NULL
a	NULL
template	NULL
and	NULL
primers	NULL
EV173	NULL
and	NULL
EV174	NULL
.	NULL

The	NULL
sequences	NULL
of	NULL
the	NULL
primers	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
EV173	NULL
,	NULL
5°	NULL
(	NULL
nt	NULL
5743	NULL
)	NULL
-CTTATTA	NULL
TGGCTTCCACTCCTGC-3	NULL
'	NULL
;	NULL
and	NULL
EV	NULL
174	NULL
,	NULL
5	NULL
``	NULL
(	NULL
nt	NULL
5063	NULL
)	NULL
-TGAT	NULL
TGTGTGGCAAGTAGACAGG-3	NULL
'	NULL
.	NULL

The	NULL
amplified	NULL
DNA	NULL
fragment	NULL
was	NULL
labeled	NULL
by	NULL
the	NULL
random	NULL
primer	NULL
reaction	NULL
(	NULL
25	NULL
)	NULL
and	NULL
was	NULL
purified	NULL
on	NULL
a	NULL
Sephadex	NULL
G-50	NULL
column	NULL
.	NULL

The	NULL
denatured	NULL
DNA	NULL
DNA-BINDING	NULL
MOTIFS	NULL
IN	NULL
THE	NULL
HIV-1	NULL
po	NULL
!	NULL

GENE	NULL
2633	NULL
probe	NULL
was	NULL
added	NULL
to	NULL
the	NULL
prehybridization	NULL
buffer	NULL
and	NULL
allowed	NULL
to	NULL
hybridize	NULL
for	NULL
at	NULL
least	NULL
16	NULL
h	NULL
at	NULL
42°C	NULL
.	NULL

After	NULL
hybridization	NULL
,	NULL
the	NULL
membranes	NULL
were	NULL
washed	NULL
and	NULL
exposed	NULL
for	NULL
autoradiography	NULL
.	NULL

Plasmid	NULL
constructs	NULL
.	NULL

Recombinant	NULL
DNA	NULL
techniques	NULL
were	NULL
performed	NULL
according	NULL
to	NULL
the	NULL
methods	NULL
described	NULL
by	NULL
Sambrook	NULL
et	NULL
al	NULL
.	NULL

(	NULL
71	NULL
)	NULL
and	NULL
Ausubel	NULL
et	NULL
al	NULL
.	NULL

(	NULL
6	NULL
)	NULL
.	NULL

To	NULL
create	NULL
plasmids	NULL
used	NULL
in	NULL
DNase	NULL
I	NULL
footprinting	NULL
analysis	NULL
,	NULL
five	NULL
overlapping	NULL
fragments	NULL
(	NULL
nt	NULL
4346	NULL
to	NULL
4521	NULL
,	NULL
nt	NULL
4391	NULL
to	NULL
4564	NULL
,	NULL
nt	NULL
4491	NULL
to	NULL
4668	NULL
,	NULL
nt	NULL
4601	NULL
to	NULL
4782	NULL
,	NULL
and	NULL
nt	NULL
4731	NULL
to	NULL
4962	NULL
[	NULL
coordinates	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
NYS5	NULL
provirus	NULL
]	NULL
)	NULL
were	NULL
generated	NULL
by	NULL
PCR	NULL
amplification	NULL
with	NULL
the	NULL
HIV-	NULL
!	NULL

;	NULL
y	NULL
»	NULL
,	NULL
genome	NULL
as	NULL
a	NULL
template	NULL
and	NULL
were	NULL
directly	NULL
cloned	NULL
in	NULL
the	NULL
vector	NULL
pCR1000	NULL
according	NULL
to	NULL
the	NULL
specifications	NULL
of	NULL
the	NULL
manufacturer	NULL
(	NULL
TA	NULL
cloning	NULL
kit	NULL
;	NULL
Invitrogen	NULL
Corporation	NULL
)	NULL
.	NULL

Re-combinants	NULL
with	NULL
fragments	NULL
inserted	NULL
in	NULL
the	NULL
antisense	NULL
orientation	NULL
were	NULL
selected	NULL
and	NULL
designated	NULL
pHXB2	NULL
(	NULL
4346-4521	NULL
)	NULL
,	NULL
pHXB2	NULL
(	NULL
4391-4564	NULL
)	NULL
,	NULL
pHXB2	NULL
(	NULL
4491-4668	NULL
)	NULL
,	NULL
pHXB2	NULL
(	NULL
4601-4782	NULL
)	NULL
,	NULL
and	NULL
pHXB2	NULL
(	NULL
4731-4962	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

A	NULL
793-bp	NULL
fragment	NULL
containing	NULL
the	NULL
HIV-1	NULL
;	NULL
a	NULL
,	NULL
5'-LTR	NULL
(	NULL
nt	NULL
1	NULL
to	NULL
792	NULL
)	NULL
was	NULL
generated	NULL
by	NULL
PCR	NULL
amplification	NULL
with	NULL
pBRU2	NULL
as	NULL
a	NULL
template	NULL
.	NULL

The	NULL
amplified	NULL
fragment	NULL
was	NULL
digested	NULL
by	NULL
Psfl	NULL
(	NULL
site	NULL
added	NULL
in	NULL
the	NULL
5	NULL
``	NULL
primer	NULL
)	NULL
and	NULL
Xbal	NULL
(	NULL
site	NULL
added	NULL
in	NULL
the	NULL
3	NULL
'	NULL
primer	NULL
)	NULL
after	NULL
gel	NULL
purification	NULL
and	NULL
was	NULL
ligated	NULL
to	NULL
the	NULL
Psfl-Xbal-re-stricted	NULL
vector	NULL
pCATBASIC	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

The	NULL
resulting	NULL
plasmid	NULL
was	NULL
designated	NULL
pLTR	NULL
.	NULL

PCR	NULL
was	NULL
used	NULL
to	NULL
amplify	NULL
the	NULL
pol	NULL
gene	NULL
fragment	NULL
(	NULL
nt	NULL
4481	NULL
to	NULL
4982	NULL
)	NULL
corresponding	NULL
to	NULL
the	NULL
nuclease-hypersensitive	NULL
region	NULL
from	NULL
the	NULL
provirus	NULL
integrated	NULL
in	NULL
U1	NULL
cells	NULL
.	NULL

BamHI	NULL
sites	NULL
were	NULL
introduced	NULL
in	NULL
the	NULL
PCR	NULL
primers	NULL
,	NULL
and	NULL
the	NULL
BamHI-restricted	NULL
PCR	NULL
fragment	NULL
was	NULL
cloned	NULL
in	NULL
the	NULL
unique	NULL
BamHI	NULL
site	NULL
of	NULL
pLTR	NULL
,	NULL
placing	NULL
the	NULL
fragment	NULL
downstream	NULL
of	NULL
the	NULL
5'-LTR-cat	NULL
transcriptional	NULL
unit	NULL
.	NULL

The	NULL
5	NULL
'	NULL
primer	NULL
oligonucleotide	NULL
encompassed	NULL
the	NULL
coding	NULL
strand	NULL
sequence	NULL
from	NULL
nt	NULL
4481	NULL
to	NULL
4505	NULL
and	NULL
contained	NULL
added	NULL
overlapping	NULL
BamHI	NULL
and	NULL
Xhol	NULL
restriction	NULL
sites	NULL
(	NULL
underlined	NULL
and	NULL
designed	NULL
in	NULL
boldface	NULL
,	NULL
respectively	NULL
)	NULL
at	NULL
the	NULL
5°	NULL
end	NULL
(	NULL
5'-CGGGATCCTCGAE	NULL
[	NULL
nt	NULL
-	NULL
4481	NULL
]	NULL
GAAGCAGAAGTAATTC	NULL
CAGCAGAG-3	NULL
'	NULL
)	NULL
.	NULL

The	NULL
3	NULL
'	NULL
primer	NULL
oligonucleotide	NULL
encompassed	NULL
the	NULL
complementary	NULL
sequence	NULL
of	NULL
the	NULL
po	NULL
!	NULL

gene	NULL
from	NULL
nt	NULL
4957	NULL
to	NULL
4982	NULL
and	NULL
contained	NULL
an	NULL
added	NULL
BamHI	NULL
site	NULL
(	NULL
underlined	NULL
)	NULL
at	NULL
the	NULL
5	NULL
end	NULL
(	NULL
5-CGGGATCCT	NULL
[	NULL
nt	NULL
4982	NULL
]	NULL
ATTACTACTGC	NULL
CCCTTCACCTTTCC-3	NULL
'	NULL
)	NULL
.	NULL

Amplification	NULL
reactions	NULL
were	NULL
conducted	NULL
with	NULL
1	NULL
pug	NULL
of	NULL
U1	NULL
genomic	NULL
DNA	NULL
according	NULL
to	NULL
the	NULL
protocol	NULL
provided	NULL
with	NULL
the	NULL
AmpliTaq	NULL
DNA	NULL
polymerase	NULL
(	NULL
Per-kin-Elmer	NULL
Cetus	NULL
)	NULL
,	NULL
using	NULL
a	NULL
Perkin-Elmer	NULL
Cetus	NULL
thermal	NULL
cycler	NULL
.	NULL

Recombinant	NULL
plasmids	NULL
containing	NULL
the	NULL
U1	NULL
fragment	NULL
(	NULL
nt	NULL
4481	NULL
to	NULL
4982	NULL
)	NULL
inserted	NULL
in	NULL
the	NULL
sense	NULL
(	NULL
S	NULL
)	NULL
and	NULL
antisense	NULL
(	NULL
AS	NULL
)	NULL
orientations	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
transcriptional	NULL
unit	NULL
were	NULL
designated	NULL
pLTR-U1	NULL
,	NULL
,	NULL
(	NULL
S8	NULL
)	NULL
and	NULL
pLTR-U1	NULL
,	NULL
(	NULL
AS	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

To	NULL
create	NULL
pLTR-U1s	NULL
,	NULL
,	NULL
(	NULL
S	NULL
)	NULL
and	NULL
pLTR-U1s	NULL
,	NULL
,	NULL
(	NULL
AS	NULL
)	NULL
,	NULL
which	NULL
contain	NULL
a	NULL
smaller	NULL
pol	NULL
gene	NULL
fragment	NULL
from	NULL
the	NULL
U1	NULL
provirus	NULL
(	NULL
nt	NULL
4481	NULL
to	NULL
4777	NULL
)	NULL
in	NULL
the	NULL
S	NULL
and	NULL
AS	NULL
orientations	NULL
,	NULL
respectively	NULL
,	NULL
the	NULL
U1	NULL
fragment	NULL
containing	NULL
this	NULL
region	NULL
was	NULL
amplified	NULL
by	NULL
PCR	NULL
from	NULL
U1	NULL
genomic	NULL
DNA	NULL
.	NULL

The	NULL
5	NULL
'	NULL
primer	NULL
was	NULL
as	NULL
described	NULL
above	NULL
.	NULL

The	NULL
3	NULL
'	NULL
primer	NULL
oligonucleotide	NULL
encompassed	NULL
the	NULL
complementary	NULL
sequence	NULL
of	NULL
the	NULL
po	NULL
!	NULL

gene	NULL
from	NULL
nt	NULL
4752	NULL
to	NULL
4777	NULL
and	NULL
contained	NULL
added	NULL
overlapping	NULL
BamHI	NULL
and	NULL
NdeI	NULL
restriction	NULL
sites	NULL
(	NULL
underlined	NULL
and	NULL
designed	NULL
in	NULL
boldface	NULL
,	NULL
respectively	NULL
)	NULL
at	NULL
the	NULL
5°	NULL
end	NULL
(	NULL
5'-CGGGATCCATAT	NULL
[	NULL
nt	NULL
4777	NULL
]	NULL
GGATGAATACTGCCATTTGTACTGC-3	NULL
'	NULL
)	NULL
.	NULL

To	NULL
test	NULL
the	NULL
potential	NULL
promoter	NULL
activity	NULL
of	NULL
the	NULL
U1	NULL
pol	NULL
gene-hypersensitive	NULL
region	NULL
,	NULL
the	NULL
large	NULL
fragment	NULL
extending	NULL
from	NULL
nt	NULL
4481	NULL
to	NULL
4982	NULL
was	NULL
also	NULL
cloned	NULL
in	NULL
pCATBASIC	NULL
.	NULL

The	NULL
5	NULL
'	NULL
primer	NULL
was	NULL
as	NULL
described	NULL
above	NULL
,	NULL
and	NULL
the	NULL
3	NULL
'	NULL
primer	NULL
encompassed	NULL
the	NULL
complementary	NULL
sequence	NULL
of	NULL
the	NULL
pol	NULL
!	NULL

gene	NULL
from	NULL
nt	NULL
4957	NULL
to	NULL
4982	NULL
with	NULL
an	NULL
additional	NULL
Xbal	NULL
restriction	NULL
site	NULL
(	NULL
underlined	NULL
)	NULL
at	NULL
the	NULL
5	NULL
'	NULL
end	NULL
(	NULL
5-GCTCTAGAT	NULL
{	NULL
nt	NULL
4982J¥ATTACTACTGCCCCT	NULL
TCACCTTTCC-3	NULL
'	NULL
)	NULL
.	NULL

Amplification	NULL
reactions	NULL
were	NULL
carried	NULL
out	NULL
2634	NULL
VAN	NULL
LINT	NULL
ET	NULL
AL	NULL
.	NULL

as	NULL
described	NULL
above	NULL
.	NULL

The	NULL
amplified	NULL
fragment	NULL
was	NULL
digested	NULL
with	NULL
Xhol	NULL
and	NULL
Xbal	NULL
and	NULL
then	NULL
ligated	NULL
into	NULL
the	NULL
Sall-Xbal	NULL
sites	NULL
of	NULL
pCATBASIC	NULL
to	NULL
generate	NULL
pIP	NULL
.	NULL

DNA	NULL
sequencing	NULL
.	NULL

All	NULL
PCR-amplified	NULL
fragments	NULL
were	NULL
sequenced	NULL
on	NULL
both	NULL
strands	NULL
by	NULL
the	NULL
dideoxynucleotide	NULL
termination	NULL
sequencing	NULL
method	NULL
(	NULL
72	NULL
)	NULL
with	NULL
Sequenase	NULL
version	NULL
2.0	NULL
(	NULL
U.S.	NULL
Biochemicals	NULL
)	NULL
.	NULL

The	NULL
nucleotide	NULL
sequence	NULL
of	NULL
the	NULL
nuclease-hypersensitive	NULL
region	NULL
in	NULL
U1	NULL
cells	NULL
was	NULL
identical	NULL
to	NULL
that	NULL
of	NULL
the	NULL
homologous	NULL
region	NULL
in	NULL
the	NULL
HIV-1	NULL
isolate	NULL
NY5	NULL
.	NULL

For	NULL
this	NULL
reason	NULL
,	NULL
the	NULL
base	NULL
pair	NULL
coordinates	NULL
of	NULL
the	NULL
U1	NULL
intragenic	NULL
region	NULL
were	NULL
numbered	NULL
according	NULL
to	NULL
the	NULL
NYS	NULL
sequence	NULL
(	NULL
where	NULL
nt	NULL
+1	NULL
is	NULL
the	NULL
start	NULL
of	NULL
U3	NULL
in	NULL
the	NULL
5'-LTR	NULL
)	NULL
.	NULL

Transfection	NULL
and	NULL
CAT	NULL
assays	NULL
.	NULL

Plasmids	NULL
were	NULL
grown	NULL
in	NULL
Escherichia	NULL
coli	NULL
HB1O1	NULL
and	NULL
purified	NULL
by	NULL
the	NULL
QUIAGEN	NULL
procedure	NULL
(	NULL
QUIAGEN	NULL
,	NULL
Inc.	NULL
,	NULL
Chatsworth	NULL
,	NULL
Calif.	NULL
)	NULL
and	NULL
then	NULL
by	NULL
two	NULL
phenol-chloroform	NULL
extractions	NULL
and	NULL
ethanol	NULL
precipitation	NULL
.	NULL

Transient	NULL
transfection	NULL
assays	NULL
were	NULL
carried	NULL
out	NULL
by	NULL
using	NULL
the	NULL
DEAE-dextran	NULL
procedure	NULL
(	NULL
6	NULL
)	NULL
with	NULL
a	NULL
Rous	NULL
sarcoma	NULL
virus	NULL
(	NULL
RSV	NULL
)	NULL
LTR-luciferase	NULL
construct	NULL
(	NULL
a	NULL
gift	NULL
from	NULL
L.	NULL
Hudson	NULL
)	NULL
as	NULL
an	NULL
internal	NULL
control	NULL
for	NULL
transfection	NULL
efficiency	NULL
in	NULL
early	NULL
experiments	NULL
.	NULL

Five	NULL
micrograms	NULL
of	NULL
control	NULL
plasmid	NULL
(	NULL
pLTR	NULL
or	NULL
pCATBASIC	NULL
)	NULL
or	NULL
equimolar	NULL
amounts	NULL
of	NULL
the	NULL
different	NULL
constructs	NULL
were	NULL
used	NULL
to	NULL
transfect	NULL
10	NULL
``	NULL
cells	NULL
.	NULL

When	NULL
indicated	NULL
,	NULL
0.5	NULL
mg	NULL
of	NULL
Tat	NULL
expression	NULL
vector	NULL
pSV	NULL
,	NULL
tat	NULL
(	NULL
AIDS	NULL
Research	NULL
Reagent	NULL
Program	NULL
,	NULL
NIAID	NULL
)	NULL
containing	NULL
the	NULL
tat	NULL
gene	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
simian	NULL
virus	NULL
40	NULL
(	NULL
SV40	NULL
)	NULL
early	NULL
promoter	NULL
region	NULL
was	NULL
cotransfected	NULL
with	NULL
the	NULL
plasmids	NULL
.	NULL

At	NULL
42	NULL
to	NULL
48	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
harvested	NULL
,	NULL
washed	NULL
once	NULL
with	NULL
phosphate-buffered	NULL
saline	NULL
,	NULL
and	NULL
resuspended	NULL
in	NULL
150	NULL
pt	NULL
of	NULL
0.25	NULL
M	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
7.8	NULL
)	NULL
.	NULL

Cell	NULL
extracts	NULL
were	NULL
prepared	NULL
by	NULL
three	NULL
cycles	NULL
of	NULL
freezing-thawing	NULL
(	NULL
-70°C-37°C	NULL
)	NULL
and	NULL
then	NULL
by	NULL
incubation	NULL
at	NULL
67°C	NULL
for	NULL
7	NULL
min	NULL
.	NULL

Protein	NULL
concentrations	NULL
were	NULL
determined	NULL
with	NULL
the	NULL
Bio-Rad	NULL
protein	NULL
determination	NULL
kit	NULL
and	NULL
gamma	NULL
globulin	NULL
as	NULL
a	NULL
standard	NULL
.	NULL

CAT	NULL
(	NULL
chloramphenicol	NULL
acetyltransferase	NULL
)	NULL
enzyme	NULL
activities	NULL
were	NULL
determined	NULL
by	NULL
the	NULL
diffusion	NULL
CAT	NULL
assay	NULL
method	NULL
(	NULL
59	NULL
)	NULL
with	NULL
equivalent	NULL
amounts	NULL
of	NULL
protein	NULL
extract	NULL
(	NULL
1	NULL
to	NULL
5	NULL
ug	NULL
,	NULL
depending	NULL
on	NULL
the	NULL
cell	NULL
line	NULL
used	NULL
)	NULL
in	NULL
250	NULL
pl	NULL
of	NULL
100	NULL
mM	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
7.8	NULL
)	NULL
containing	NULL
0.5	NULL
pCi	NULL
of	NULL
coenzyme	NULL
A	NULL
(	NULL
200	NULL
mCi/mmol	NULL
;	NULL
Dupont-New	NULL
England	NULL
Nuclear	NULL
)	NULL
and	NULL
1	NULL
mM	NULL
chloramphenicol	NULL
.	NULL

Each	NULL
sample	NULL
was	NULL
placed	NULL
under	NULL
5	NULL
ml	NULL
of	NULL
Econofluor	NULL
(	NULL
Dupont-New	NULL
England	NULL
Nuclear	NULL
)	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
and	NULL
scintillation	NULL
counting	NULL
was	NULL
performed	NULL
every	NULL
hour	NULL
for	NULL
4	NULL
h.	NULL
Six	NULL
to	NULL
eight	NULL
independent	NULL
transfections	NULL
were	NULL
performed	NULL
with	NULL
two	NULL
separately	NULL
prepared	NULL
plasmid	NULL
stocks	NULL
.	NULL

DNA-protein	NULL
interaction	NULL
analyses	NULL
.	NULL

(	NULL
i	NULL
)	NULL
Electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSAs	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
according	NULL
to	NULL
the	NULL
method	NULL
described	NULL
by	NULL
Dignam	NULL
et	NULL
al	NULL
.	NULL

(	NULL
19	NULL
)	NULL
with	NULL
modifications	NULL
(	NULL
2	NULL
)	NULL
.	NULL

To	NULL
minimize	NULL
proteolysis	NULL
,	NULL
all	NULL
buffers	NULL
included	NULL
the	NULL
following	NULL
protease	NULL
inhibitors	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
)	NULL
:	NULL
10	NULL
ug	NULL
of	NULL
antipain	NULL
,	NULL
2	NULL
ug	NULL
of	NULL
aprotinin	NULL
,	NULL
10	NULL
pg	NULL
of	NULL
chymostatin	NULL
,	NULL
1	NULL
mg	NULL
of	NULL
leupeptin	NULL
,	NULL
and	NULL
1	NULL
wg	NULL
of	NULL
pepstatin	NULL
per	NULL
ml	NULL
.	NULL

Protein	NULL
concentrations	NULL
were	NULL
determined	NULL
by	NULL
the	NULL
Bradford	NULL
method	NULL
(	NULL
10	NULL
)	NULL
by	NULL
using	NULL
the	NULL
Bio-Rad	NULL
protein	NULL
assay	NULL
with	NULL
bovine	NULL
plasma	NULL
gamma	NULL
globulin	NULL
as	NULL
the	NULL
standard	NULL
.	NULL

Oligonucleotides	NULL
were	NULL
synthesized	NULL
on	NULL
an	NULL
Applied	NULL
Biosys-tems	NULL
A380	NULL
synthesizer	NULL
by	NULL
the	NULL
phosphoroamidate	NULL
method	NULL
and	NULL
were	NULL
purified	NULL
on	NULL
denaturing	NULL
polyacrylamide	NULL
gels	NULL
and	NULL
Sep-Pak	NULL
cartridges	NULL
for	NULL
solid-phase	NULL
extraction	NULL
(	NULL
Waters	NULL
,	NULL
Millipore	NULL
,	NULL
Mass	NULL
.	NULL
)	NULL

(	NULL
71	NULL
)	NULL
.	NULL

The	NULL
concentration	NULL
of	NULL
single-stranded	NULL
oligonucleotides	NULL
was	NULL
determined	NULL
according	NULL
to	NULL
the	NULL
method	NULL
described	NULL
by	NULL
Sambrook	NULL
et	NULL
al	NULL
.	NULL

(	NULL
71	NULL
)	NULL
after	NULL
measurement	NULL
of	NULL
the	NULL
A4	NULL
;	NULL
,	NULL
,	NULL
.	NULL

The	NULL
DNA	NULL
sequences	NULL
of	NULL
the	NULL
coding	NULL
strands	NULL
of	NULL
oligonucleotides	NULL
used	NULL
in	NULL
this	NULL
study	NULL
are	NULL
listed	NULL
in	NULL
Table	NULL
1	NULL
.	NULL

EMSAs	NULL
were	NULL
performed	NULL
with	NULL
modifications	NULL
of	NULL
previously	NULL
described	NULL
procedures	NULL
(	NULL
2	NULL
,	NULL
81	NULL
)	NULL
.	NULL

Double-stranded	NULL
oligonucleo-	NULL
J.	NULL
Viror	NULL
.	NULL

tides	NULL
were	NULL
5	NULL
'	NULL
end	NULL
labeled	NULL
with	NULL
[	NULL
y-°	NULL
``	NULL
P	NULL
]	NULL
ATP	NULL
(	NULL
>	NULL
5,000	NULL
Ci/mmol	NULL
;	NULL
Amersham	NULL
)	NULL
and	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
,	NULL
purified	NULL
after	NULL
isolation	NULL
from	NULL
polyacrylamide	NULL
gels	NULL
,	NULL
and	NULL
used	NULL
as	NULL
probes	NULL
.	NULL

The	NULL
typical	NULL
protein-DNA	NULL
binding	NULL
reactions	NULL
were	NULL
carried	NULL
out	NULL
as	NULL
follows	NULL
.	NULL

Nuclear	NULL
extract	NULL
(	NULL
10	NULL
to	NULL
15	NULL
pug	NULL
of	NULL
protein	NULL
)	NULL
was	NULL
first	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
10	NULL
min	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
probe	NULL
and	NULL
specific	NULL
competitor	NULL
DNA	NULL
in	NULL
a	NULL
16-pl	NULL
reaction	NULL
mixture	NULL
containing	NULL
10	NULL
g	NULL
of	NULL
DNase-free	NULL
bovine	NULL
serum	NULL
albumin	NULL
(	NULL
Pharmacia	NULL
)	NULL
,	NULL
1	NULL
to	NULL
2	NULL
wg	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
(	NULL
Pharmacia	NULL
)	NULL
as	NULL
nonspecific	NULL
competitor	NULL
DNA	NULL
,	NULL
50	NULL
wM	NULL
ZnCl	NULL
;	NULL
,	NULL
,	NULL
0.25	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
20	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.3	NULL
)	NULL
,	NULL
60	NULL
mM	NULL
KCI	NULL
,	NULL
1	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
,	NULL
and	NULL
10	NULL
%	NULL
(	NULL
vol/vol	NULL
)	NULL
glycerol	NULL
.	NULL

A	NULL
total	NULL
of	NULL
10,000	NULL
to	NULL
20,000	NULL
cpm	NULL
of	NULL
probe	NULL
(	NULL
10	NULL
to	NULL
40	NULL
fmol	NULL
)	NULL
was	NULL
then	NULL
added	NULL
to	NULL
the	NULL
mixture	NULL
with	NULL
or	NULL
without	NULL
a	NULL
molar	NULL
excess	NULL
of	NULL
an	NULL
unlabeled	NULL
competitor	NULL
,	NULL
and	NULL
the	NULL
mixture	NULL
was	NULL
incubated	NULL
for	NULL
15	NULL
min	NULL
on	NULL
ice	NULL
.	NULL

The	NULL
reaction	NULL
mixture	NULL
was	NULL
loaded	NULL
directly	NULL
onto	NULL
a	NULL
6	NULL
%	NULL
nondenaturing	NULL
polyacrylamide	NULL
gel	NULL
which	NULL
had	NULL
been	NULL
pre-electrophoresed	NULL
for	NULL
1	NULL
h	NULL
at	NULL
150	NULL
V.	NULL
Samples	NULL
were	NULL
electrophoresed	NULL
at	NULL
room	NULL
temperature	NULL
at	NULL
150	NULL
V	NULL
for	NULL
2	NULL
to	NULL
3	NULL
h	NULL
in	NULL
1	NULL
%	NULL
TGE	NULL
buffer	NULL
(	NULL
25	NULL
mM	NULL
Tris-acetate	NULL
[	NULL
pH	NULL
8.3	NULL
]	NULL
,	NULL
190	NULL
mM	NULL
glycine	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
)	NULL
.	NULL

Gels	NULL
were	NULL
dried	NULL
,	NULL
and	NULL
autoradiographic	NULL
exposures	NULL
were	NULL
carried	NULL
out	NULL
with	NULL
Kodak	NULL
XAR-Omat	NULL
films	NULL
for	NULL
16	NULL
to	NULL
24	NULL
h	NULL
at	NULL
-70°C	NULL
with	NULL
two	NULL
intensifying	NULL
screens	NULL
.	NULL

For	NULL
each	NULL
oligonucleotide	NULL
probe	NULL
tested	NULL
,	NULL
a	NULL
range	NULL
of	NULL
protein	NULL
and	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
concentrations	NULL
was	NULL
used	NULL
in	NULL
preliminary	NULL
experiments	NULL
.	NULL

For	NULL
analysis	NULL
of	NULL
Ets1	NULL
binding	NULL
,	NULL
whole-cell	NULL
extracts	NULL
of	NULL
Spodopt-era	NULL
frugiperda	NULL
SF9	NULL
cells	NULL
infected	NULL
with	NULL
a	NULL
recombinant	NULL
Ac-NPV-Ets1	NULL
baculovirus	NULL
(	NULL
9	NULL
)	NULL
were	NULL
used	NULL
as	NULL
a	NULL
source	NULL
for	NULL
Ets1	NULL
protein	NULL
,	NULL
and	NULL
extracts	NULL
from	NULL
uninfected	NULL
insect	NULL
cells	NULL
were	NULL
used	NULL
as	NULL
a	NULL
control	NULL
.	NULL

Conditions	NULL
for	NULL
EMSA	NULL
were	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
9	NULL
)	NULL
.	NULL

For	NULL
analysis	NULL
of	NULL
PU.1	NULL
binding	NULL
,	NULL
whole-cell	NULL
lysates	NULL
of	NULL
COS1	NULL
cells	NULL
transfected	NULL
with	NULL
AEB-PU.1	NULL
,	NULL
an	NULL
SV40	NULL
promoter-based	NULL
expression	NULL
vector	NULL
for	NULL
human	NULL
PU.1/Spi-1	NULL
(	NULL
68	NULL
)	NULL
,	NULL
were	NULL
utilized	NULL
.	NULL

At	NULL
48	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
pelleted	NULL
cells	NULL
were	NULL
lysed	NULL
on	NULL
ice	NULL
for	NULL
15	NULL
min	NULL
in	NULL
3	NULL
volumes	NULL
of	NULL
a	NULL
solution	NULL
containing	NULL
10	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
0.3	NULL
M	NULL
NaCl	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
0.5	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
10	NULL
pg	NULL
of	NULL
leupeptin	NULL
per	NULL
ml	NULL
,	NULL
1	NULL
%	NULL
aprotinin	NULL
(	NULL
Sigma	NULL
)	NULL
,	NULL
and	NULL
100	NULL
pg	NULL
of	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
per	NULL
ml	NULL
and	NULL
centrifuged	NULL
for	NULL
15	NULL
min	NULL
at	NULL
12,000	NULL
x	NULL
g.	NULL
An	NULL
aliquot	NULL
of	NULL
the	NULL
supernatant	NULL
fraction	NULL
(	NULL
approximately	NULL
2	NULL
ug	NULL
of	NULL
total	NULL
protein	NULL
)	NULL
was	NULL
used	NULL
in	NULL
EMSAs	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
68	NULL
)	NULL
.	NULL

Extracts	NULL
of	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
empty	NULL
AEB	NULL
expression	NULL
vector	NULL
were	NULL
used	NULL
as	NULL
a	NULL
control	NULL
.	NULL

(	NULL
ii	NULL
)	NULL
DNase	NULL
I	NULL
footprinting	NULL
assays	NULL
.	NULL

End-labeled	NULL
DNA	NULL
probes	NULL
were	NULL
prepared	NULL
either	NULL
by	NULL
filling	NULL
in	NULL
with	NULL
the	NULL
Klenow	NULL
fragment	NULL
of	NULL
DNA	NULL
polymerase	NULL
I	NULL
or	NULL
by	NULL
5'-end	NULL
phosphorylation	NULL
with	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
after	NULL
dephosphorylation	NULL
with	NULL
calf	NULL
intestinal	NULL
alkaline	NULL
phosphatase	NULL
.	NULL

Probes	NULL
were	NULL
purified	NULL
by	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
,	NULL
elution	NULL
,	NULL
and	NULL
passing	NULL
through	NULL
a	NULL
NACS	NULL
52	NULL
column	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
2	NULL
)	NULL
.	NULL

DNase	NULL
I	NULL
footprinting	NULL
reactions	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
by	NULL
Dynan	NULL
(	NULL
21	NULL
)	NULL
,	NULL
with	NULL
the	NULL
following	NULL
modifications	NULL
.	NULL

A	NULL
typical	NULL
reaction	NULL
mixture	NULL
contained	NULL
20,000	NULL
cpm	NULL
of	NULL
probe	NULL
,	NULL
50	NULL
jug	NULL
of	NULL
crude	NULL
nuclear	NULL
extract	NULL
,	NULL
and	NULL
4	NULL
pg	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
(	NULL
Pharmacia	NULL
)	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
50	NULL
ul	NULL
.	NULL

The	NULL
final	NULL
ionic	NULL
composition	NULL
was	NULL
10	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
50	NULL
mM	NULL
KCI	NULL
,	NULL
0.5	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
50	NULL
wM	NULL
ZnCl	NULL
;	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
,	NULL
and	NULL
10	NULL
%	NULL
(	NULL
vol/vol	NULL
)	NULL
glycerol	NULL
.	NULL

This	NULL
mixture	NULL
was	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
15	NULL
min	NULL
.	NULL

After	NULL
binding	NULL
,	NULL
an	NULL
equal	NULL
volume	NULL
of	NULL
a	NULL
solution	NULL
containing	NULL
5	NULL
mM	NULL
CaCl	NULL
,	NULL
and	NULL
10	NULL
mM	NULL
MgCl	NULL
;	NULL
was	NULL
added	NULL
to	NULL
the	NULL
reaction	NULL
mixture	NULL
,	NULL
and	NULL
the	NULL
mixture	NULL
was	NULL
incubated	NULL
for	NULL
1	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

A	NULL
freshly	NULL
diluted	NULL
solution	NULL
of	NULL
DNase	NULL
I	NULL
(	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
)	NULL
was	NULL
added	NULL
at	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
0.1	NULL
to	NULL
20	NULL
ug/ml	NULL
.	NULL

DNase	NULL
I	NULL
digestions	NULL
were	NULL
performed	NULL
for	NULL
2	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
and	NULL
were	NULL
stopped	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
90	NULL
pl	NULL
of	NULL
a	NULL
solution	NULL
containing	NULL
0.2	NULL
M	NULL
NaCl	NULL
,	NULL
0.03	NULL
M	NULL
EDTA	NULL
,	NULL
1	NULL
%	NULL
sodium	NULL
Vor	NULL
.	NULL

68	NULL
,	NULL
1994	NULL
ho	NULL
wo	NULL
tn	NULL
DNA-BINDING	NULL
MOTIFS	NULL
IN	NULL
THE	NULL
HIV-1	NULL
po	NULL
!	NULL

GENE	NULL
6	NULL
TABLE	NULL
1	NULL
.	NULL

Oligonucleotides	NULL
used	NULL
in	NULL
EMSA	NULL
experiments	NULL
Oligonucleotide	NULL
Sequence	NULL
Source	NULL
(	NULL
genomic	NULL
position	NULL
)	NULL
``	NULL
Source	NULL
or	NULL
reference	NULL
AP-1	NULL
5-TGTTATAAAGCATGAGTCAGACACCTCTCEGCTTTCTG-3	NULL
'	NULL
Collagenase	NULL
gene	NULL
enhancer	NULL
3	NULL
(	NULL
nt	NULL
-84	NULL
to	NULL
-48	NULL
)	NULL
NF-kB	NULL
5	NULL
!	NULL

-AGTTGAGGGGACTTTCCCAGGC-3	NULL
'	NULL
SV40	NULL
enhancer	NULL
49	NULL
TCF-1	NULL
5-GACTGAGAACAAAGCGCTCTCACAC-3	NULL
``	NULL
CD3s	NULL
enhancer	NULL
(	NULL
nt	NULL
74	NULL
to	NULL
96	NULL
)	NULL
80	NULL
TCF-la	NULL
5-GATCTAGGGCACCCTTTGAAGCTCT-3	NULL
'	NULL
T-cell	NULL
receptor	NULL
«	NULL
enhancer	NULL
87	NULL
(	NULL
nt	NULL
57	NULL
to	NULL
81	NULL
)	NULL
Ets	NULL
!	NULL

(	NULL
HXB2	NULL
)	NULL
S'-AACAGGGCAGGAAACAGCATATT-3	NULL
'	NULL
HIV-	NULL
!	NULL

jiyp	NULL
>	NULL
(	NULL
nt	NULL
4505	NULL
to	NULL
4527	NULL
)	NULL
This	NULL
study	NULL
Eis	NULL
!	NULL

(	NULL
U1	NULL
)	NULL
5-GACAGGGCAAGAAACAGCATACT-3	NULL
'	NULL
HIV-1	NULL
;	NULL
;	NULL
,	NULL
(	NULL
nt	NULL
4505	NULL
to	NULL
4527	NULL
)	NULL
This	NULL
study	NULL
ETSI	NULL
5'-ATAAACAGGAAGTGGT-3	NULL
'	NULL
32	NULL
ETSImut	NULL
5'-ATAAACACCAAGTGGT-3	NULL
'	NULL
32	NULL
SV40PU.1	NULL
5'-GATCTGAAATAACCTCTGAAAGAGGAACTTGGTTAGCTA-3	NULL
'	NULL
Variant	NULL
enhancer-minus	NULL
of	NULL
SV40	NULL
45	NULL
SV40PU.1mut	NULL
5'-GATCTGAAATAACCTCTGAAACACCAACTTGGTTAGCGTA-3	NULL
'	NULL
Variant	NULL
enhancer-minus	NULL
of	NULL
SV40	NULL
45	NULL
U1	NULL
site	NULL
B	NULL
short	NULL
S'-ATACTTCCTCTTAAAATTAG-3	NULL
'	NULL
(	NULL
nt	NULL
4523	NULL
to	NULL
4542	NULL
)	NULL
This	NULL
study	NULL
U1	NULL
site	NULL
B	NULL
5-CAGCATACTTCCTCTTAAAATTAGCAG-3	NULL
'	NULL
HIV-1	NULL
;	NULL
;	NULL
,	NULL
(	NULL
nt	NULL
4519	NULL
to	NULL
4545	NULL
)	NULL
This	NULL
study	NULL
SF2	NULL
site	NULL
B	NULL
5-CAGCATATTTTCTCTTAAAATTAGCAG-3	NULL
'	NULL
HIV-13	NULL
;	NULL
;	NULL
(	NULL
nt	NULL
4519	NULL
to	NULL
4545	NULL
)	NULL
This	NULL
study	NULL
HXB2	NULL
site	NULL
B	NULL
5-CAGCATATTTTCTTTTAAAATTAGCAG-3	NULL
'	NULL
HIV-ljxp	NULL
;	NULL
(	NULL
nt	NULL
4519	NULL
to	NULL
4545	NULL
)	NULL
This	NULL
study	NULL
LAI	NULL
site	NULL
B	NULL
5-CAGCATACTTTCTTTTAAAATTAGCAG-3	NULL
'	NULL
HIV-1	NULL
;	NULL
a	NULL
,	NULL
;	NULL
(	NULL
nt	NULL
4519	NULL
to	NULL
4545	NULL
)	NULL
This	NULL
study	NULL
Site	NULL
D	NULL
5'-CAGGGGAAAGAATAGTAGACATAATAGCAACAGACA-3	NULL
'	NULL
HIV-1	NULL
;	NULL
,	NULL
,	NULL
(	NULL
nt	NULL
4816	NULL
to	NULL
4851	NULL
)	NULL
This	NULL
study	NULL
Site	NULL
C	NULL
5'-TAGAATCTATGAATAAAGAAT-3	NULL
'	NULL
HIV-1	NULL
;	NULL
,	NULL
,	NULL
(	NULL
nt	NULL
4681	NULL
to	NULL
4701	NULL
)	NULL
This	NULL
study	NULL
``	NULL
Genomic	NULL
positions	NULL
of	NULL
all	NULL
HIV-1	NULL
sequences	NULL
are	NULL
given	NULL
according	NULL
to	NULL
the	NULL
numbering	NULL
of	NULL
the	NULL
HIV-lIyys	NULL
genome	NULL
(	NULL
where	NULL
nt	NULL
+1	NULL
is	NULL
the	NULL
start	NULL
of	NULL
U3	NULL
in	NULL
the	NULL
S-LTR	NULL
)	NULL
independently	NULL
of	NULL
the	NULL
considered	NULL
isolate	NULL
.	NULL

dodecyl	NULL
sulfate	NULL
,	NULL
and	NULL
100	NULL
ug	NULL
of	NULL
yeast	NULL
tRNA	NULL
per	NULL
ml	NULL
.	NULL

Proteinase	NULL
K	NULL
was	NULL
added	NULL
to	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
200	NULL
pug/m	NULL
!	NULL

at	NULL
56°C	NULL
for	NULL
1	NULL
h.	NULL
The	NULL
DNA	NULL
was	NULL
extracted	NULL
with	NULL
phenol-chloroform	NULL
,	NULL
precipitated	NULL
with	NULL
ethanol	NULL
,	NULL
and	NULL
analyzed	NULL
by	NULL
electrophoresis	NULL
on	NULL
6	NULL
to	NULL
8	NULL
%	NULL
polyacrylamide	NULL
sequencing	NULL
gels	NULL
.	NULL

Binding	NULL
reactions	NULL
with	NULL
purified	NULL
Sp1	NULL
were	NULL
performed	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
nonspecific	NULL
competitor	NULL
DNA	NULL
according	NULL
to	NULL
the	NULL
instructions	NULL
provided	NULL
by	NULL
the	NULL
manufacturer	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

Maxam	NULL
and	NULL
Gilbert	NULL
purine	NULL
sequencing	NULL
reaction	NULL
(	NULL
51	NULL
)	NULL
products	NULL
of	NULL
the	NULL
probes	NULL
were	NULL
used	NULL
as	NULL
size	NULL
markers	NULL
.	NULL

(	NULL
iii	NULL
)	NULL
Methylation	NULL
interference	NULL
assays	NULL
.	NULL

Double-stranded	NULL
oligonucleotides	NULL
end	NULL
labeled	NULL
on	NULL
one	NULL
strand	NULL
only	NULL
were	NULL
partially	NULL
methylated	NULL
with	NULL
dimethyl	NULL
sulfate	NULL
by	NULL
standard	NULL
procedures	NULL
(	NULL
51	NULL
)	NULL
and	NULL
were	NULL
incubated	NULL
with	NULL
nuclear	NULL
extract	NULL
.	NULL

DNA-protein	NULL
complexes	NULL
were	NULL
separated	NULL
from	NULL
the	NULL
free	NULL
probe	NULL
by	NULL
EMSAs	NULL
.	NULL

The	NULL
entire	NULL
gel	NULL
was	NULL
electrophoretically	NULL
transferred	NULL
to	NULL
a	NULL
DEAE	NULL
membrane	NULL
(	NULL
NA4S	NULL
;	NULL
Schleicher	NULL
&	NULL
Schuell	NULL
)	NULL
at	NULL
28	NULL
V	NULL
(	NULL
0.8	NULL
A	NULL
)	NULL
for	NULL
30	NULL
min	NULL
.	NULL

After	NULL
electrophoretic	NULL
transfer	NULL
,	NULL
the	NULL
DEAE	NULL
membrane	NULL
was	NULL
exposed	NULL
for	NULL
autoradiography	NULL
,	NULL
and	NULL
the	NULL
relevant	NULL
bands	NULL
were	NULL
cut	NULL
.	NULL

DNA	NULL
was	NULL
eluted	NULL
at	NULL
65°C	NULL
for	NULL
1	NULL
h	NULL
in	NULL
200	NULL
pl	NULL
of	NULL
elution	NULL
buffer	NULL
(	NULL
10	NULL
mM	NULL
Tris-HCI	NULL
[	NULL
pH	NULL
8.0	NULL
]	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
[	NULL
pH	NULL
8.0	NULL
]	NULL
,	NULL
1	NULL
M	NULL
NaCl	NULL
)	NULL
.	NULL

DNA	NULL
was	NULL
purified	NULL
by	NULL
phenol-chloroform	NULL
extraction	NULL
and	NULL
ethanol	NULL
precipitation	NULL
,	NULL
resuspended	NULL
in	NULL
water	NULL
,	NULL
and	NULL
cleaved	NULL
at	NULL
the	NULL
methylated	NULL
purines	NULL
with	NULL
1	NULL
M	NULL
piperidine	NULL
for	NULL
30	NULL
min	NULL
at	NULL
90°C	NULL
.	NULL

Cleavage	NULL
products	NULL
were	NULL
separated	NULL
on	NULL
a	NULL
15	NULL
%	NULL
sequencing	NULL
gel	NULL
.	NULL

RESULTS	NULL
High-resolution	NULL
mapping	NULL
of	NULL
the	NULL
hypersensitive	NULL
site	NULL
located	NULL
in	NULL
the	NULL
pol	NULL
gene	NULL
of	NULL
HIV-1	NULL
.	NULL

Previous	NULL
study	NULL
of	NULL
HIV-1	NULL
proviral	NULL
chromatin	NULL
organization	NULL
in	NULL
chronically	NULL
infected	NULL
cell	NULL
lines	NULL
at	NULL
low	NULL
resolution	NULL
has	NULL
identified	NULL
a	NULL
major	NULL
constitutive	NULL
DNase	NULL
I-hypersensitive	NULL
site	NULL
in	NULL
the	NULL
po	NULL
!	NULL

gene	NULL
of	NULL
the	NULL
U1	NULL
cell	NULL
line	NULL
but	NULL
not	NULL
in	NULL
the	NULL
ACH2	NULL
and	NULL
8E5	NULL
cell	NULL
lines	NULL
(	NULL
82	NULL
)	NULL
.	NULL

The	NULL
fact	NULL
that	NULL
this	NULL
intragenic	NULL
hypersensitive	NULL
site	NULL
was	NULL
observed	NULL
only	NULL
in	NULL
cells	NULL
of	NULL
monocytic	NULL
origin	NULL
(	NULL
U1	NULL
)	NULL
(	NULL
27	NULL
)	NULL
and	NULL
not	NULL
in	NULL
two	NULL
cell	NULL
lines	NULL
of	NULL
lymphoid	NULL
origin	NULL
(	NULL
ACH2	NULL
and	NULL
8ES	NULL
)	NULL
(	NULL
15	NULL
,	NULL
28	NULL
)	NULL
suggested	NULL
that	NULL
a	NULL
cellular	NULL
specificity	NULL
was	NULL
associated	NULL
with	NULL
this	NULL
element	NULL
.	NULL

To	NULL
map	NULL
the	NULL
intragenic	NULL
DNase	NULL
I-hypersensitive	NULL
site	NULL
at	NULL
higher	NULL
resolution	NULL
,	NULL
this	NULL
experiment	NULL
was	NULL
repeated	NULL
with	NULL
a	NULL
new	NULL
probe	NULL
that	NULL
was	NULL
located	NULL
more	NULL
closely	NULL
to	NULL
the	NULL
hypersensitive	NULL
site	NULL
.	NULL

Purified	NULL
nuclei	NULL
from	NULL
TPA-treated	NULL
and	NULL
untreated	NULL
U1	NULL
cells	NULL
were	NULL
digested	NULL
in	NULL
vitro	NULL
with	NULL
DNase	NULL
I	NULL
or	NULL
micrococcal	NULL
nuclease	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
or	NULL
B	NULL
,	NULL
respectively	NULL
)	NULL
,	NULL
and	NULL
digestion	NULL
products	NULL
were	NULL
analyzed	NULL
by	NULL
Southern	NULL
blotting	NULL
with	NULL
indirect	NULL
end	NULL
labeling	NULL
(	NULL
82	NULL
,	NULL
84	NULL
,	NULL
92	NULL
)	NULL
.	NULL

U1	NULL
cells	NULL
were	NULL
examined	NULL
both	NULL
with	NULL
and	NULL
without	NULL
TPA	NULL
treatment	NULL
,	NULL
since	NULL
this	NULL
agent	NULL
was	NULL
previously	NULL
shown	NULL
to	NULL
induce	NULL
viral	NULL
expression	NULL
in	NULL
these	NULL
cells	NULL
(	NULL
27	NULL
)	NULL
.	NULL

The	NULL
efficiency	NULL
of	NULL
viral	NULL
induction	NULL
following	NULL
TPA	NULL
treatment	NULL
was	NULL
monitored	NULL
by	NULL
measuring	NULL
the	NULL
secreted	NULL
p24	NULL
antigen	NULL
in	NULL
the	NULL
culture	NULL
medium	NULL
.	NULL

DNase	NULL
I	NULL
digestion	NULL
of	NULL
U1	NULL
nuclei	NULL
resulted	NULL
in	NULL
the	NULL
appearance	NULL
of	NULL
two	NULL
hypersensitive	NULL
sites	NULL
(	NULL
one	NULL
major	NULL
and	NULL
one	NULL
minor	NULL
,	NULL
indicated	NULL
in	NULL
Fig	NULL
.	NULL

1A	NULL
by	NULL
arrows	NULL
I	NULL
and	NULL
II	NULL
,	NULL
respectively	NULL
)	NULL
mapping	NULL
to	NULL
the	NULL
pol	NULL
gene	NULL
.	NULL

The	NULL
exact	NULL
positions	NULL
of	NULL
these	NULL
hypersensitive	NULL
sites	NULL
in	NULL
the	NULL
viral	NULL
genome	NULL
were	NULL
determined	NULL
by	NULL
using	NULL
markers	NULL
containing	NULL
double	NULL
digestions	NULL
of	NULL
,	NULL
.	NULL

;	NULL
DNA	NULL
by	NULL
EcoRI	NULL
and	NULL
several	NULL
restriction	NULL
enzymes	NULL
throughout	NULL
the	NULL
region	NULL
.	NULL

Site	NULL
I	NULL
mapped	NULL
to	NULL
nt	NULL
4450	NULL
to	NULL
4566	NULL
,	NULL
and	NULL
site	NULL
II	NULL
,	NULL
which	NULL
was	NULL
more	NULL
clearly	NULL
detectable	NULL
after	NULL
a	NULL
longer	NULL
exposure	NULL
of	NULL
the	NULL
same	NULL
gel	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
mapped	NULL
to	NULL
nt	NULL
4701	NULL
to	NULL
4773	NULL
(	NULL
values	NULL
averaged	NULL
from	NULL
two	NULL
independent	NULL
experiments	NULL
)	NULL
.	NULL

To	NULL
prove	NULL
that	NULL
the	NULL
hypersensitive	NULL
sites	NULL
observed	NULL
were	NULL
a	NULL
consequence	NULL
of	NULL
chromatin	NULL
organization	NULL
and	NULL
not	NULL
secondary	NULL
to	NULL
sequence-directed	NULL
cleavage	NULL
preference	NULL
by	NULL
DNase	NULL
I	NULL
,	NULL
the	NULL
pattern	NULL
of	NULL
digestion	NULL
of	NULL
U1	NULL
nuclei	NULL
by	NULL
DNase	NULL
I	NULL
was	NULL
compared	NULL
with	NULL
that	NULL
of	NULL
U1	NULL
naked	NULL
DNA	NULL
digested	NULL
in	NULL
vitro	NULL
.	NULL

The	NULL
range	NULL
of	NULL
DNase	NULL
I	NULL
concentrations	NULL
was	NULL
chosen	NULL
to	NULL
generate	NULL
similar	NULL
levels	NULL
of	NULL
digestion	NULL
under	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
conditions	NULL
.	NULL

No	NULL
sequence	NULL
preference	NULL
for	NULL
cutting	NULL
by	NULL
DNase	NULL
I	NULL
was	NULL
observed	NULL
in	NULL
vitro	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
lanes	NULL
9	NULL
to	NULL
10	NULL
)	NULL
.	NULL

As	NULL
previously	NULL
described	NULL
(	NULL
82	NULL
)	NULL
,	NULL
TPA	NULL
induction	NULL
resulted	NULL
in	NULL
a	NULL
threefold	NULL
reduction	NULL
in	NULL
the	NULL
intensity	NULL
of	NULL
these	NULL
sites	NULL
(	NULL
by	NULL
densitometry	NULL
scanning	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
lanes	NULL
5	NULL
to	NULL
8	NULL
)	NULL
.	NULL

To	NULL
confirm	NULL
these	NULL
results	NULL
with	NULL
another	NULL
nuclease	NULL
,	NULL
we	NULL
used	NULL
micrococcal	NULL
nuclease	NULL
.	NULL

This	NULL
enzyme	NULL
preferentially	NULL
cuts	NULL
DNA	NULL
present	NULL
in	NULL
nucleosome-free	NULL
regions	NULL
in	NULL
chromatin	NULL
,	NULL
as	NULL
well	NULL
as	NULL
DNA	NULL
present	NULL
in	NULL
linker	NULL
domains	NULL
between	NULL
adjacent	NULL
nucleo-somes	NULL
.	NULL

Although	NULL
in	NULL
vitro	NULL
micrococcal	NULL
nuclease	NULL
exhibited	NULL
sequence	NULL
preference	NULL
for	NULL
cutting	NULL
naked	NULL
DNA	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
lanes	NULL
9	NULL
to	NULL
10	NULL
)	NULL
,	NULL
two	NULL
hypersensitive	NULL
sites	NULL
mapping	NULL
to	NULL
the	NULL
same	NULL
region	NULL
as	NULL
the	NULL
DNase	NULL
I-hypersensitive	NULL
sites	NULL
were	NULL
noted	NULL
only	NULL
in	NULL
vivo	NULL
(	NULL
indicated	NULL
by	NULL
arrows	NULL
in	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
,	NULL
supporting	NULL
the	NULL
hypothesis	NULL
that	NULL
they	NULL
were	NULL
secondary	NULL
to	NULL
chromatin	NULL
organization	NULL
.	NULL

Site	NULL
I	NULL
mapped	NULL
to	NULL
nt	NULL
4490	NULL
to	NULL
4529	NULL
,	NULL
and	NULL
site	NULL
II	NULL
mapped	NULL
to	NULL
nt	NULL
4585	NULL
to	NULL
4621	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
after	NULL
TPA	NULL
treatment	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
lanes	NULL
5	NULL
to	NULL
8	NULL
)	NULL
.	NULL

2636	NULL
VAN	NULL
LINT	NULL
ET	NULL
AL	NULL
.	NULL

A	NULL
.	NULL

--	NULL
IN	NULL
VIVO	NULL
-	NULL
IN	NULL
VITRO	NULL
«	NULL
TPA	NULL
+TPA	NULL
DNase	NULL
I	NULL
A	NULL
A	NULL
§	NULL
5	NULL
6	NULL
7	NULL
9	NULL
10	NULL
M	NULL
ff	NULL
a	NULL
-	NULL
#	NULL
#	NULL
#	NULL
#	NULL
-	NULL
a	NULL
b	NULL
-	NULL
#	NULL
#	NULL
#	NULL
#	NULL
-	NULL
b	NULL
c	NULL
-	NULL
#	NULL
#	NULL
“	NULL
#	NULL
-	NULL
'	NULL
!	NULL

#	NULL
#	NULL
-	NULL
c	NULL
£11	NULL
d	NULL
-	NULL
w	NULL
»	NULL
w	NULL
-	NULL
d	NULL
e	NULL
-	NULL
®	NULL
-	NULL
e	NULL
f-	NULL
-	NULL
f	NULL
J	NULL
.	NULL

Vigor	NULL
.	NULL

B	NULL
.	NULL

--	NULL
-	NULL
IN	NULL
VIVO	NULL
=	NULL
--	NULL
-4	NULL
[	NULL
INVIHU	NULL
)	NULL
‘	NULL
l	NULL
TPA	NULL
+TPA	NULL
MCnue	NULL
A	NULL
[	NULL
A	NULL
Mod	NULL
2	NULL
3	NULL
5	NULL
6	NULL
9	NULL
10	NULL
M	NULL
#	NULL
#	NULL
099	NULL
a	NULL
#	NULL
.	NULL

#	NULL
a	NULL
w	NULL
jas	NULL
#	NULL
ﬂ	NULL
i	NULL
8	NULL
H	NULL
®	NULL
#	NULL
i	NULL
%	NULL
os	NULL
a	NULL
wh	NULL
-	NULL
2	NULL
b	NULL
-	NULL
#	NULL
¢	NULL
W	NULL
-b	NULL
c	NULL
-	NULL
W	NULL
4	NULL
,	NULL
1	NULL
k	NULL
C	NULL
€	NULL
B	NULL
:	NULL
8B	NULL
&	NULL
i	NULL
#	NULL
-	NULL
>	NULL
d	NULL
-	NULL
#	NULL
#	NULL
ww	NULL
-	NULL
d	NULL
e	NULL
-	NULL
w	NULL
|	NULL
-	NULL
c	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

High-resolution	NULL
analysis	NULL
of	NULL
a	NULL
nuclease-hypersensitive	NULL
site	NULL
in	NULL
the	NULL
po	NULL
!	NULL

gene	NULL
of	NULL
HIV-1	NULL
.	NULL

Nuclei	NULL
from	NULL
U1	NULL
cells	NULL
that	NULL
were	NULL
untreated	NULL
or	NULL
treated	NULL
with	NULL
TPA	NULL
(	NULL
10	NULL
nM	NULL
)	NULL
for	NULL
12	NULL
h	NULL
were	NULL
incubated	NULL
with	NULL
either	NULL
DNase	NULL
I	NULL
on	NULL
ice	NULL
for	NULL
10	NULL
min	NULL
(	NULL
A	NULL
)	NULL
or	NULL
micrococcal	NULL
nuclease	NULL
(	NULL
MCnuc	NULL
)	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
20	NULL
min	NULL
(	NULL
B	NULL
)	NULL
.	NULL

DNAs	NULL
were	NULL
then	NULL
purified	NULL
,	NULL
digested	NULL
in	NULL
vitro	NULL
with	NULL
EcoRI	NULL
,	NULL
and	NULL
analyzed	NULL
by	NULL
indirect	NULL
end	NULL
labeling	NULL
with	NULL
a	NULL
probe	NULL
(	NULL
nt	NULL
5063	NULL
to	NULL
5743	NULL
)	NULL
abutting	NULL
the	NULL
unique	NULL
restriction	NULL
site	NULL
EcoRI	NULL
(	NULL
nt	NULL
5743	NULL
)	NULL
.	NULL

(	NULL
A	NULL
)	NULL
The	NULL
following	NULL
doses	NULL
of	NULL
DNase	NULL
I	NULL
were	NULL
used	NULL
in	NULL
vivo	NULL
:	NULL
0	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
5	NULL
)	NULL
,	NULL
10	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
6	NULL
)	NULL
,	NULL
15	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
7	NULL
)	NULL
,	NULL
and	NULL
20	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
8	NULL
)	NULL
U/ml	NULL
.	NULL

As	NULL
a	NULL
control	NULL
,	NULL
naked	NULL
U1	NULL
genomic	NULL
DNA	NULL
was	NULL
digested	NULL
in	NULL
vitro	NULL
with	NULL
DNase	NULL
I	NULL
(	NULL
0.5	NULL
and	NULL
0.25	NULL
U/ml	NULL
[	NULL
lanes	NULL
9	NULL
and	NULL
10	NULL
,	NULL
respectively	NULL
]	NULL
)	NULL
.	NULL

Molecular	NULL
weight	NULL
markers	NULL
are	NULL
double	NULL
digests	NULL
of	NULL
HIV-1y	NULL
;	NULL
,	NULL
.	NULL

;	NULL
DNA	NULL
with	NULL
EcoRI	NULL
(	NULL
nt	NULL
5743	NULL
)	NULL
and	NULL
KpnI	NULL
(	NULL
nt	NULL
4158	NULL
[	NULL
marker	NULL
al	NULL
)	NULL
,	NULL
Pvull	NULL
(	NULL
nt	NULL
4345	NULL
[	NULL
marker	NULL
bJ	NULL
)	NULL
,	NULL
XmnI	NULL
(	NULL
nt	NULL
4492	NULL
[	NULL
marker	NULL
cJ	NULL
)	NULL
,	NULL
Drel	NULL
(	NULL
nt	NULL
4784	NULL
[	NULL
marker	NULL
d	NULL
]	NULL
)	NULL
,	NULL
Avall	NULL
(	NULL
nt	NULL
4938	NULL
[	NULL
marker	NULL
and	NULL
NdeI	NULL
(	NULL
nt	NULL
5123	NULL
[	NULL
marker	NULL
f	NULL
]	NULL
)	NULL
.	NULL

Hypersensitive	NULL
sites	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
and	NULL
roman	NULL
numerals	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
following	NULL
doses	NULL
of	NULL
micrococcal	NULL
nuclease	NULL
were	NULL
used	NULL
:	NULL
0	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
5	NULL
)	NULL
,	NULL
0.015	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
6	NULL
)	NULL
,	NULL
0.03	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
7	NULL
)	NULL
,	NULL
and	NULL
0.06	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
8	NULL
)	NULL
U/ml	NULL
.	NULL

As	NULL
a	NULL
control	NULL
,	NULL
naked	NULL
U1	NULL
genomic	NULL
DNA	NULL
was	NULL
digested	NULL
in	NULL
vitro	NULL
with	NULL
micrococcal	NULL
nuclease	NULL
(	NULL
0.04	NULL
and	NULL
0.02	NULL
U/ml	NULL
!	NULL

[	NULL
lanes	NULL
9	NULL
and	NULL
10	NULL
,	NULL
respectively	NULL
]	NULL
)	NULL
.	NULL

Hypersensitive	NULL
sites	NULL
identified	NULL
in	NULL
vivo	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
.	NULL

High-resolution	NULL
mapping	NULL
of	NULL
the	NULL
intragenic	NULL
hypersensitive	NULL
site	NULL
in	NULL
U1	NULL
cells	NULL
identified	NULL
two	NULL
hypersensitive	NULL
sites	NULL
after	NULL
both	NULL
DNase	NULL
I	NULL
and	NULL
micrococcal	NULL
nuclease	NULL
digestion	NULL
.	NULL

Since	NULL
nuclease-hypersensitive	NULL
sites	NULL
usually	NULL
indicate	NULL
the	NULL
presence	NULL
of	NULL
nonnucleo-somal	NULL
DNA	NULL
in	NULL
vivo	NULL
,	NULL
we	NULL
conclude	NULL
that	NULL
the	NULL
region	NULL
of	NULL
the	NULL
pol	NULL
gene	NULL
centered	NULL
around	NULL
nt	NULL
4490	NULL
to	NULL
4766	NULL
is	NULL
nucleosome	NULL
free	NULL
in	NULL
vivo	NULL
.	NULL

The	NULL
intragenic	NULL
hypersensitive	NULL
site	NULL
region	NULL
increases	NULL
5'-LTR-directed	NULL
gene	NULL
expression	NULL
in	NULL
U937	NULL
and	NULL
CEM	NULL
cells	NULL
in	NULL
transient	NULL
transfection	NULL
assays	NULL
.	NULL

Nuclease-hypersensitive	NULL
sites	NULL
have	NULL
been	NULL
found	NULL
in	NULL
association	NULL
with	NULL
regulatory	NULL
regions	NULL
of	NULL
genes	NULL
such	NULL
as	NULL
enhancers	NULL
,	NULL
promoters	NULL
,	NULL
upstream	NULL
activating	NULL
sequences	NULL
,	NULL
silenc-ers	NULL
,	NULL
terminators	NULL
,	NULL
recombination	NULL
loci	NULL
,	NULL
telomeres	NULL
,	NULL
and	NULL
centro-meres	NULL
(	NULL
36	NULL
)	NULL
.	NULL

To	NULL
address	NULL
the	NULL
potential	NULL
role	NULL
of	NULL
the	NULL
pol-hypersensitive	NULL
region	NULL
,	NULL
we	NULL
tested	NULL
its	NULL
potential	NULL
enhancer	NULL
activity	NULL
on	NULL
the	NULL
transcription	NULL
rate	NULL
of	NULL
the	NULL
HIV-1	NULL
promoter	NULL
.	NULL

A	NULL
region	NULL
extending	NULL
from	NULL
nt	NULL
4481	NULL
to	NULL
4982	NULL
,	NULL
encompassing	NULL
the	NULL
nuclease-hypersensitive	NULL
region	NULL
,	NULL
was	NULL
amplified	NULL
by	NULL
PCR	NULL
from	NULL
U1	NULL
genomic	NULL
DNA	NULL
and	NULL
sequenced	NULL
.	NULL

Its	NULL
nucleotide	NULL
sequence	NULL
was	NULL
identical	NULL
to	NULL
that	NULL
of	NULL
the	NULL
homologous	NULL
region	NULL
in	NULL
the	NULL
HIV-1	NULL
isolate	NULL
NYS	NULL
.	NULL

The	NULL
fragment	NULL
was	NULL
subcloned	NULL
into	NULL
the	NULL
construct	NULL
pLTR	NULL
in	NULL
the	NULL
S	NULL
and	NULL
AS	NULL
orientations	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
transcriptional	NULL
unit	NULL
,	NULL
downstream	NULL
of	NULL
the	NULL
cat	NULL
reporter	NULL
gene	NULL
[	NULL
pLTR-U1	NULL
;	NULL
,	NULL
(	NULL
S	NULL
)	NULL
and	NULL
pLTR-U1	NULL
;	NULL
,	NULL
(	NULL
AS	NULL
)	NULL
,	NULL
respectively	NULL
]	NULL
.	NULL

The	NULL
pLTR	NULL
construct	NULL
contains	NULL
the	NULL
complete	NULL
5'-LTR	NULL
(	NULL
plus	NULL
the	NULL
leader	NULL
sequence	NULL
up	NULL
to	NULL
the	NULL
ATG	NULL
of	NULL
gag	NULL
)	NULL
driving	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
cat	NULL
gene	NULL
.	NULL

Constructs	NULL
were	NULL
transiently	NULL
transfected	NULL
into	NULL
the	NULL
CD4*	NULL
T-lymphoid	NULL
cell	NULL
line	NULL
CEM	NULL
and	NULL
the	NULL
promonocytic	NULL
cell	NULL
line	NULL
U937	NULL
with	NULL
or	NULL
without	NULL
the	NULL
Tat	NULL
expression	NULL
vector	NULL
pSV	NULL
;	NULL
,	NULL
TAT	NULL
.	NULL

In	NULL
preliminary	NULL
experiments	NULL
,	NULL
transfections	NULL
were	NULL
normalized	NULL
for	NULL
the	NULL
levels	NULL
of	NULL
luciferase	NULL
activity	NULL
by	NULL
including	NULL
as	NULL
an	NULL
internal	NULL
control	NULL
an	NULL
RSV	NULL
LTR-luciferase	NULL
construct	NULL
in	NULL
each	NULL
transfection	NULL
mixture	NULL
.	NULL

Since	NULL
no	NULL
significant	NULL
variations	NULL
were	NULL
noted	NULL
in	NULL
transfection	NULL
efficiencies	NULL
between	NULL
samples	NULL
from	NULL
a	NULL
single	NULL
experiment	NULL
,	NULL
the	NULL
RSV	NULL
LTR-luciferase	NULL
construct	NULL
was	NULL
not	NULL
further	NULL
utilized	NULL
.	NULL

In	NULL
the	NULL
absence	NULL
of	NULL
Tat	NULL
,	NULL
low	NULL
CAT	NULL
activity	NULL
was	NULL
detected	NULL
with	NULL
all	NULL
constructs	NULL
in	NULL
the	NULL
two	NULL
cell	NULL
lines	NULL
tested	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
the	NULL
presence	NULL
of	NULL
Tat	NULL
,	NULL
a	NULL
46-fold	NULL
increase	NULL
in	NULL
CAT	NULL
activity	NULL
was	NULL
observed	NULL
with	NULL
pLTR	NULL
compared	NULL
with	NULL
the	NULL
absence	NULL
of	NULL
Tat	NULL
.	NULL

All	NULL
values	NULL
were	NULL
normalized	NULL
to	NULL
the	NULL
amount	NULL
of	NULL
CAT	NULL
activity	NULL
of	NULL
the	NULL
control	NULL
pLTR	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
Tat	NULL
to	NULL
obtain	NULL
relative	NULL
CAT	NULL
activity	NULL
.	NULL

In	NULL
U937	NULL
cells	NULL
,	NULL
transfection	NULL
of	NULL
plasmid	NULL
pLTR-U1	NULL
;	NULL
,	NULL
(	NULL
S	NULL
)	NULL
caused	NULL
a	NULL
2.4-fold	NULL
increase	NULL
in	NULL
CAT	NULL
activity	NULL
compared	NULL
with	NULL
that	NULL
of	NULL
the	NULL
control	NULL
plasmid	NULL
pLTR	NULL
tested	NULL
under	NULL
the	NULL
same	NULL
conditions	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

This	NULL
effect	NULL
was	NULL
strongly	NULL
orientation	NULL
dependent	NULL
,	NULL
since	NULL
the	NULL
same	NULL
fragment	NULL
cloned	NULL
in	NULL
the	NULL
AS	NULL
orientation	NULL
exhibited	NULL
no	NULL
enhancing	NULL
activity	NULL
[	NULL
pLTR-U1	NULL
,	NULL
,	NULL
(	NULL
AS	NULL
)	NULL
;	NULL
Fig	NULL
.	NULL

2	NULL
]	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
for	NULL
CEM	NULL
cells	NULL
[	NULL
2.4-	NULL
and	NULL
1.5-fold	NULL
for	NULL
pLTR-U1	NULL
,	NULL
,	NULL
(	NULL
S	NULL
)	NULL
and	NULL
pLTR-U1	NULL
,	NULL
(	NULL
AS	NULL
)	NULL
,	NULL
respectively	NULL
;	NULL
Fig	NULL
.	NULL

2	NULL
]	NULL
.	NULL

These	NULL
results	NULL
``	NULL
indicate	NULL
that	NULL
the	NULL
region	NULL
associated	NULL
with	NULL
the	NULL
intragenic	NULL
hypersensitive	NULL
site	NULL
functions	NULL
as	NULL
a	NULL
weak	NULL
T-lymphoid	NULL
and	NULL
monocytic	NULL
transcriptional	NULL
enhancer	NULL
when	NULL
it	NULL
is	NULL
cloned	NULL
in	NULL
a	NULL
position	NULL
similar	NULL
to	NULL
that	NULL
observed	NULL
within	NULL
the	NULL
viral	NULL
genome	NULL
(	NULL
downstream	NULL
and	NULL
in	NULL
the	NULL
S	NULL
orientation	NULL
relative	NULL
to	NULL
the	NULL
5'-LTR-cat	NULL
transcriptional	NULL
unit	NULL
)	NULL
.	NULL

To	NULL
define	NULL
further	NULL
the	NULL
region	NULL
contributing	NULL
to	NULL
transcriptional	NULL
enhancing	NULL
activity	NULL
,	NULL
a	NULL
smaller	NULL
fragment	NULL
(	NULL
nt	NULL
4481	NULL
to	NULL
4777	NULL
)	NULL
was	NULL
also	NULL
tested	NULL
after	NULL
cloning	NULL
into	NULL
pLTR	NULL
in	NULL
the	NULL
S	NULL
and	NULL
AS	NULL
orientations	NULL
[	NULL
pLTR-U15	NULL
,	NULL
,	NULL
(	NULL
$	NULL
)	NULL
and	NULL
respectively	NULL
]	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
the	NULL
smaller	NULL
fragment	NULL
exhibited	NULL
enhancing	NULL
activity	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
the	NULL
larger	NULL
fragment	NULL
in	NULL
both	NULL
U937	NULL
cells	NULL
and	NULL
CEM	NULL
cells	NULL
.	NULL

This	NULL
enhancing	NULL
activity	NULL
was	NULL
strongly	NULL
dependent	NULL
on	NULL
the	NULL
orientation	NULL
of	NULL
the	NULL
fragment	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
promoter	NULL
,	NULL
as	NULL
described	NULL
for	NULL
the	NULL
larger	NULL
fragment	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Vor	NULL
.	NULL

68	NULL
,	NULL
1994	NULL
w	NULL
24	NULL
(	NULL
0.3	NULL
)	NULL
2.4	NULL
(	NULL
0.2	NULL
)	NULL
22	NULL
(	NULL
0.1	NULL
)	NULL
2.5	NULL
(	NULL
0.4	NULL
)	NULL
3	NULL
'	NULL
~	NULL
|	NULL
P	NULL
bof	NULL
$	NULL
f	NULL
|	NULL
bof	NULL
40g	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Transcriptional	NULL
enhancing	NULL
activity	NULL
of	NULL
the	NULL
intragenic	NULL
hyper-sensitive-site	NULL
region	NULL
.	NULL

The	NULL
enhancer	NULL
activity	NULL
of	NULL
the	NULL
region	NULL
associated	NULL
with	NULL
the	NULL
po	NULL
!	NULL

gene-hypersensitive	NULL
site	NULL
was	NULL
tested	NULL
after	NULL
cloning	NULL
in	NULL
pLTR	NULL
and	NULL
transfection	NULL
of	NULL
the	NULL
plasmids	NULL
in	NULL
U937	NULL
and	NULL
CEM	NULL
cells	NULL
with	NULL
the	NULL
Tat	NULL
expression	NULL
vector	NULL
pSV	NULL
,	NULL
TAT	NULL
.	NULL

CAT	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

The	NULL
results	NULL
are	NULL
presented	NULL
as	NULL
histograms	NULL
indicating	NULL
CAT	NULL
activities	NULL
relative	NULL
to	NULL
that	NULL
of	NULL
vector	NULL
pLTR	NULL
,	NULL
which	NULL
was	NULL
assigned	NULL
a	NULL
value	NULL
of	NULL
1	NULL
.	NULL

Means	NULL
and	NULL
standard	NULL
errors	NULL
of	NULL
the	NULL
means	NULL
from	NULL
6	NULL
to	NULL
8	NULL
independent	NULL
transfections	NULL
performed	NULL
with	NULL
two	NULL
different	NULL
DNA	NULL
preparations	NULL
are	NULL
indicated	NULL
.	NULL

We	NULL
also	NULL
tested	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
nuclease-hypersensitive	NULL
region	NULL
to	NULL
function	NULL
as	NULL
a	NULL
promoter	NULL
.	NULL

The	NULL
large	NULL
fragment	NULL
was	NULL
cloned	NULL
upstream	NULL
of	NULL
the	NULL
cat	NULL
gene	NULL
in	NULL
pCATBASIC	NULL
.	NULL

Very	NULL
low	NULL
CAT	NULL
activity	NULL
was	NULL
measured	NULL
after	NULL
transfection	NULL
of	NULL
the	NULL
resulting	NULL
plasmid	NULL
pIP	NULL
in	NULL
CEM	NULL
and	NULL
U937	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

We	NULL
also	NULL
considered	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
promoter	NULL
activity	NULL
is	NULL
inducible	NULL
or	NULL
dependent	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
viral	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
.	NULL

The	NULL
same	NULL
construct	NULL
pIP	NULL
was	NULL
cotransfected	NULL
in	NULL
CEM	NULL
and	NULL
U937	NULL
cells	NULL
,	NULL
along	NULL
with	NULL
a	NULL
Tat	NULL
expression	NULL
vector	NULL
or	NULL
the	NULL
plasmid	NULL
pNLA4-3	NULL
(	NULL
1	NULL
)	NULL
containing	NULL
the	NULL
complete	NULL
HIV-1	NULL
genome	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
the	NULL
absence	NULL
of	NULL
TPA	NULL
.	NULL

None	NULL
of	NULL
these	NULL
conditions	NULL
significantly	NULL
increased	NULL
CAT	NULL
activity	NULL
in	NULL
any	NULL
of	NULL
the	NULL
cell	NULL
lines	NULL
tested	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
additional	NULL
experiments	NULL
,	NULL
we	NULL
cotransfected	NULL
the	NULL
construct	NULL
pLTR	NULL
along	NULL
with	NULL
the	NULL
plasmid	NULL
pBRU2	NULL
,	NULL
which	NULL
was	NULL
digested	NULL
by	NULL
Psfl	NULL
(	NULL
cutting	NULL
at	NULL
nt	NULL
1419	NULL
)	NULL
and	NULL
Secl	NULL
(	NULL
cutting	NULL
at	NULL
nt	NULL
492	NULL
and	NULL
682	NULL
)	NULL
,	NULL
thereby	NULL
preventing	NULL
elongation	NULL
of	NULL
the	NULL
transcripts	NULL
initiated	NULL
in	NULL
the	NULL
5'-LTR	NULL
.	NULL

Since	NULL
the	NULL
level	NULL
of	NULL
expression	NULL
of	NULL
the	NULL
reporter	NULL
cat	NULL
gene	NULL
present	NULL
in	NULL
pLTR	NULL
is	NULL
dependent	NULL
on	NULL
the	NULL
transactivation	NULL
of	NULL
the	NULL
HIV-1	NULL
promoter	NULL
by	NULL
the	NULL
viral	NULL
protein	NULL
Tat	NULL
,	NULL
the	NULL
presence	NULL
in	NULL
the	NULL
digested	NULL
pBRU2	NULL
plasmid	NULL
of	NULL
an	NULL
intragenic	NULL
promoter	NULL
able	NULL
to	NULL
produce	NULL
Tat	NULL
should	NULL
be	NULL
revealed	NULL
by	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
CAT	NULL
expression	NULL
of	NULL
the	NULL
reporter	NULL
system	NULL
pLTR	NULL
.	NULL

No	NULL
transactivation	NULL
of	NULL
the	NULL
HIV-1	NULL
promoter	NULL
present	NULL
in	NULL
pLTR	NULL
was	NULL
detected	NULL
.	NULL

We	NULL
conclude	NULL
from	NULL
these	NULL
experiments	NULL
that	NULL
the	NULL
intragenic	NULL
nuclease-hypersensitive	NULL
region	NULL
does	NULL
not	NULL
exhibit	NULL
any	NULL
promoter	NULL
activity	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
when	NULL
cloned	NULL
downstream	NULL
and	NULL
in	NULL
the	NULL
sense	NULL
orientation	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
HIV-1	NULL
promoter	NULL
,	NULL
a	NULL
pol	NULL
region	NULL
associated	NULL
with	NULL
a	NULL
nuclease-hypersensitive	NULL
domain	NULL
in	NULL
U1	NULL
cells	NULL
was	NULL
found	NULL
to	NULL
reproducibly	NULL
increase	NULL
(	NULL
two-	NULL
or	NULL
threefold	NULL
)	NULL
transcription	NULL
mediated	NULL
by	NULL
the	NULL
viral	NULL
5-LTR	NULL
in	NULL
U937	NULL
and	NULL
CEM	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
Tat	NULL
.	NULL

Identification	NULL
of	NULL
sites	NULL
of	NULL
interaction	NULL
with	NULL
nuclear	NULL
proteins	NULL
within	NULL
the	NULL
hypersensitive	NULL
site	NULL
region	NULL
by	NULL
DNase	NULL
I	NULL
footprinting	NULL
analysis	NULL
.	NULL

The	NULL
transcriptional	NULL
control	NULL
of	NULL
gene	NULL
expression	NULL
is	NULL
the	NULL
result	NULL
of	NULL
interactions	NULL
between	NULL
cis-acting	NULL
DNA	NULL
sequences	NULL
and	NULL
trans-acting	NULL
factors	NULL
in	NULL
regulatory	NULL
regions	NULL
(	NULL
for	NULL
reviews	NULL
,	NULL
see	NULL
references	NULL
39	NULL
and	NULL
55	NULL
)	NULL
.	NULL

An	NULL
open	NULL
chromatin	NULL
configuration	NULL
can	NULL
indicate	NULL
that	NULL
the	NULL
underlying	NULL
DNA	NULL
is	NULL
occupied	NULL
by	NULL
DNA-binding	NULL
proteins	NULL
,	NULL
preventing	NULL
its	NULL
incorporation	NULL
into	NULL
nucleosomes	NULL
(	NULL
26	NULL
,	NULL
DNA-BINDING	NULL
MOTIFS	NULL
IN	NULL
THE	NULL
HIV-1	NULL
po	NULL
!	NULL

GENE	NULL
2637	NULL
46	NULL
,	NULL
91	NULL
)	NULL
.	NULL

To	NULL
identify	NULL
transcription	NULL
factors	NULL
susceptible	NULL
to	NULL
interaction	NULL
with	NULL
DNA	NULL
within	NULL
the	NULL
pol	NULL
gene-hypersensitive	NULL
site	NULL
,	NULL
we	NULL
first	NULL
performed	NULL
a	NULL
screening	NULL
of	NULL
the	NULL
region	NULL
using	NULL
DNase	NULL
I	NULL
footprinting	NULL
analysis	NULL
.	NULL

Five	NULL
overlapping	NULL
DNA	NULL
subfragments	NULL
encompassing	NULL
the	NULL
nuclease-hypersensitive	NULL
region	NULL
were	NULL
used	NULL
as	NULL
probes	NULL
in	NULL
footprinting	NULL
reactions	NULL
with	NULL
crude	NULL
nuclear	NULL
extracts	NULL
from	NULL
CEM	NULL
and	NULL
U937	NULL
cells	NULL
.	NULL

This	NULL
initial	NULL
screening	NULL
identified	NULL
four	NULL
potential	NULL
nuclear	NULL
protein	NULL
binding	NULL
sites	NULL
,	NULL
called	NULL
sites	NULL
A	NULL
,	NULL
B	NULL
,	NULL
C	NULL
,	NULL
and	NULL
D	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
through	NULL
C	NULL
)	NULL
.	NULL

Site	NULL
A	NULL
footprint	NULL
was	NULL
partial	NULL
and	NULL
not	NULL
reproducible	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
and	NULL
was	NULL
not	NULL
further	NULL
studied	NULL
.	NULL

Site	NULL
B	NULL
footprint	NULL
encompassed	NULL
nt	NULL
4521	NULL
to	NULL
4539	NULL
and	NULL
was	NULL
observed	NULL
with	NULL
extracts	NULL
from	NULL
U937	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
and	NULL
CEM	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Site	NULL
C	NULL
footprint	NULL
encompassed	NULL
nt	NULL
4682	NULL
to	NULL
4715	NULL
and	NULL
was	NULL
detected	NULL
with	NULL
extracts	NULL
from	NULL
U937	NULL
and	NULL
CEM	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
lanes	NULL
4	NULL
and	NULL
6	NULL
,	NULL
respectively	NULL
)	NULL
but	NULL
not	NULL
with	NULL
extracts	NULL
from	NULL
HeLa	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

Site	NULL
D	NULL
footprint	NULL
encompassed	NULL
nt	NULL
4817	NULL
to	NULL
4841	NULL
and	NULL
was	NULL
observed	NULL
with	NULL
extracts	NULL
from	NULL
U937	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
and	NULL
CEM	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

All	NULL
footprints	NULL
were	NULL
flanked	NULL
by	NULL
sites	NULL
of	NULL
increased	NULL
DNase	NULL
I	NULL
sensitivity	NULL
(	NULL
indicated	NULL
by	NULL
arrows	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
,	NULL
a	NULL
phenomenon	NULL
often	NULL
observed	NULL
as	NULL
consequence	NULL
of	NULL
protein	NULL
binding	NULL
to	NULL
DNA	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
when	NULL
the	NULL
monovalent	NULL
cation	NULL
concentration	NULL
(	NULL
Na	NULL
*	NULL
or	NULL
K*	NULL
)	NULL
was	NULL
increased	NULL
,	NULL
the	NULL
protected	NULL
regions	NULL
became	NULL
sensitive	NULL
to	NULL
DNase	NULL
I	NULL
attack	NULL
,	NULL
resulting	NULL
in	NULL
a	NULL
digestion	NULL
pattern	NULL
indistinguishable	NULL
from	NULL
that	NULL
observed	NULL
in	NULL
the	NULL
control	NULL
lane	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
[	NULL
compare	NULL
lanes	NULL
3	NULL
,	NULL
4	NULL
,	NULL
and	NULL
5	NULL
and	NULL
3	NULL
,	NULL
6	NULL
,	NULL
and	NULL
7	NULL
for	NULL
site	NULL
BJ	NULL
,	NULL
Fig	NULL
.	NULL

3C	NULL
[	NULL
compare	NULL
lanes	NULL
3	NULL
,	NULL
4	NULL
,	NULL
and	NULL
5	NULL
for	NULL
site	NULL
D	NULL
]	NULL
,	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
[	NULL
for	NULL
site	NULL
CJ	NULL
)	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
DNase	NULL
I	NULL
protection	NULL
in	NULL
site	NULL
C	NULL
,	NULL
competition	NULL
experiments	NULL
were	NULL
performed	NULL
with	NULL
a	NULL
double-stranded	NULL
55-bp	NULL
oligonucleotide	NULL
encompassing	NULL
the	NULL
site	NULL
C	NULL
footprint	NULL
.	NULL

This	NULL
competitor	NULL
was	NULL
found	NULL
to	NULL
abolish	NULL
the	NULL
site	NULL
C	NULL
footprint	NULL
when	NULL
present	NULL
at	NULL
a	NULL
molar	NULL
excess	NULL
between	NULL
10-	NULL
and	NULL
100-fold	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
lanes	NULL
9	NULL
and	NULL
10	NULL
,	NULL
respectively	NULL
)	NULL
,	NULL
whereas	NULL
an	NULL
oligonucleotide	NULL
with	NULL
similar	NULL
size	NULL
and	NULL
base	NULL
composition	NULL
but	NULL
with	NULL
an	NULL
unrelated	NULL
sequence	NULL
failed	NULL
to	NULL
inhibit	NULL
footprint	NULL
formation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Each	NULL
site	NULL
was	NULL
further	NULL
characterized	NULL
by	NULL
EMSA	NULL
and	NULL
methylation	NULL
interference	NULL
analysis	NULL
.	NULL

Characterization	NULL
of	NULL
nuclear	NULL
factors	NULL
binding	NULL
to	NULL
site	NULL
B	NULL
.	NULL

Comparison	NULL
of	NULL
the	NULL
nucleotide	NULL
sequences	NULL
of	NULL
site	NULL
B	NULL
among	NULL
several	NULL
HIV-1	NULL
isolates	NULL
revealed	NULL
that	NULL
site	NULL
B	NULL
displayed	NULL
a	NULL
high	NULL
degree	NULL
of	NULL
sequence	NULL
polymorphism	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
this	NULL
polymorphism	NULL
generated	NULL
different	NULL
binding	NULL
specificities	NULL
,	NULL
four	NULL
sites	NULL
B	NULL
with	NULL
different	NULL
sequences	NULL
(	NULL
U1	NULL
[	NULL
=	NULL
NYS	NULL
)	NULL
,	NULL
SF2	NULL
,	NULL
LAI	NULL
,	NULL
and	NULL
HXB2	NULL
)	NULL
were	NULL
tested	NULL
as	NULL
probes	NULL
in	NULL
EMSAs	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
the	NULL
following	NULL
human	NULL
cell	NULL
lines	NULL
with	NULL
different	NULL
origins	NULL
:	NULL
SupT1	NULL
,	NULL
Jurkat	NULL
,	NULL
and	NULL
A3.01	NULL
(	NULL
a	NULL
clonal	NULL
derivative	NULL
of	NULL
the	NULL
CEM	NULL
cell	NULL
line	NULL
)	NULL
(	NULL
CD4¢*	NULL
T-lymphocytic	NULL
cell	NULL
lines	NULL
)	NULL
;	NULL
HeLa	NULL
(	NULL
an	NULL
epithelial	NULL
cell	NULL
line	NULL
)	NULL
;	NULL
U937	NULL
and	NULL
KG-1	NULL
(	NULL
promonocytic/macrophage	NULL
cell	NULL
lines	NULL
)	NULL
;	NULL
and	NULL
Raji	NULL
and	NULL
Namalwa	NULL
(	NULL
B-lymphocytic	NULL
cell	NULL
lines	NULL
)	NULL
.	NULL

Two	NULL
different	NULL
patterns	NULL
were	NULL
observed	NULL
,	NULL
and	NULL
these	NULL
are	NULL
illustrated	NULL
in	NULL
Fig	NULL
.	NULL

4B	NULL
by	NULL
the	NULL
U1	NULL
and	NULL
SF2	NULL
sites	NULL
B	NULL
.	NULL

A	NULL
pattern	NULL
of	NULL
four	NULL
major	NULL
retarded	NULL
DNA-protein	NULL
complexes	NULL
was	NULL
observed	NULL
with	NULL
U1	NULL
site	NULL
B	NULL
as	NULL
a	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
:	NULL
a	NULL
ubiquitous	NULL
complex	NULL
(	NULL
B1	NULL
)	NULL
,	NULL
a	NULL
B-cell-specific	NULL
complex	NULL
(	NULL
B2	NULL
)	NULL
,	NULL
a	NULL
T-cell-specific	NULL
complex	NULL
(	NULL
B3	NULL
)	NULL
,	NULL
and	NULL
a	NULL
monocyte/	NULL
macrophage-	NULL
and	NULL
B-cell-specific	NULL
complex	NULL
(	NULL
B4	NULL
)	NULL
.	NULL

With	NULL
SF2	NULL
site	NULL
B	NULL
as	NULL
a	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
,	NULL
only	NULL
retarded	NULL
complexes	NULL
B1	NULL
,	NULL
B2	NULL
,	NULL
and	NULL
B3	NULL
were	NULL
generated	NULL
.	NULL

Oligonucleotides	NULL
containing	NULL
the	NULL
site	NULL
B	NULL
sequence	NULL
from	NULL
LAI	NULL
or	NULL
HXB2	NULL
behaved	NULL
like	NULL
SF2	NULL
site	NULL
B	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
macrophage-	NULL
and	NULL
B-cell-specific	NULL
complex	NULL
(	NULL
B4	NULL
)	NULL
was	NULL
detected	NULL
only	NULL
with	NULL
U1	NULL
site	NULL
B	NULL
as	NULL
a	NULL
probe	NULL
.	NULL

Binding	NULL
of	NULL
proteins	NULL
in	NULL
complexes	NULL
B1	NULL
,	NULL
B2	NULL
,	NULL
B3	NULL
,	NULL
and	NULL
B4	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
sequence	NULL
specific	NULL
by	NULL
competition	NULL
EMSAs	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
and	NULL
D	NULL
)	NULL
.	NULL

U1	NULL
site	NULL
B	NULL
oligonucleotide	NULL
probe	NULL
was	NULL
incubated	NULL
with	NULL
nuclear	NULL
extract	NULL
from	NULL
Raji	NULL
or	NULL
U937	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
different	NULL
competitor	NULL
oligonucleotides	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
.	NULL

All	NULL
complexes	NULL
were	NULL
inhibited	NULL
by	NULL
an	NULL
excess	NULL
of	NULL
unlabeled	NULL
homologous	NULL
oligonucleo-	NULL
2638	NULL
VAN	NULL
LINT	NULL
ET	NULL
AL	NULL
.	NULL

J.	NULL
ViroL	NULL
.	NULL

KCI	NULL
Control	NULL
Control	NULL
nos	NULL
z	NULL
e	NULL
&	NULL
R	NULL
@	NULL
-	NULL
s=	NULL
&	NULL
&	NULL
€	NULL
&	NULL
``	NULL
2	NULL
(	NULL
mM	NULL
)	NULL
ilk	NULL
20	NULL
m	NULL
o	NULL
<	NULL
-	NULL
A	NULL
a	NULL
m	NULL
u	NULL
d	NULL
3	NULL
2s	NULL
200	NULL
(	NULL
mM	NULL
)	NULL
3	NULL
%	NULL
-	NULL
:	NULL
Land	NULL
<	NULL
-	NULL
S	NULL
*	NULL
#	NULL
i	NULL
nt	NULL
4521	NULL
I	NULL
md	NULL
;	NULL
«	NULL
-	NULL
-	NULL
>	NULL
_-	NULL
]	NULL
nt	NULL
4539	NULL
E	NULL
«	NULL
--	NULL
-	NULL
m	NULL
Hong	NULL
``	NULL
sam	NULL
<	NULL
-	NULL
,	NULL
nt	NULL
4682	NULL
C	NULL
is	NULL
4	NULL
B	NULL
]	NULL
5	NULL
=	NULL
neas17	NULL
mn	NULL
W	NULL
T	NULL
|	NULL
I	NULL
|	NULL
,	NULL
r	NULL
.	NULL

%	NULL
|	NULL
T	NULL
oe	NULL
teres	NULL
tty	NULL
sous	NULL
E	NULL
z	NULL
J	NULL
asan	NULL
£	NULL
smg	NULL
ee	NULL
E4	NULL
%	NULL
-	NULL
t	NULL
48	NULL
*	NULL
aap	NULL
out	NULL
aay	NULL
o	NULL
c	NULL
omron	NULL
.	NULL

®	NULL
)	NULL
nt	NULL
4715	NULL
&	NULL
D	NULL
«	NULL
rns	NULL
G	NULL
w	NULL
»	NULL
G00	NULL
we	NULL
o	NULL
>	NULL
ee	NULL
cies	NULL
weer	NULL
cen	NULL
cone	NULL
quam	NULL
cme	NULL
l	NULL
P	NULL
r	NULL
I	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
I	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
1	NULL
2	NULL
3	NULL
4	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

DNase	NULL
I	NULL
footprinting	NULL
analysis	NULL
of	NULL
the	NULL
hypersensitive	NULL
site	NULL
.	NULL

Overlapping	NULL
DNA	NULL
fragments	NULL
encompassing	NULL
the	NULL
nuclease-hypersensitive	NULL
region	NULL
(	NULL
nt	NULL
4346	NULL
to	NULL
4962	NULL
)	NULL
were	NULL
used	NULL
as	NULL
probes	NULL
in	NULL
footprinting	NULL
reactions	NULL
.	NULL

Probes	NULL
were	NULL
partially	NULL
digested	NULL
with	NULL
DNase	NULL
I	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
protein	NULL
(	NULL
control	NULL
lanes	NULL
)	NULL
or	NULL
after	NULL
incubation	NULL
with	NULL
50	NULL
pg	NULL
of	NULL
total	NULL
nuclear	NULL
extract	NULL
from	NULL
different	NULL
cell	NULL
lines	NULL
.	NULL

Protected	NULL
areas	NULL
are	NULL
indicated	NULL
by	NULL
brackets	NULL
.	NULL

Numbers	NULL
at	NULL
the	NULL
tops	NULL
and	NULL
bottoms	NULL
of	NULL
the	NULL
brackets	NULL
represent	NULL
the	NULL
positions	NULL
of	NULL
the	NULL
nucleotides	NULL
in	NULL
the	NULL
HIV-1yys	NULL
genome	NULL
.	NULL

Maxam	NULL
and	NULL
Gilbert	NULL
purine	NULL
sequencing	NULL
reaction	NULL
products	NULL
of	NULL
the	NULL
same	NULL
probes	NULL
were	NULL
run	NULL
in	NULL
parallel	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
as	NULL
size	NULL
markers	NULL
.	NULL

Arrows	NULL
indicate	NULL
hypersensitive	NULL
bands	NULL
.	NULL

(	NULL
A	NULL
)	NULL
A	NULL
215-bp	NULL
HindlII-Sacll	NULL
restriction	NULL
fragment	NULL
of	NULL
plasmid	NULL
pHXB2	NULL
(	NULL
4491-4668	NULL
)	NULL
was	NULL
5	NULL
'	NULL
end	NULL
labeled	NULL
at	NULL
the	NULL
HindIII	NULL
site	NULL
on	NULL
the	NULL
noncoding	NULL
strand	NULL
and	NULL
was	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
in	NULL
footprinting	NULL
reactions	NULL
with	NULL
a	NULL
nuclear	NULL
extract	NULL
from	NULL
U937	NULL
cells	NULL
at	NULL
a	NULL
final	NULL
KCI	NULL
concentration	NULL
of	NULL
25	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
or	NULL
200	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
mM	NULL
or	NULL
at	NULL
a	NULL
final	NULL
NaCl	NULL
concentration	NULL
of	NULL
25	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
or	NULL
200	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
mM	NULL
.	NULL

(	NULL
B	NULL
)	NULL
A	NULL
221-bp	NULL
HindIII-Sacll	NULL
fragment	NULL
of	NULL
plasmid	NULL
pHXB2	NULL
(	NULL
4601-4782	NULL
)	NULL
was	NULL
5	NULL
'	NULL
end	NULL
labeled	NULL
at	NULL
the	NULL
HindIII	NULL
site	NULL
on	NULL
the	NULL
noncoding	NULL
strand	NULL
and	NULL
was	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
in	NULL
footprinting	NULL
reactions	NULL
with	NULL
a	NULL
nuclear	NULL
extract	NULL
from	NULL
U937	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
HeLa	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
or	NULL
CEM	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
cells	NULL
.	NULL

In	NULL
lanes	NULL
7	NULL
to	NULL
11	NULL
,	NULL
increasing	NULL
amounts	NULL
of	NULL
a	NULL
double-stranded	NULL
55-bp	NULL
oligonucleotide	NULL
(	NULL
nt	NULL
4670	NULL
to	NULL
4724	NULL
)	NULL
homologous	NULL
to	NULL
site	NULL
C	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
U937	NULL
nuclear	NULL
extract	NULL
before	NULL
addition	NULL
of	NULL
the	NULL
probe	NULL
.	NULL

The	NULL
number	NULL
at	NULL
the	NULL
top	NULL
of	NULL
each	NULL
lane	NULL
represents	NULL
the	NULL
molar	NULL
ratio	NULL
of	NULL
the	NULL
55-bp	NULL
oligonucleotide	NULL
competitor	NULL
to	NULL
the	NULL
HIV-1	NULL
probe	NULL
.	NULL

(	NULL
C	NULL
)	NULL
A	NULL
269-bp	NULL
HindIII-Sacil	NULL
fragment	NULL
of	NULL
plasmid	NULL
pHXB2	NULL
(	NULL
4731-4962	NULL
)	NULL
was	NULL
5	NULL
'	NULL
end	NULL
labeled	NULL
at	NULL
the	NULL
HindIII	NULL
site	NULL
on	NULL
the	NULL
noncoding	NULL
strand	NULL
and	NULL
was	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
in	NULL
footprinting	NULL
reactions	NULL
with	NULL
a	NULL
U937	NULL
nuclear	NULL
extract	NULL
at	NULL
a	NULL
final	NULL
NaCl	NULL
concentration	NULL
of	NULL
25	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
or	NULL
200	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
mM	NULL
.	NULL

tide	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
,	NULL
lanes	NULL
2	NULL
to	NULL
4	NULL
)	NULL
but	NULL
not	NULL
by	NULL
an	NULL
oligonucleotide	NULL
with	NULL
an	NULL
unrelated	NULL
sequence	NULL
containing	NULL
a	NULL
binding	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
,	NULL
lanes	NULL
5	NULL
to	NULL
7	NULL
)	NULL
.	NULL

Complexes	NULL
B1	NULL
,	NULL
B2	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
,	NULL
and	NULL
B3	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
were	NULL
inhibited	NULL
by	NULL
SF2	NULL
site	NULL
B	NULL
oligonucleotide	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
,	NULL
lanes	NULL
8	NULL
to	NULL
10	NULL
)	NULL
and	NULL
site	NULL
C	NULL
oligonucleotide	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
,	NULL
lanes	NULL
11	NULL
to	NULL
13	NULL
;	NULL
see	NULL
below	NULL
)	NULL
.	NULL

Similar	NULL
competition	NULL
experiments	NULL
with	NULL
SF2	NULL
site	NULL
B	NULL
as	NULL
a	NULL
probe	NULL
and	NULL
nuclear	NULL
extracts	NULL
from	NULL
Raji	NULL
and	NULL
CEM	NULL
cells	NULL
confirmed	NULL
these	NULL
results	NULL
(	NULL
Fig	NULL
.	NULL

4D	NULL
)	NULL
.	NULL

Similar	NULL
competition	NULL
EMSAs	NULL
with	NULL
LAI	NULL
site	NULL
B	NULL
and	NULL
HXB2	NULL
site	NULL
B	NULL
as	NULL
probes	NULL
showed	NULL
similar	NULL
results	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
cell	NULL
specificity	NULL
of	NULL
complex	NULL
B4	NULL
and	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
PU	NULL
box	NULL
on	NULL
the	NULL
noncoding	NULL
strand	NULL
in	NULL
U1	NULL
site	NULL
B	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
suggested	NULL
that	NULL
B4	NULL
could	NULL
result	NULL
from	NULL
binding	NULL
of	NULL
the	NULL
macrophage-	NULL
and	NULL
B-cell-specific	NULL
transcription	NULL
factor	NULL
Spi-1/PU.1	NULL
(	NULL
33	NULL
,	NULL
45	NULL
,	NULL
56	NULL
,	NULL
63	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
present	NULL
in	NULL
complex	NULL
B4	NULL
was	NULL
related	NULL
to	NULL
the	NULL
transcription	NULL
factor	NULL
Spi-1/PU.1	NULL
,	NULL
an	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
PU	NULL
box	NULL
from	NULL
the	NULL
enhancer	NULL
of	NULL
an	NULL
SV40	NULL
variant	NULL
(	NULL
45	NULL
)	NULL
was	NULL
used	NULL
as	NULL
a	NULL
competitor	NULL
in	NULL
EMSAs	NULL
.	NULL

The	NULL
SV40PU.1	NULL
oligonucleotide	NULL
inhibited	NULL
specifically	NULL
the	NULL
formation	NULL
of	NULL
complex	NULL
B4	NULL
at	NULL
a	NULL
20-fold	NULL
molar	NULL
excess	NULL
,	NULL
whereas	NULL
no	NULL
competition	NULL
of	NULL
binding	NULL
in	NULL
complexes	NULL
B1	NULL
and	NULL
B2	NULL
was	NULL
observed	NULL
at	NULL
the	NULL
same	NULL
molar	NULL
excess	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
,	NULL
lane	NULL
15	NULL
)	NULL
.	NULL

A	NULL
shorter	NULL
oligonucleotide	NULL
(	NULL
U1	NULL
site	NULL
B	NULL
short	NULL
[	NULL
nt	NULL
4523	NULL
to	NULL
4542	NULL
]	NULL
)	NULL
which	NULL
was	NULL
centered	NULL
on	NULL
the	NULL
putative	NULL
PU	NULL
box	NULL
present	NULL
in	NULL
site	NULL
B	NULL
was	NULL
used	NULL
in	NULL
EMSAs	NULL
and	NULL
was	NULL
found	NULL
to	NULL
generate	NULL
only	NULL
complex	NULL
B4	NULL
when	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
with	NULL
the	NULL
different	NULL
nuclear	NULL
extracts	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
same	NULL
oligonucleotide	NULL
(	NULL
U1	NULL
site	NULL
B	NULL
short	NULL
)	NULL
inhibited	NULL
only	NULL
the	NULL
formation	NULL
of	NULL
complex	NULL
B4	NULL
when	NULL
used	NULL
as	NULL
a	NULL
competitor	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
,	NULL
lanes	NULL
17	NULL
to	NULL
19	NULL
)	NULL
.	NULL

To	NULL
demonstrate	NULL
directly	NULL
that	NULL
the	NULL
PU.1	NULL
protein	NULL
could	NULL
bind	NULL
to	NULL
U1	NULL
site	NULL
B	NULL
,	NULL
the	NULL
U1	NULL
site	NULL
B	NULL
short	NULL
probe	NULL
was	NULL
incubated	NULL
with	NULL
human	NULL
PU.1/Spi-1	NULL
protein	NULL
,	NULL
derived	NULL
from	NULL
lysates	NULL
of	NULL
COS1	NULL
cells	NULL
transfected	NULL
with	NULL
a	NULL
PU.1/Spi-1	NULL
expression	NULL
vector	NULL
(	NULL
68	NULL
)	NULL
.	NULL

One	NULL
retarded	NULL
complex	NULL
was	NULL
generated	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
whereas	NULL
incubation	NULL
with	NULL
lysates	NULL
of	NULL
COS1	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
control	NULL
vector	NULL
showed	NULL
no	NULL
retarded	NULL
band	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

Competition	NULL
experiments	NULL
showed	NULL
that	NULL
this	NULL
protein-DNA	NULL
complex	NULL
was	NULL
inhibited	NULL
by	NULL
the	NULL
unlabeled	NULL
homologous	NULL
oligonucleotide	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
lanes	NULL
3	NULL
to	NULL
5	NULL
)	NULL
and	NULL
by	NULL
the	NULL
SV40PU.1	NULL
oligonucleotide	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
lanes	NULL
6	NULL
to	NULL
8	NULL
)	NULL
,	NULL
whereas	NULL
a	NULL
mutated	NULL
version	NULL
of	NULL
this	NULL
oligonucleotide	NULL
(	NULL
SV40PU.1mut	NULL
)	NULL
,	NULL
in	NULL
which	NULL
two	NULL
guanines	NULL
crucial	NULL
for	NULL
the	NULL
binding	NULL
activity	NULL
of	NULL
the	NULL
PU	NULL
box	NULL
were	NULL
changed	NULL
to	NULL
cytosines	NULL
,	NULL
failed	NULL
to	NULL
compete	NULL
when	NULL
used	NULL
at	NULL
a	NULL
100-fold	NULL
molar	NULL
excess	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
lane	NULL
9	NULL
)	NULL
,	NULL
demonstrating	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
complex	NULL
.	NULL

Thus	NULL
,	NULL
PU.1	NULL
transiently	NULL
expressed	NULL
in	NULL
transfected	NULL
COS1	NULL
cells	NULL
specifically	NULL
bound	NULL
to	NULL
the	NULL
HIV-1	NULL
PU.1/Spi-1	NULL
binding	NULL
site	NULL
.	NULL

Interestingly	NULL
,	NULL
HIV-1	NULL
isolates	NULL
which	NULL
do	NULL
not	NULL
contain	NULL
the	NULL
PU	NULL
box	NULL
(	NULL
HXB2	NULL
,	NULL
LAI	NULL
,	NULL
and	NULL
SF2	NULL
)	NULL
do	NULL
contain	NULL
,	NULL
just	NULL
upstream	NULL
of	NULL
site	NULL
B	NULL
,	NULL
a	NULL
potential	NULL
binding	NULL
site	NULL
for	NULL
Ets1	NULL
and	NULL
closely	NULL
related	NULL
factors	NULL
of	NULL
the	NULL
Ets	NULL
family	NULL
of	NULL
DNA-binding	NULL
proteins	NULL
to	NULL
which	NULL
PU.1	NULL
belongs	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

EMSAs	NULL
with	NULL
an	NULL
oligonucleotide	NULL
probe	NULL
containing	NULL
the	NULL
potential	NULL
Ets1	NULL
site	NULL
of	NULL
HIV-lpyyp	NULL
,	NULL
(	NULL
nt	NULL
4505	NULL
to	NULL
4527	NULL
)	NULL
and	NULL
extracts	NULL
from	NULL
SF9	NULL
cells	NULL
infected	NULL
with	NULL
a	NULL
recombinant	NULL
baculovirus	NULL
expressing	NULL
the	NULL
Ets1	NULL
protein	NULL
(	NULL
9	NULL
)	NULL
resulted	NULL
in	NULL
a	NULL
retarded	NULL
band	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
whereas	NULL
a	NULL
control	NULL
extract	NULL
generated	NULL
no	NULL
shift	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

This	NULL
retarded	NULL
band	NULL
was	NULL
specific	NULL
since	NULL
it	NULL
was	NULL
inhibited	NULL
by	NULL
an	NULL
excess	NULL
of	NULL
unlabeled	NULL
Etslyyp	NULL
,	NULL
oligonucleotide	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
or	NULL
by	NULL
an	NULL
oligonucleotide	NULL
corresponding	NULL
to	NULL
a	NULL
VoL	NULL
.	NULL

68	NULL
,	NULL
1994	NULL
DNA-BINDING	NULL
MOTIFS	NULL
IN	NULL
THE	NULL
HIV-1	NULL
pol	NULL
GENE	NULL
2639	NULL
t	NULL
&	NULL
U1	NULL
cells	NULL
5	NULL
'	NULL
AcaG	NULL
3	NULL
G	NULL
x	NULL
c	NULL
&	NULL
a*	NULL
3+	NULL
T	NULL
s	NULL
Ge	NULL
“	NULL
59°	NULL
(	NULL
S	NULL
£va	NULL
3°	NULL
;	NULL
A	NULL
”	NULL
?	NULL

N	NULL
‘	NULL
s	NULL
*	NULL
&	NULL
*	NULL
&	NULL
9	NULL
©	NULL
®	NULL
5	NULL
3	NULL
competitor	NULL
=	NULL
_-	NULL
34	NULL
«	NULL
«	NULL
-	NULL
i	NULL
maa	NULL
,	NULL
``	NULL
HxB2	NULL
s	NULL
s	NULL
s	NULL
%	NULL
_L	NULL
Bi	NULL
Lar	NULL
$	NULL
6	NULL
510-8	NULL
,	NULL
Ben	NULL
3	NULL
!	NULL

#	NULL
as	NULL
UW	NULL
W	NULL
e	NULL
-	NULL
w	NULL
i	NULL
-_	NULL
B2	NULL
SF2	NULL
5	NULL
iG	NULL
0008	NULL
se	NULL
s	NULL
s	NULL
.	NULL

Raji	NULL
Jrcer	NULL
5	NULL
ru	NULL
naa	NULL
au	NULL
's	NULL
3+	NULL
ort	NULL
s	NULL
er	NULL
3	NULL
.	NULL

©	NULL
=	NULL
aB	NULL
ee	NULL
e	NULL
s	NULL
o	NULL
s	NULL
«	NULL
-	NULL
B4	NULL
CAML	NULL
5	NULL
3	NULL
_	NULL
B1	NULL
PU-box	NULL
3°	NULL
AAGGAG	NULL
5°	NULL
Etsl	NULL
consensus	NULL
5°	NULL
GGA	NULL
5A	NULL
3+	NULL
U937	NULL
@	NULL
a-	NULL
a	NULL
a	NULL
u	NULL
u	NULL
v	NULL
v	NULL
o	NULL
o	NULL
&	NULL
-	NULL
«	NULL
B4	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
15	NULL
16	NULL
17	NULL
18	NULL
19	NULL
probe	NULL
’	NULL
_	NULL
U1-SITE	NULL
B	NULL
—|	NULL
l—SFZ-SITE	NULL
B	NULL
_|	NULL
R	NULL
a	NULL
we	NULL
lat	NULL
&	NULL
=	NULL
&	NULL
E	NULL
$	NULL
g	NULL
tn	NULL
v	NULL
$	NULL
Ao	NULL
§	NULL
z	NULL
&	NULL
n	NULL
-	NULL
G	NULL
a	NULL
€	NULL
%	NULL
4	NULL
mo	NULL
.	NULL

E=	NULL
£24	NULL
Bo	NULL
%	NULL
.	NULL

5	NULL
%	NULL
extract	NULL
__	NULL
&	NULL
4	NULL
8	NULL
3	NULL
§	NULL
§	NULL
2	NULL
2	NULL
$	NULL
4	NULL
6	NULL
2	NULL
§	NULL
§	NULL
i	NULL
2	NULL
D	NULL
an	NULL
de	NULL
w	NULL
»	NULL
am	NULL
«	NULL
%	NULL
m	NULL
cam	NULL
am	NULL
ae	NULL
a~	NULL
%	NULL
&	NULL
&	NULL
Fa	NULL
~	NULL
B1	NULL
__	NULL
t	NULL
...	NULL
#	NULL
wut	NULL
Yog	NULL
Nut	NULL
at	NULL
O	NULL
)	NULL
mat	NULL
mat	NULL
tut	NULL
th	NULL
ltt	NULL
_-	NULL
C	NULL
1	NULL
&	NULL
*	NULL
N	NULL
&	NULL
,	NULL
¥	NULL
_	NULL
.	NULL

>	NULL
o	NULL
¢	NULL
¢	NULL
¢	NULL
B2	NULL
.	NULL

Q	NULL
wll	NULL
__	NULL
s	NULL
>	NULL
&	NULL
C	NULL
f	NULL
-	NULL
~	NULL
£	NULL
o	NULL
a	NULL
``	NULL
a	NULL
B3	NULL
,	NULL
°	NULL
o	NULL
-_	NULL
``	NULL
Wt	NULL
wt	NULL
wp	NULL
wo	NULL
«	NULL
B3	NULL
competitor	NULL
\_	NULL
e	NULL
le	NULL
tre	NULL
}	NULL
ie	NULL
cl	NULL
e	NULL
]	NULL
we	NULL
B4	NULL
-	NULL
»	NULL
«	NULL
e	NULL
@	NULL
we	NULL
L-B1	NULL
©	NULL
.	NULL

Raji	NULL
a	NULL
``	NULL
®	NULL
wt	NULL
g	NULL
w	NULL
«	NULL
~	NULL
w	NULL
w	NULL
¥	NULL
w	NULL
-	NULL
.	NULL
'	NULL

W	NULL
=	NULL
’	NULL
.	NULL

'.w	NULL
<	NULL
-	NULL
B2	NULL
ww*	NULL
B1	NULL
uve	NULL
-uwu	NULL
@	NULL
u	NULL
-	NULL
w-	NULL
ft	NULL
CEM	NULL
#	NULL
#	NULL
tt	NULL
=	NULL
»	NULL
we	NULL
tas	NULL
wt	NULL
we	NULL
wt	NULL
we	NULL
«	NULL
tt	NULL
**	NULL
``	NULL
-	NULL
B3	NULL
FP	NULL
-	NULL
»	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
15	NULL
16	NULL
17	NULL
18	NULL
19	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
15	NULL
16	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

EMSA	NULL
analysis	NULL
of	NULL
nuclear	NULL
factors	NULL
binding	NULL
to	NULL
site	NULL
B	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Alignment	NULL
of	NULL
the	NULL
site	NULL
B	NULL
regions	NULL
from	NULL
several	NULL
sequenced	NULL
HIV-1	NULL
isolates	NULL
.	NULL

Data	NULL
were	NULL
retrieved	NULL
from	NULL
reference	NULL
57	NULL
.	NULL

The	NULL
site	NULL
B	NULL
oligonucleotide	NULL
(	NULL
nt	NULL
4519	NULL
to	NULL
4545	NULL
)	NULL
is	NULL
indicated	NULL
by	NULL
a	NULL
line	NULL
above	NULL
the	NULL
sequence	NULL
.	NULL

Nucleotides	NULL
different	NULL
from	NULL
the	NULL
U1	NULL
sequence	NULL
are	NULL
indicated	NULL
.	NULL

The	NULL
potential	NULL
Ets1	NULL
consensus	NULL
binding	NULL
site	NULL
and	NULL
PU	NULL
box	NULL
are	NULL
indicated	NULL
.	NULL

(	NULL
B	NULL
)	NULL
U1	NULL
site	NULL
B	NULL
and	NULL
SF2	NULL
site	NULL
B	NULL
oligonucleotide	NULL
probes	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
8	NULL
and	NULL
9	NULL
to	NULL
16	NULL
,	NULL
respectively	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
human	NULL
cell	NULL
lines	NULL
of	NULL
different	NULL
origins	NULL
(	NULL
indicated	NULL
above	NULL
the	NULL
lanes	NULL
)	NULL
.	NULL

Retarded	NULL
DNA-protein	NULL
complexes	NULL
(	NULL
B1	NULL
,	NULL
B2	NULL
,	NULL
B3	NULL
,	NULL
and	NULL
B4	NULL
)	NULL
and	NULL
the	NULL
free	NULL
probes	NULL
(	NULL
FP	NULL
)	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
.	NULL

(	NULL
C	NULL
)	NULL
The	NULL
U1	NULL
site	NULL
B	NULL
oligonucleotide	NULL
probe	NULL
was	NULL
incubated	NULL
with	NULL
nuclear	NULL
extract	NULL
from	NULL
Raji	NULL
or	NULL
U937	NULL
cells	NULL
.	NULL

Binding	NULL
assays	NULL
were	NULL
performed	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
competitor	NULL
(	NULL
lanes	NULL
1	NULL
)	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
4	NULL
(	NULL
lanes	NULL
2	NULL
,	NULL
5	NULL
,	NULL
8	NULL
,	NULL
11	NULL
,	NULL
14	NULL
,	NULL
and	NULL
17	NULL
)	NULL
-	NULL
,	NULL
20	NULL
(	NULL
lanes	NULL
3	NULL
,	NULL
6	NULL
,	NULL
9	NULL
,	NULL
12	NULL
,	NULL
15	NULL
,	NULL
and	NULL
18	NULL
)	NULL
-	NULL
,	NULL
or	NULL
100	NULL
(	NULL
lanes	NULL
4	NULL
,	NULL
7	NULL
,	NULL
10	NULL
,	NULL
13	NULL
,	NULL
16	NULL
,	NULL
and	NULL
19	NULL
)	NULL
-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
specific	NULL
competitor	NULL
oligonucleotides	NULL
.	NULL

The	NULL
competitors	NULL
used	NULL
are	NULL
indicated	NULL
above	NULL
the	NULL
lanes	NULL
.	NULL

The	NULL
figure	NULL
shows	NULL
only	NULL
the	NULL
specific	NULL
retarded	NULL
bands	NULL
of	NULL
interest	NULL
.	NULL

(	NULL
D	NULL
)	NULL
The	NULL
SF2	NULL
site	NULL
B	NULL
oligonucleotide	NULL
probe	NULL
was	NULL
incubated	NULL
with	NULL
nuclear	NULL
extract	NULL
from	NULL
Raji	NULL
or	NULL
CEM	NULL
cells	NULL
.	NULL

Binding	NULL
assays	NULL
were	NULL
performed	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
competitor	NULL
(	NULL
lanes	NULL
1	NULL
)	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
4	NULL
(	NULL
lanes	NULL
2	NULL
,	NULL
5	NULL
,	NULL
8	NULL
,	NULL
11	NULL
,	NULL
14	NULL
,	NULL
and	NULL
17	NULL
)	NULL
-	NULL
,	NULL
20	NULL
(	NULL
lanes	NULL
3	NULL
,	NULL
6	NULL
,	NULL
9	NULL
,	NULL
12	NULL
,	NULL
15	NULL
,	NULL
and	NULL
18	NULL
)	NULL
-	NULL
,	NULL
or	NULL
100	NULL
(	NULL
lanes	NULL
4	NULL
,	NULL
7	NULL
,	NULL
10	NULL
,	NULL
13	NULL
,	NULL
16	NULL
,	NULL
and	NULL
19	NULL
)	NULL
-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
specific	NULL
competitor	NULL
oligonucleotides	NULL
.	NULL

The	NULL
competitors	NULL
used	NULL
are	NULL
indicated	NULL
at	NULL
the	NULL
top	NULL
of	NULL
each	NULL
lane	NULL
.	NULL

The	NULL
figure	NULL
shows	NULL
only	NULL
the	NULL
specific	NULL
retarded	NULL
bands	NULL
of	NULL
interest	NULL
.	NULL

previously	NULL
described	NULL
high-affinity	NULL
Ets1	NULL
binding	NULL
site	NULL
(	NULL
32	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
but	NULL
not	NULL
by	NULL
the	NULL
same	NULL
oligonucleotide	NULL
containing	NULL
a	NULL
mutation	NULL
that	NULL
eliminates	NULL
Ets1	NULL
binding	NULL
(	NULL
ETSimut	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

No	NULL
complex	NULL
was	NULL
formed	NULL
in	NULL
similar	NULL
EMSAs	NULL
with	NULL
the	NULL
homologous	NULL
region	NULL
of	NULL
NYS	NULL
as	NULL
a	NULL
probe	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
recognition	NULL
core	NULL
sequence	NULL
5'-GGA	NULL
(	NULL
A/T	NULL
)	NULL
-3	NULL
'	NULL
is	NULL
present	NULL
in	NULL
the	NULL
Ets-binding	NULL
sites	NULL
described	NULL
so	NULL
far	NULL
for	NULL
Ets1	NULL
,	NULL
Erg	NULL
,	NULL
Elf-1	NULL
,	NULL
E74	NULL
,	NULL
PEA3	NULL
,	NULL
Spi-1/PU.1	NULL
,	NULL
and	NULL
Spi-B	NULL
and	NULL
appears	NULL
to	NULL
be	NULL
essential	NULL
for	NULL
Ets	NULL
proteins	NULL
to	NULL
bind	NULL
DNA	NULL
(	NULL
42	NULL
,	NULL
60	NULL
,	NULL
85	NULL
)	NULL
.	NULL

However	NULL
,	NULL
multiple	NULL
Ets	NULL
family	NULL
members	NULL
display	NULL
distinct	NULL
DNA-binding	NULL
specificities	NULL
that	NULL
are	NULL
determined	NULL
in	NULL
part	NULL
by	NULL
the	NULL
bases	NULL
flanking	NULL
this	NULL
sequence	NULL
(	NULL
11	NULL
,	NULL
74	NULL
,	NULL
85	NULL
,	NULL
86	NULL
)	NULL
.	NULL

For	NULL
this	NULL
reason	NULL
,	NULL
the	NULL
binding	NULL
of	NULL
Ets	NULL
!	NULL

to	NULL
the	NULL
PU	NULL
box	NULL
of	NULL
U1	NULL
site	NULL
B	NULL
and	NULL
the	NULL
binding	NULL
of	NULL
PU.1/Spi-1	NULL
to	NULL
the	NULL
Ets1	NULL
site	NULL
were	NULL
also	NULL
tested	NULL
.	NULL

The	NULL
Ets1	NULL
site	NULL
was	NULL
found	NULL
to	NULL
bind	NULL
only	NULL
Ets1	NULL
and	NULL
not	NULL
PU.1/Spi-1	NULL
,	NULL
whereas	NULL
the	NULL
PU	NULL
box	NULL
bound	NULL
only	NULL
PU.1/Spi-1	NULL
and	NULL
not	NULL
Ets1	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
two	NULL
sites	NULL
identified	NULL
2640	NULL
VAN	NULL
LINT	NULL
ET	NULL
AL	NULL
.	NULL

A	NULL
B	NULL
control	NULL
|	NULL
cos	NULL
extract	NULL
extract	NULL
£5	NULL
Eis	NULL
!	NULL

baculovirus	NULL
Self	NULL
SV40	NULL
PU.1	NULL
$	NULL
V40	NULL
PU	NULL
.	NULL

In	NULL
\	NULL
competitor	NULL
competitor	NULL
a	NULL
>	NULL
__	NULL
buch	NULL
mut	NULL
dart	NULL
Authtnt	NULL
vo	NULL
_.	NULL
Cub	NULL
Aut	NULL
hart	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
1	NULL
Dol	NULL
4s	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Binding	NULL
analysis	NULL
of	NULL
PU.1	NULL
and	NULL
Ets1	NULL
.	NULL

(	NULL
A	NULL
)	NULL
PU.1	NULL
.	NULL

The	NULL
U1	NULL
site	NULL
B	NULL
short	NULL
oligonucleotide	NULL
probe	NULL
(	NULL
nt	NULL
4523	NULL
to	NULL
4542	NULL
)	NULL
was	NULL
incubated	NULL
with	NULL
lysates	NULL
of	NULL
COS1	NULL
cells	NULL
transfected	NULL
with	NULL
AEB-PU.1	NULL
(	NULL
lanes	NULL
2	NULL
to	NULL
9	NULL
)	NULL
or	NULL
lysates	NULL
of	NULL
COS1	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
AEB	NULL
vector	NULL
(	NULL
cos	NULL
control	NULL
[	NULL
lane	NULL
1	NULL
}	NULL
)	NULL
.	NULL

In	NULL
competition	NULL
assays	NULL
,	NULL
the	NULL
homologous	NULL
oligonucileotide	NULL
was	NULL
added	NULL
at	NULL
a	NULL
10	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
-	NULL
,	NULL
40	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
-	NULL
,	NULL
and	NULL
100	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
-fold	NULL
molar	NULL
excess	NULL
;	NULL
an	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
SV40PU.1	NULL
site	NULL
was	NULL
added	NULL
at	NULL
a	NULL
10	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
-	NULL
,	NULL
40	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
-	NULL
,	NULL
and	NULL
100	NULL
(	NULL
lane	NULL
8	NULL
)	NULL
-fold	NULL
molar	NULL
excess	NULL
;	NULL
and	NULL
the	NULL
same	NULL
oligonucleotide	NULL
containing	NULL
a	NULL
mutation	NULL
abolishing	NULL
PU.1	NULL
binding	NULL
(	NULL
SV40PU.1mut	NULL
)	NULL
was	NULL
added	NULL
at	NULL
a	NULL
100-fold	NULL
(	NULL
lane	NULL
9	NULL
)	NULL
molar	NULL
excess	NULL
.	NULL

The	NULL
DNA-protein	NULL
complex	NULL
and	NULL
free	NULL
probe	NULL
(	NULL
FP	NULL
)	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Ets1	NULL
.	NULL

Competition	NULL
EMSAs	NULL
were	NULL
performed	NULL
with	NULL
the	NULL
Etslyyp	NULL
;	NULL
oligonucleotide	NULL
as	NULL
a	NULL
probe	NULL
and	NULL
whole-cell	NULL
extracts	NULL
from	NULL
uninfected	NULL
SF9	NULL
cells	NULL
(	NULL
baculovirus	NULL
control	NULL
)	NULL
or	NULL
from	NULL
SF9	NULL
cells	NULL
infected	NULL
with	NULL
an	NULL
Ac-NPV-Ets	NULL
!	NULL

recombinant	NULL
baculovirus	NULL
(	NULL
Ets1	NULL
baculovirus	NULL
)	NULL
.	NULL

Binding	NULL
reactions	NULL
were	NULL
performed	NULL
either	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
competitor	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
an	NULL
optimized	NULL
high-affinity	NULL
Ets1	NULL
binding	NULL
site	NULL
oligonucleotide	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
mutant	NULL
version	NULL
derived	NULL
from	NULL
it	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
homologous	NULL
Etsl	NULL
xp	NULL
;	NULL
oligonucleotide	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
the	NULL
Ets	NULL
!	NULL

complex	NULL
and	NULL
free	NULL
probe	NULL
(	NULL
FP	NULL
)	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
.	NULL

are	NULL
specific	NULL
for	NULL
the	NULL
binding	NULL
of	NULL
their	NULL
respective	NULL
factor	NULL
of	NULL
the	NULL
Ets	NULL
oncogene	NULL
family	NULL
.	NULL

The	NULL
transcription	NULL
factor	NULL
Spi-1/PU.1	NULL
is	NULL
expressed	NULL
in	NULL
macrophages	NULL
and	NULL
B	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
T-lymphoid	NULL
cell	NULL
lines	NULL
(	NULL
30	NULL
,	NULL
45	NULL
,	NULL
68	NULL
)	NULL
,	NULL
whereas	NULL
Ets1	NULL
is	NULL
known	NULL
to	NULL
be	NULL
expressed	NULL
in	NULL
thymocytes	NULL
and	NULL
T	NULL
cells	NULL
(	NULL
8a	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
our	NULL
data	NULL
suggest	NULL
that	NULL
the	NULL
site	NULL
B	NULL
polymorphism	NULL
could	NULL
be	NULL
responsible	NULL
for	NULL
a	NULL
switch	NULL
from	NULL
a	NULL
macrophage/B-cell	NULL
specificity	NULL
to	NULL
a	NULL
T-cell	NULL
specificity	NULL
.	NULL

Characterization	NULL
of	NULL
nuclear	NULL
factors	NULL
binding	NULL
to	NULL
site	NULL
C.	NULL
Interactions	NULL
of	NULL
nuclear	NULL
factors	NULL
with	NULL
the	NULL
site	NULL
C	NULL
region	NULL
were	NULL
analyzed	NULL
by	NULL
EMSAs	NULL
with	NULL
an	NULL
oligonucleotide	NULL
probe	NULL
(	NULL
site	NULL
C	NULL
[	NULL
nt	NULL
4681	NULL
to	NULL
4701	NULL
]	NULL
)	NULL
centered	NULL
on	NULL
the	NULL
site	NULL
C	NULL
footprint	NULL
described	NULL
above	NULL
.	NULL

Incubation	NULL
of	NULL
this	NULL
probe	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
different	NULL
cell	NULL
lines	NULL
generated	NULL
a	NULL
pattern	NULL
of	NULL
three	NULL
retarded	NULL
complexes	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
:	NULL
a	NULL
ubiquitous	NULL
complex	NULL
(	NULL
complex	NULL
C1	NULL
[	NULL
lanes	NULL
1	NULL
to	NULL
9	NULL
]	NULL
)	NULL
,	NULL
a	NULL
B-cell-specific	NULL
complex	NULL
(	NULL
complex	NULL
C2	NULL
[	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
]	NULL
)	NULL
,	NULL
and	NULL
a	NULL
T-cell-specific	NULL
complex	NULL
(	NULL
complex	NULL
C3	NULL
[	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
]	NULL
)	NULL
.	NULL

This	NULL
pattern	NULL
was	NULL
highly	NULL
reminiscent	NULL
of	NULL
that	NULL
observed	NULL
with	NULL
site	NULL
B	NULL
,	NULL
except	NULL
for	NULL
the	NULL
B4	NULL
complex	NULL
,	NULL
suggesting	NULL
that	NULL
site	NULL
B	NULL
and	NULL
site	NULL
C	NULL
bind	NULL
the	NULL
same	NULL
nuclear	NULL
factors	NULL
.	NULL

The	NULL
specificities	NULL
of	NULL
the	NULL
complexes	NULL
were	NULL
demonstrated	NULL
by	NULL
competition	NULL
experiments	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

When	NULL
a	NULL
CEM	NULL
nuclear	NULL
extract	NULL
was	NULL
used	NULL
,	NULL
complexes	NULL
C1	NULL
and	NULL
C3	NULL
were	NULL
outcompeted	NULL
by	NULL
the	NULL
homologous	NULL
site	NULL
C	NULL
oligonucleotide	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
,	NULL
lanes	NULL
2	NULL
to	NULL
4	NULL
)	NULL
or	NULL
by	NULL
an	NULL
oligonucleotide	NULL
containing	NULL
site	NULL
B	NULL
(	NULL
HXB2	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
,	NULL
lanes	NULL
8	NULL
to	NULL
10	NULL
)	NULL
but	NULL
not	NULL
by	NULL
the	NULL
NF-kB	NULL
oligonucleotide	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
,	NULL
lanes	NULL
5	NULL
to	NULL
7	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
in	NULL
competition	NULL
EMSAs	NULL
with	NULL
a	NULL
Raji	NULL
or	NULL
U937	NULL
nuclear	NULL
extract	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
reverse	NULL
experiments	NULL
in	NULL
which	NULL
a	NULL
labeled	NULL
probe	NULL
containing	NULL
site	NULL
B	NULL
was	NULL
used	NULL
and	NULL
inhibited	NULL
by	NULL
unlabeled	NULL
oligonucleotide	NULL
containing	NULL
site	NULL
C	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
,	NULL
lanes	NULL
J	NULL
.	NULL

Vigor	NULL
.	NULL

11	NULL
to	NULL
13	NULL
,	NULL
and	NULL
D	NULL
,	NULL
lanes	NULL
8	NULL
to	NULL
10	NULL
)	NULL
confirmed	NULL
that	NULL
site	NULL
B	NULL
and	NULL
site	NULL
C	NULL
oligonucleotides	NULL
are	NULL
recognized	NULL
by	NULL
related	NULL
proteins	NULL
.	NULL

We	NULL
conclude	NULL
from	NULL
these	NULL
experiments	NULL
that	NULL
site	NULL
C	NULL
specifically	NULL
binds	NULL
three	NULL
distinct	NULL
nuclear	NULL
protein	NULL
complexes	NULL
and	NULL
that	NULL
the	NULL
factors	NULL
binding	NULL
to	NULL
site	NULL
C	NULL
have	NULL
a	NULL
DNA-binding	NULL
specificity	NULL
similar	NULL
to	NULL
those	NULL
of	NULL
factors	NULL
B1	NULL
,	NULL
B2	NULL
,	NULL
and	NULL
B3	NULL
binding	NULL
to	NULL
site	NULL
B.	NULL
Methylation	NULL
interference	NULL
analysis	NULL
of	NULL
site	NULL
C	NULL
was	NULL
performed	NULL
to	NULL
identify	NULL
contact	NULL
guanine	NULL
and	NULL
adenine	NULL
residues	NULL
in	NULL
the	NULL
DNA-binding	NULL
site	NULL
.	NULL

An	NULL
oligonucleotide	NULL
consisting	NULL
of	NULL
site	NULL
C	NULL
(	NULL
nt	NULL
4683	NULL
to	NULL
4716	NULL
)	NULL
was	NULL
5	NULL
end	NULL
labeled	NULL
on	NULL
the	NULL
coding	NULL
strand	NULL
,	NULL
partially	NULL
methylated	NULL
with	NULL
dimethyl	NULL
sulfate	NULL
,	NULL
incubated	NULL
with	NULL
extract	NULL
,	NULL
and	NULL
subjected	NULL
to	NULL
EMSAs	NULL
.	NULL

DNAs	NULL
were	NULL
isolated	NULL
from	NULL
complexes	NULL
C1	NULL
,	NULL
C2	NULL
,	NULL
and	NULL
C3	NULL
and	NULL
from	NULL
the	NULL
free	NULL
probe	NULL
and	NULL
were	NULL
treated	NULL
with	NULL
piperidine	NULL
to	NULL
cleave	NULL
the	NULL
phosphodiester	NULL
backbone	NULL
at	NULL
the	NULL
position	NULL
of	NULL
each	NULL
methylated	NULL
base	NULL
.	NULL

The	NULL
positions	NULL
in	NULL
the	NULL
DNA	NULL
sequence	NULL
at	NULL
which	NULL
methylation	NULL
interfered	NULL
with	NULL
formation	NULL
of	NULL
the	NULL
complex	NULL
were	NULL
revealed	NULL
by	NULL
comparison	NULL
of	NULL
the	NULL
cleavage	NULL
patterns	NULL
of	NULL
DNAs	NULL
from	NULL
the	NULL
retarded	NULL
and	NULL
from	NULL
the	NULL
free	NULL
probes	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6C	NULL
,	NULL
analysis	NULL
of	NULL
DNA	NULL
purified	NULL
from	NULL
complex	NULL
C3	NULL
showed	NULL
that	NULL
methylation	NULL
of	NULL
the	NULL
guanine	NULL
residue	NULL
at	NULL
position	NULL
4691	NULL
on	NULL
the	NULL
coding	NULL
strand	NULL
abolished	NULL
formation	NULL
of	NULL
this	NULL
complex	NULL
.	NULL

The	NULL
guanine	NULL
residue	NULL
at	NULL
position	NULL
4683	NULL
could	NULL
not	NULL
be	NULL
examined	NULL
with	NULL
the	NULL
probe	NULL
used	NULL
.	NULL

The	NULL
same	NULL
analysis	NULL
was	NULL
carried	NULL
out	NULL
with	NULL
complexes	NULL
C1	NULL
and	NULL
C2	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
and	NULL
the	NULL
same	NULL
guanine	NULL
residue	NULL
at	NULL
position	NULL
4691	NULL
was	NULL
identified	NULL
to	NULL
be	NULL
important	NULL
for	NULL
binding	NULL
,	NULL
suggesting	NULL
the	NULL
presence	NULL
of	NULL
overlapping	NULL
binding	NULL
sites	NULL
in	NULL
site	NULL
C	NULL
or	NULL
competition	NULL
among	NULL
factors	NULL
for	NULL
a	NULL
same	NULL
site	NULL
.	NULL

The	NULL
T-cell-specific	NULL
factor	NULL
binding	NULL
to	NULL
sites	NULL
B	NULL
and	NULL
C	NULL
is	NULL
distinct	NULL
from	NULL
TCF-1/TCF-1	NULL
«	NULL
.	NULL

Computer	NULL
analysis	NULL
of	NULL
DNA	NULL
sequences	NULL
of	NULL
sites	NULL
B	NULL
and	NULL
C	NULL
revealed	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
potential	NULL
binding	NULL
site	NULL
for	NULL
two	NULL
highly	NULL
related	NULL
T-cell-specific	NULL
transcription	NULL
factors	NULL
,	NULL
TCF-1	NULL
and	NULL
TCF-1a	NULL
(	NULL
48	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
T-cell-specific	NULL
factor	NULL
binding	NULL
to	NULL
sites	NULL
B	NULL
and	NULL
C	NULL
belongs	NULL
to	NULL
the	NULL
TCF-1/TCF-1	NULL
«	NULL
family	NULL
,	NULL
EMSAs	NULL
were	NULL
carried	NULL
out	NULL
with	NULL
oligonucleotides	NULL
corresponding	NULL
to	NULL
two	NULL
distinct	NULL
TCF-1	NULL
elements	NULL
:	NULL
the	NULL
TCF-1a	NULL
«	NULL
motif	NULL
of	NULL
the	NULL
T-cell	NULL
receptor	NULL
«	NULL
enhancer	NULL
(	NULL
87	NULL
)	NULL
and	NULL
the	NULL
TCF-1	NULL
motif	NULL
of	NULL
the	NULL
CD3e	NULL
gene	NULL
enhancer	NULL
(	NULL
80	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

As	NULL
previously	NULL
reported	NULL
(	NULL
87	NULL
)	NULL
,	NULL
a	NULL
T-cell-specific	NULL
factor	NULL
bound	NULL
to	NULL
the	NULL
TCF-1a	NULL
oligonucleotide	NULL
probe	NULL
(	NULL
complex	NULL
Ta	NULL
;	NULL
Fig	NULL
.	NULL

7B	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

The	NULL
TCF-1	NULL
oligonucleotide	NULL
probe	NULL
yielded	NULL
the	NULL
same	NULL
pattern	NULL
of	NULL
bands	NULL
as	NULL
the	NULL
TCF-la	NULL
«	NULL
probe	NULL
,	NULL
with	NULL
the	NULL
addition	NULL
of	NULL
a	NULL
faster	NULL
migrating	NULL
complex	NULL
detected	NULL
with	NULL
all	NULL
nuclear	NULL
extracts	NULL
tested	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Comparison	NULL
with	NULL
site	NULL
C	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
,	NULL
lanes	NULL
7	NULL
to	NULL
12	NULL
)	NULL
revealed	NULL
that	NULL
the	NULL
T-cell-specific	NULL
complex	NULL
that	NULL
we	NULL
identified	NULL
(	NULL
C3	NULL
)	NULL
migrated	NULL
more	NULL
slowly	NULL
than	NULL
complex	NULL
Ta	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
,	NULL
compare	NULL
lanes	NULL
2	NULL
to	NULL
3	NULL
with	NULL
lanes	NULL
8	NULL
to	NULL
9	NULL
)	NULL
and	NULL
that	NULL
the	NULL
doublet	NULL
characteristic	NULL
of	NULL
the	NULL
TCF-1	NULL
«	NULL
and	NULL
TCF-1	NULL
probes	NULL
with	NULL
the	NULL
CEM	NULL
nuclear	NULL
extract	NULL
was	NULL
not	NULL
observed	NULL
with	NULL
the	NULL
site	NULL
C	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
,	NULL
compare	NULL
lane	NULL
2	NULL
with	NULL
lane	NULL
8	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
T-cell-specific	NULL
factor	NULL
present	NULL
in	NULL
complex	NULL
C3	NULL
is	NULL
different	NULL
from	NULL
TCF-1/TCF-1	NULL
«	NULL
.	NULL

Competition	NULL
experiments	NULL
with	NULL
TCF-1a	NULL
«	NULL
and	NULL
site	NULL
C	NULL
probes	NULL
and	NULL
a	NULL
CEM	NULL
nuclear	NULL
extract	NULL
confirmed	NULL
this	NULL
prediction	NULL
(	NULL
Fig	NULL
.	NULL

7C	NULL
)	NULL
.	NULL

Complex	NULL
Ta	NULL
was	NULL
efficiently	NULL
inhibited	NULL
by	NULL
unlabeled	NULL
homologous	NULL
oligonucleotide	NULL
(	NULL
Fig	NULL
.	NULL

7C	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
but	NULL
not	NULL
by	NULL
unrelated	NULL
oligonucleotides	NULL
containing	NULL
a	NULL
NF-kB	NULL
or	NULL
an	NULL
AP-1	NULL
binding	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

7C	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

The	NULL
TCF-1	NULL
oligonucleotide	NULL
was	NULL
a	NULL
effective	NULL
competitor	NULL
of	NULL
binding	NULL
to	NULL
the	NULL
TCF-1	NULL
«	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

7C	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
confirming	NULL
that	NULL
the	NULL
same	NULL
T-cell	NULL
factor	NULL
binds	NULL
to	NULL
both	NULL
sites	NULL
.	NULL

Both	NULL
site	NULL
C	NULL
and	NULL
site	NULL
B	NULL
(	NULL
HXB2	NULL
)	NULL
oligonucleotides	NULL
partially	NULL
competed	NULL
for	NULL
formation	NULL
of	NULL
complex	NULL
Ta	NULL
(	NULL
Fig	NULL
.	NULL

7C	NULL
,	NULL
lanes	NULL
6	NULL
and	NULL
7	NULL
,	NULL
respec-tively	NULL
)	NULL
.	NULL

These	NULL
results	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
low-affinity	NULL
TCF-1	NULL
binding	NULL
site	NULL
in	NULL
site	NULL
B	NULL
and	NULL
site	NULL
C	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
T-cell	NULL
factor	NULL
present	NULL
in	NULL
complex	NULL
C3	NULL
was	NULL
distinct	NULL
from	NULL
TCF-1/TCF-1	NULL
«	NULL
,	NULL
since	NULL
it	NULL
was	NULL
not	NULL
inhibited	NULL
by	NULL
either	NULL
the	NULL
TCF-1	NULL
«	NULL
or	NULL
the	NULL
TCF-1	NULL
oligonucleotide	NULL
(	NULL
Fig	NULL
.	NULL

7C	NULL
,	NULL
lanes	NULL
12	NULL
and	NULL
13	NULL
,	NULL
respectively	NULL
)	NULL
but	NULL
was	NULL
well	NULL
inhibited	NULL
by	NULL
site	NULL
B	NULL
(	NULL
HXB2	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

Vor	NULL
.	NULL

68	NULL
,	NULL
1994	NULL
A	NULL
HeLaS3	NULL
nuclear	NULL
extract	NULL
«	NULL
--	NULL
C1	NULL
-	NULL
C2	NULL
None	NULL
-	NULL
Self	NULL
NF-kB	NULL
_	NULL
Site	NULL
B	NULL
(	NULL
HXB2	NULL
)	NULL
__|	NULL
c	NULL
]	NULL
#	NULL
v	NULL
-	NULL
W	NULL
we	NULL
#	NULL
9	NULL
in	NULL
in	NULL
us	NULL
competitor	NULL
<	NULL
-	NULL
C1	NULL
«	NULL
C3	NULL
1	NULL
%	NULL
:	NULL
%	NULL
07	NULL
%	NULL
9	NULL
10	NULL
DNA-BINDING	NULL
MOTIFS	NULL
IN	NULL
THE	NULL
HIV-1	NULL
po	NULL
!	NULL

GENE	NULL
2641	NULL
C	NULL
coding	NULL
strand	NULL
be	NULL
|	NULL
C	NULL
f	NULL
I	NULL
free	NULL
nt	NULL
4709	NULL
FP	NULL
A	NULL
PHJ	NULL
``	NULL
mm	NULL
,	NULL
nt	NULL
4688	NULL
nt	NULL
4681	NULL
l	NULL
nt	NULL
4716	NULL
|	NULL
+	NULL
+	NULL
s	NULL
I	NULL
.	NULL

,	NULL
gs	NULL
5	NULL
SITE	NULL
C	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

EMSA	NULL
and	NULL
methylation	NULL
interference	NULL
analysis	NULL
of	NULL
site	NULL
C.	NULL
(	NULL
A	NULL
)	NULL
The	NULL
site	NULL
C	NULL
oligonucleotide	NULL
probe	NULL
was	NULL
incubated	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
different	NULL
cell	NULL
lines	NULL
(	NULL
indicated	NULL
at	NULL
the	NULL
top	NULL
of	NULL
each	NULL
lane	NULL
)	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
complexes	NULL
C1	NULL
,	NULL
C2	NULL
,	NULL
and	NULL
C3	NULL
and	NULL
of	NULL
the	NULL
free	NULL
probe	NULL
(	NULL
FP	NULL
)	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
site	NULL
C	NULL
probe	NULL
was	NULL
incubated	NULL
with	NULL
a	NULL
CEM	NULL
nuclear	NULL
extract	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
competitor	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
increasing	NULL
molar	NULL
excesses	NULL
(	NULL
10-	NULL
,	NULL
40-	NULL
,	NULL
and	NULL
100-fold	NULL
)	NULL
of	NULL
the	NULL
homologous	NULL
oligonucleotide	NULL
(	NULL
lanes	NULL
2	NULL
,	NULL
3	NULL
,	NULL
and	NULL
4	NULL
)	NULL
,	NULL
of	NULL
an	NULL
NF-kB	NULL
binding	NULL
site	NULL
oligonucleotide	NULL
(	NULL
lanes	NULL
5	NULL
,	NULL
6	NULL
,	NULL
and	NULL
7	NULL
)	NULL
or	NULL
of	NULL
HXB2	NULL
site	NULL
B	NULL
oligonucleotide	NULL
(	NULL
lanes	NULL
8	NULL
,	NULL
9	NULL
,	NULL
and	NULL
10	NULL
)	NULL
.	NULL

Retarded	NULL
complexes	NULL
are	NULL
indicated	NULL
(	NULL
C1	NULL
and	NULL
C3	NULL
)	NULL
.	NULL

The	NULL
figure	NULL
shows	NULL
only	NULL
the	NULL
specific	NULL
retarded	NULL
bands	NULL
of	NULL
interest	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Methylation	NULL
interference	NULL
analysis	NULL
of	NULL
site	NULL
C.	NULL
An	NULL
oligonucleotide	NULL
(	NULL
nt	NULL
4683	NULL
to	NULL
4716	NULL
)	NULL
consisting	NULL
of	NULL
site	NULL
C	NULL
was	NULL
5	NULL
'	NULL
end	NULL
labeled	NULL
on	NULL
the	NULL
coding	NULL
strand	NULL
,	NULL
partially	NULL
methylated	NULL
with	NULL
dimethyl	NULL
sulfate	NULL
,	NULL
and	NULL
subjected	NULL
to	NULL
EMSA	NULL
with	NULL
a	NULL
CEM	NULL
nuclear	NULL
extract	NULL
.	NULL

Complexes	NULL
C3	NULL
(	NULL
bound	NULL
)	NULL
and	NULL
free	NULL
probe	NULL
were	NULL
isolated	NULL
and	NULL
chemically	NULL
cleaved	NULL
by	NULL
piperidine	NULL
.	NULL

Cleavage	NULL
products	NULL
were	NULL
separated	NULL
on	NULL
a	NULL
15	NULL
%	NULL
denaturing	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

Asterisks	NULL
indicate	NULL
the	NULL
guanine	NULL
residues	NULL
.	NULL

The	NULL
position	NULL
of	NULL
the	NULL
guanine	NULL
residue	NULL
that	NULL
was	NULL
contacted	NULL
by	NULL
the	NULL
protein	NULL
is	NULL
indicated	NULL
by	NULL
an	NULL
arrow	NULL
.	NULL

At	NULL
the	NULL
bottom	NULL
,	NULL
the	NULL
sequence	NULL
of	NULL
the	NULL
site	NULL
C	NULL
region	NULL
is	NULL
shown	NULL
along	NULL
with	NULL
the	NULL
methylation	NULL
interference	NULL
data	NULL
.	NULL

The	NULL
numbers	NULL
above	NULL
the	NULL
DNA	NULL
sequence	NULL
represent	NULL
the	NULL
positions	NULL
of	NULL
the	NULL
nucleotides	NULL
in	NULL
the	NULL
HIV-1yy	NULL
,	NULL
genome	NULL
.	NULL

7C	NULL
,	NULL
lane	NULL
14	NULL
)	NULL
.	NULL

Similar	NULL
competition	NULL
experiments	NULL
with	NULL
a	NULL
Jurkat	NULL
nuclear	NULL
extract	NULL
or	NULL
the	NULL
TCF-1	NULL
oligonucleotide	NULL
probe	NULL
showed	NULL
identical	NULL
results	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
sites	NULL
B	NULL
and	NULL
C	NULL
contain	NULL
a	NULL
high-affinity	NULL
binding	NULL
site	NULL
for	NULL
a	NULL
T-cell	NULL
factor	NULL
that	NULL
is	NULL
distinct	NULL
from	NULL
TCF-1/TCF-1	NULL
«	NULL
.	NULL

The	NULL
intragenic	NULL
hypersensitive	NULL
site	NULL
contains	NULL
a	NULL
binding	NULL
site	NULL
for	NULL
Sp1	NULL
.	NULL

A	NULL
computer	NULL
search	NULL
identified	NULL
a	NULL
potential	NULL
binding	NULL
site	NULL
for	NULL
transcription	NULL
factor	NULL
Spl	NULL
in	NULL
the	NULL
hypersensitive	NULL
site	NULL
region	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
)	NULL
.	NULL

In	NULL
vitro	NULL
DNase	NULL
I	NULL
footprinting	NULL
analysis	NULL
with	NULL
affinity-purified	NULL
human	NULL
Sp1	NULL
resulted	NULL
in	NULL
protection	NULL
of	NULL
a	NULL
GC-rich	NULL
region	NULL
extending	NULL
from	NULL
nt	NULL
4617	NULL
to	NULL
4636	NULL
on	NULL
the	NULL
noncoding	NULL
strand	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
,	NULL
left	NULL
panel	NULL
)	NULL
and	NULL
from	NULL
nt	NULL
4618	NULL
to	NULL
4637	NULL
on	NULL
the	NULL
coding	NULL
strand	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
,	NULL
right	NULL
panel	NULL
)	NULL
.	NULL

Footprints	NULL
on	NULL
both	NULL
strands	NULL
were	NULL
flanked	NULL
by	NULL
sites	NULL
of	NULL
increased	NULL
DNase	NULL
I	NULL
sensitivity	NULL
(	NULL
marked	NULL
by	NULL
the	NULL
arrows	NULL
in	NULL
Fig	NULL
.	NULL

8B	NULL
)	NULL
.	NULL

Since	NULL
the	NULL
Sp1	NULL
site	NULL
was	NULL
not	NULL
perfectly	NULL
conserved	NULL
among	NULL
different	NULL
HIV-1	NULL
isolates	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
)	NULL
,	NULL
we	NULL
also	NULL
examined	NULL
the	NULL
DNase	NULL
I	NULL
protection	NULL
pattern	NULL
of	NULL
the	NULL
potential	NULL
HXB2	NULL
Spl	NULL
site	NULL
on	NULL
both	NULL
strands	NULL
and	NULL
detected	NULL
the	NULL
same	NULL
two	NULL
regions	NULL
protected	NULL
from	NULL
DNase	NULL
I	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
experiments	NULL
demonstrate	NULL
that	NULL
the	NULL
DNA	NULL
sequence	NULL
identified	NULL
by	NULL
homology	NULL
to	NULL
the	NULL
Spl	NULL
consensus	NULL
sequence	NULL
in	NULL
the	NULL
U1l-hypersensitive	NULL
site	NULL
binds	NULL
Spl	NULL
in	NULL
vitro	NULL
.	NULL

Characterization	NULL
of	NULL
nuclear	NULL
factors	NULL
binding	NULL
to	NULL
site	NULL
D.	NULL
Interactions	NULL
of	NULL
nuclear	NULL
factors	NULL
with	NULL
the	NULL
site	NULL
D	NULL
region	NULL
were	NULL
analyzed	NULL
by	NULL
EMSAs	NULL
with	NULL
the	NULL
site	NULL
D	NULL
oligonucleotide	NULL
probe	NULL
(	NULL
nt	NULL
4816	NULL
to	NULL
4851	NULL
)	NULL
.	NULL

Incubation	NULL
of	NULL
this	NULL
probe	NULL
resulted	NULL
in	NULL
one	NULL
major	NULL
nuclear	NULL
protein	NULL
complex	NULL
(	NULL
labeled	NULL
D	NULL
in	NULL
Fig	NULL
.	NULL

9A	NULL
)	NULL
with	NULL
all	NULL
nuclear	NULL
extracts	NULL
tested	NULL
.	NULL

The	NULL
relative	NULL
intensity	NULL
of	NULL
complex	NULL
D	NULL
varied	NULL
among	NULL
cell	NULL
lines	NULL
(	NULL
Fig	NULL
.	NULL

9A	NULL
)	NULL
.	NULL

Complex	NULL
D	NULL
was	NULL
specific	NULL
,	NULL
since	NULL
its	NULL
formation	NULL
was	NULL
suppressed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
excess	NULL
of	NULL
unlabeled	NULL
homologous	NULL
oligonucleotide	NULL
(	NULL
Fig	NULL
.	NULL

9B	NULL
,	NULL
lanes	NULL
2	NULL
to	NULL
5	NULL
)	NULL
but	NULL
not	NULL
by	NULL
an	NULL
excess	NULL
of	NULL
an	NULL
unrelated	NULL
oligonucleotide	NULL
,	NULL
even	NULL
at	NULL
a	NULL
400-fold	NULL
molar	NULL
excess	NULL
(	NULL
Fig	NULL
.	NULL

9B	NULL
,	NULL
lanes	NULL
6	NULL
to	NULL
9	NULL
)	NULL
.	NULL

Methylation	NULL
interference	NULL
analysis	NULL
of	NULL
site	NULL
D	NULL
was	NULL
performed	NULL
for	NULL
both	NULL
strands	NULL
to	NULL
identify	NULL
the	NULL
guanine	NULL
residues	NULL
that	NULL
are	NULL
important	NULL
for	NULL
binding	NULL
.	NULL

Methylation	NULL
of	NULL
two	NULL
guanines	NULL
residues	NULL
at	NULL
positions	NULL
4830	NULL
and	NULL
4833	NULL
on	NULL
the	NULL
coding	NULL
strand	NULL
(	NULL
Fig	NULL
.	NULL

9C	NULL
,	NULL
left	NULL
panel	NULL
)	NULL
and	NULL
of	NULL
one	NULL
guanine	NULL
residue	NULL
at	NULL
position	NULL
4835	NULL
on	NULL
the	NULL
noncoding	NULL
strand	NULL
(	NULL
Fig	NULL
.	NULL

9C	NULL
,	NULL
right	NULL
panel	NULL
)	NULL
was	NULL
shown	NULL
to	NULL
strongly	NULL
interfere	NULL
with	NULL
binding	NULL
to	NULL
site	NULL
D.	NULL
These	NULL
three	NULL
guanine	NULL
residues	NULL
are	NULL
positioned	NULL
in	NULL
the	NULL
center	NULL
of	NULL
the	NULL
region	NULL
identified	NULL
by	NULL
DNase	NULL
I	NULL
footprinting	NULL
analysis	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
T	NULL
residue	NULL
at	NULL
position	NULL
4838	NULL
showed	NULL
enhanced	NULL
intensity	NULL
in	NULL
the	NULL
bound-probe	NULL
lane	NULL
relative	NULL
to	NULL
the	NULL
free-probe	NULL
lane	NULL
(	NULL
Fig	NULL
.	NULL

9C	NULL
)	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
a	NULL
ubiquitously	NULL
expressed	NULL
factor	NULL
interacts	NULL
specifically	NULL
with	NULL
site	NULL
D.	NULL
No	NULL
homology	NULL
to	NULL
any	NULL
of	NULL
the	NULL
published	NULL
DNA	NULL
motifs	NULL
has	NULL
been	NULL
found	NULL
for	NULL
this	NULL
site	NULL
.	NULL

DISCUSSION	NULL
In	NULL
the	NULL
present	NULL
report	NULL
,	NULL
we	NULL
describe	NULL
the	NULL
identification	NULL
and	NULL
physical	NULL
characterization	NULL
of	NULL
a	NULL
transcriptional	NULL
regulatory	NULL
ele-	NULL
2642	NULL
VAN	NULL
LINT	NULL
ET	NULL
AL	NULL
.	NULL

A	NULL
U1-SITE	NULL
B	NULL
5+	NULL
CA	NULL
SF2-SITR	NULL
B	NULL
$	NULL
*	NULL
HXB2-SITE	NULL
B	NULL
5+	NULL
C	NULL
LATI-SITE	NULL
B	NULL
$	NULL
+	NULL
0C	NULL
SITE	NULL
C	NULL
5°	NULL
TAGAATCTATGAATAAAGAAT	NULL
3°	NULL
TCF-10	NULL
(	NULL
GTCR	NULL
)	NULL
5	NULL
'	NULL
GATCTAGGGCACCCTTTGAAGCTCT	NULL
3	NULL
:	NULL
TCF-1	NULL
(	NULL
CD3€	NULL
)	NULL
5+	NULL
3+	NULL
C	NULL
C	NULL
TAA	NULL
TCF-1	NULL
CONSENSUS	NULL
CT	NULL
T	NULL
T	NULL
T	NULL
GTT	NULL
B	NULL
probe	NULL
l	NULL
``	NULL
TCF-1alpha	NULL
-I	NULL
r—	NULL
SITE	NULL
C	NULL
a	NULL
a	NULL
P	NULL
%	NULL
#	NULL
&	NULL
a	NULL
ais	NULL
Phani	NULL
a	NULL
f	NULL
c	NULL
<	NULL
aG	NULL
G	NULL
rj	NULL
g	NULL
nuclear	NULL
extract	NULL
=	NULL
O	NULL
A	NULL
a	NULL
Z	NULL
o	NULL
m	NULL
O	NULL
A	NULL
m	NULL
Z	NULL
D	NULL
a*	NULL
GP	NULL
tt	NULL
«	NULL
_	NULL
C1	NULL
The-	NULL
»	NULL
m.	NULL
st	NULL
C	NULL
3	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
probe	NULL
l—	NULL
TCF-1alpha	NULL
_I	NULL
|——	NULL
SITE	NULL
C	NULL
——	NULL
]	NULL
5	NULL
a	NULL
a	NULL
a	NULL
a	NULL
i	NULL
2	NULL
4	NULL
m	NULL
nok	NULL
$	NULL
a	NULL
-	NULL
a	NULL
n	NULL
E	NULL
s	NULL
$	NULL
2	NULL
fk	NULL
tA	NULL
so	NULL
E	NULL
%	NULL
n	NULL
Lk	NULL
t	NULL
.	NULL

5	NULL
$	NULL
w	NULL
oa	NULL
0	NULL
8	NULL
£	NULL
5	NULL
$	NULL
wok	NULL
0	NULL
0	NULL
£	NULL
competitor	NULL
Z	NULL
I	NULL
Z	NULL
<	NULL
-	NULL
a	NULL
a	NULL
Z	NULL
I	NULL
Z	NULL
<	NULL
hob	NULL
i	NULL
©	NULL
-	NULL
-	NULL
-c	NULL
:	NULL
~-	NULL
#	NULL
#	NULL
8	NULL
s	NULL
#	NULL
-	NULL
wWwwew	NULL
=	NULL
LCs	NULL
10203	NULL
40	NULL
50	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

The	NULL
T-cell-specific	NULL
factor	NULL
binding	NULL
to	NULL
sites	NULL
B	NULL
and	NULL
site	NULL
C	NULL
is	NULL
distinct	NULL
from	NULL
TCF-1/TCF-1	NULL
@	NULL
.	NULL

(	NULL
A	NULL
)	NULL
The	NULL
sequences	NULL
of	NULL
sites	NULL
B	NULL
and	NULL
of	NULL
site	NULL
C	NULL
are	NULL
aligned	NULL
with	NULL
the	NULL
TCF-1	NULL
consensus	NULL
DNA-binding	NULL
site	NULL
(	NULL
48	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
TCF-1a	NULL
«	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
6	NULL
)	NULL
and	NULL
site	NULL
C	NULL
(	NULL
lanes	NULL
7	NULL
to	NULL
12	NULL
)	NULL
oligonucleotide	NULL
probes	NULL
were	NULL
incubated	NULL
with	NULL
different	NULL
nuclear	NULL
extracts	NULL
(	NULL
indicated	NULL
at	NULL
the	NULL
top	NULL
of	NULL
each	NULL
lane	NULL
)	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
the	NULL
free	NULL
probe	NULL
(	NULL
FP	NULL
)	NULL
,	NULL
of	NULL
the	NULL
TCF-l	NULL
«	NULL
complex	NULL
(	NULL
Ta	NULL
)	NULL
,	NULL
and	NULL
of	NULL
complexes	NULL
C1	NULL
,	NULL
C2	NULL
,	NULL
and	NULL
C3	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Competition	NULL
EMSAs	NULL
were	NULL
performed	NULL
with	NULL
oligonucleotide	NULL
TCF-l	NULL
«	NULL
or	NULL
site	NULL
C	NULL
as	NULL
probe	NULL
and	NULL
CEM	NULL
nuclear	NULL
extract	NULL
.	NULL

Binding	NULL
reactions	NULL
were	NULL
performed	NULL
either	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
competitor	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
8	NULL
)	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
50-fold	NULL
molar	NULL
excess	NULL
of	NULL
competitor	NULL
oligonucleotides	NULL
.	NULL

The	NULL
competitors	NULL
used	NULL
are	NULL
indicated	NULL
at	NULL
the	NULL
top	NULL
of	NULL
each	NULL
lane	NULL
.	NULL

Complexes	NULL
Ta	NULL
,	NULL
C1	NULL
,	NULL
and	NULL
C3	NULL
are	NULL
indicated	NULL
.	NULL

The	NULL
figure	NULL
shows	NULL
only	NULL
the	NULL
specific	NULL
retarded	NULL
bands	NULL
of	NULL
interest	NULL
.	NULL

J.	NULL
Viroc	NULL
.	NULL

U1	NULL
cells	NULL
5	NULL
'	NULL
3°	NULL
NYS	NULL
==	NULL
>	NULL
``	NULL
Z	NULL
HXB2	NULL
--	NULL
--	NULL
--	NULL
--	NULL
A	NULL
LAL	NULL
-A	NULL
SF2	NULL
--	NULL
--	NULL
-A	NULL
--	NULL
-JRCSF	NULL
-~	NULL
T	NULL
--	NULL
-oYI	NULL
MN	NULL
~	NULL
--	NULL
A-~-~-A	NULL
SP1	NULL
CONSENSUS	NULL
noncoding	NULL
strand	NULL
coding	NULL
strand	NULL
J	NULL
«	NULL
+	NULL
6	NULL
w	NULL
Warod	NULL
ts	NULL
AH	NULL
|	NULL
#	NULL
#	NULL
48	NULL
&	NULL
tH	NULL
wn	NULL
;	NULL
METH	NULL
¥	NULL
t	NULL
:	NULL
a	NULL
wiqme	NULL
10	NULL
|=	NULL
)	NULL
HI	NULL
II	NULL
MH	NULL
U	NULL
ti	NULL
;	NULL
‘	NULL
t	NULL
‘	NULL
x§	NULL
B8	NULL
'	NULL
m	NULL
m	NULL
Contr	NULL
#	NULL
+	NULL
#	NULL
+	NULL
nt	NULL
4599	NULL
nt	NULL
4652	NULL
1	NULL
|	NULL
}	NULL
I	NULL
}	NULL
a	NULL
5°	NULL
ACTA	NULL
ATT	NULL
3	NULL
!	NULL

3	NULL
%	NULL
3A	NULL
AM	NULL
7	NULL
ACCCGCCCCTA	NULL
A	NULL
AA	NULL
5°	NULL
ttt	NULL
fff	NULL
tht	NULL
fff	NULL
FIG	NULL
.	NULL

8	NULL
.	NULL

DNase	NULL
I	NULL
footprinting	NULL
analysis	NULL
of	NULL
Spl	NULL
binding	NULL
.	NULL

(	NULL
A	NULL
)	NULL
The	NULL
potential	NULL
SpI	NULL
site	NULL
identified	NULL
in	NULL
the	NULL
pol	NULL
gene	NULL
of	NULL
U1	NULL
cells	NULL
is	NULL
aligned	NULL
with	NULL
the	NULL
homologous	NULL
sequences	NULL
of	NULL
other	NULL
HIV-1	NULL
isolates	NULL
and	NULL
with	NULL
the	NULL
Sp1	NULL
consensus	NULL
binding	NULL
site	NULL
.	NULL

Nucleotides	NULL
different	NULL
from	NULL
the	NULL
U1	NULL
sequence	NULL
are	NULL
indicated	NULL
.	NULL

Data	NULL
were	NULL
retrieved	NULL
from	NULL
reference	NULL
57	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
263-bp	NULL
Xhol-Afill	NULL
restriction	NULL
fragment	NULL
(	NULL
nt	NULL
4480	NULL
to	NULL
4743	NULL
)	NULL
of	NULL
plasmid	NULL
pLTR-U1ls	NULL
,	NULL
,	NULL
(	NULL
S	NULL
$	NULL
)	NULL
was	NULL
labeled	NULL
at	NULL
the	NULL
AffIl	NULL
site	NULL
either	NULL
on	NULL
the	NULL
5¢	NULL
end	NULL
on	NULL
the	NULL
noncoding	NULL
strand	NULL
with	NULL
[	NULL
y-*°P	NULL
]	NULL
ATP	NULL
and	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
(	NULL
left	NULL
panel	NULL
)	NULL
or	NULL
on	NULL
the	NULL
3	NULL
'	NULL
end	NULL
on	NULL
the	NULL
coding	NULL
strand	NULL
with	NULL
[	NULL
«	NULL
-P	NULL
]	NULL
dTTP	NULL
and	NULL
the	NULL
Klenow	NULL
fragment	NULL
of	NULL
DNA	NULL
polymerase	NULL
I	NULL
(	NULL
right	NULL
panel	NULL
)	NULL
.	NULL

The	NULL
probes	NULL
were	NULL
partially	NULL
digested	NULL
with	NULL
DNase	NULL
I	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
protein	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
7	NULL
)	NULL
or	NULL
after	NULL
incubation	NULL
with	NULL
1	NULL
footprinting	NULL
unit	NULL
of	NULL
affinity-purified	NULL
Spl	NULL
(	NULL
Promega	NULL
)	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
8	NULL
)	NULL
.	NULL

The	NULL
Spi-protected	NULL
areas	NULL
are	NULL
indicated	NULL
by	NULL
open	NULL
boxes	NULL
.	NULL

Maxam	NULL
and	NULL
Gilbert	NULL
purine	NULL
sequencing	NULL
reaction	NULL
products	NULL
of	NULL
the	NULL
probes	NULL
are	NULL
shown	NULL
in	NULL
the	NULL
two	NULL
leftmost	NULL
lanes	NULL
as	NULL
size	NULL
markers	NULL
.	NULL

Arrows	NULL
indicate	NULL
sites	NULL
of	NULL
increased	NULL
DNase	NULL
I	NULL
sensitivity	NULL
associated	NULL
with	NULL
Vor	NULL
.	NULL

68	NULL
,	NULL
1994	NULL
A	NULL
C	NULL
DNA-BINDING	NULL
MOTIFS	NULL
IN	NULL
THE	NULL
HIV-1	NULL
po/	NULL
GENE	NULL
2643	NULL
C	NULL
coding	NULL
strand	NULL
noncoding	NULL
strand	NULL
&	NULL
c	NULL
&	NULL
5	NULL
&	NULL
£	NULL
£	NULL
3	NULL
3	NULL
nuclear	NULL
extract	NULL
e-	NULL
D	NULL
Z	NULL
m	NULL
9	NULL
®	NULL
©	NULL
©	NULL
Boz	NULL
£	NULL
E	NULL
<	NULL
L	NULL
of	NULL
{	NULL
$	NULL
a	NULL
2	NULL
&	NULL
+0	NULL
$	NULL
30	NULL
$	NULL
+	NULL
3	NULL
$	NULL
0	NULL
E	NULL
4	NULL
E	NULL
0	NULL
&	NULL
A	NULL
&	NULL
E	NULL
&	NULL
8	NULL
~s	NULL
~	NULL
-	NULL
Shas	NULL
a	NULL
»	NULL
«	NULL
#	NULL
D	NULL
-	NULL
D	NULL
ms	NULL
«	NULL
s	NULL
**	NULL
-	NULL
G	NULL
nt	NULL
4842	NULL
8	NULL
2	NULL
=	NULL
:	NULL
a	NULL
»	NULL
€	NULL
«	NULL
»	NULL
as	NULL
G	NULL
--	NULL
we	NULL
3	NULL
z-	NULL
#	NULL
®	NULL
C	NULL
;	NULL
<	NULL
-	NULL
ont	NULL
4835	NULL
am	NULL
.	NULL

we	NULL
C	NULL
«	NULL
«	NULL
>	NULL
mg	NULL
*	NULL
«	NULL
»	NULL
«	NULL
»	NULL
0	NULL
U	NULL
#	NULL
¢	NULL
G	NULL
UD	NULL
ao	NULL
**	NULL
.	NULL

®®	NULL
G	NULL
nt	NULL
4846	NULL
B	NULL
%	NULL
md	NULL
G	NULL
-	NULL
nt	NULL
4820	NULL
P	NULL
5	NULL
!	NULL

5	NULL
!	NULL

None	NULL
Homologous	NULL
-	NULL
Heterologous	NULL
competitor	NULL
$	NULL
A	NULL
A	NULL
nt	NULL
4816	NULL
nt	NULL
4851	NULL
Uw	NULL
--	NULL
-	NULL
babe	NULL
»	NULL
--	NULL
0	NULL
4	NULL
|I	NULL
'	NULL
5°	NULL
CAGCCCAAACAATAGTAGACATAATZ	NULL
AACZ	NULL
A	NULL
3	NULL
!	NULL

3	NULL
!	NULL

5	NULL
``	NULL
I	NULL
2	NULL
3	NULL
4	NULL
50	NULL
6	NULL
7	NULL
8	NULL
%	NULL
9	NULL
|	NULL
tx	NULL
FIG	NULL
.	NULL

9	NULL
.	NULL

EMSA	NULL
and	NULL
methylation	NULL
interference	NULL
analysis	NULL
of	NULL
site	NULL
D.	NULL
(	NULL
A	NULL
)	NULL
Site	NULL
D	NULL
oligonucleotide	NULL
probe	NULL
was	NULL
incubated	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
different	NULL
cell	NULL
lines	NULL
(	NULL
as	NULL
indicated	NULL
at	NULL
the	NULL
top	NULL
of	NULL
each	NULL
lane	NULL
)	NULL
.	NULL

Free	NULL
probe	NULL
(	NULL
FP	NULL
)	NULL
and	NULL
the	NULL
major	NULL
nuclear	NULL
protein	NULL
complex	NULL
(	NULL
D	NULL
)	NULL
generated	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Competition	NULL
EMSAs	NULL
were	NULL
performed	NULL
with	NULL
site	NULL
D	NULL
oligonucleotide	NULL
as	NULL
the	NULL
probe	NULL
and	NULL
CEM	NULL
nuclear	NULL
extract	NULL
.	NULL

Binding	NULL
reactions	NULL
were	NULL
performed	NULL
either	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
competitor	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
50	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
6	NULL
)	NULL
-	NULL
,	NULL
100	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
7	NULL
)	NULL
-	NULL
,	NULL
200	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
8	NULL
)	NULL
-	NULL
,	NULL
or	NULL
400	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
9	NULL
)	NULL
-fold	NULL
molar	NULL
excess	NULL
of	NULL
competitor	NULL
oligonucleotides	NULL
.	NULL

The	NULL
competitors	NULL
used	NULL
were	NULL
either	NULL
the	NULL
homologous	NULL
site	NULL
D	NULL
oligonucleotide	NULL
(	NULL
lanes	NULL
2	NULL
to	NULL
5	NULL
)	NULL
or	NULL
the	NULL
heterologous	NULL
site	NULL
C	NULL
(	NULL
nt	NULL
4683	NULL
to	NULL
4716	NULL
)	NULL
oligonucleotide	NULL
(	NULL
lanes	NULL
6	NULL
to	NULL
9	NULL
)	NULL
.	NULL

Complex	NULL
D	NULL
is	NULL
indicated	NULL
by	NULL
an	NULL
arrow	NULL
.	NULL

The	NULL
figure	NULL
shows	NULL
only	NULL
the	NULL
specific	NULL
retarded	NULL
bands	NULL
of	NULL
interest	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Methylation	NULL
interference	NULL
analysis	NULL
of	NULL
site	NULL
D.	NULL
Site	NULL
D	NULL
oligonucleotide	NULL
was	NULL
5	NULL
'	NULL
end	NULL
labeled	NULL
either	NULL
on	NULL
the	NULL
coding	NULL
strand	NULL
(	NULL
left	NULL
panel	NULL
)	NULL
or	NULL
on	NULL
the	NULL
noncoding	NULL
strand	NULL
(	NULL
right	NULL
panel	NULL
)	NULL
,	NULL
partially	NULL
methylated	NULL
with	NULL
dimethyl	NULL
sulfate	NULL
,	NULL
and	NULL
subjected	NULL
to	NULL
EMSA	NULL
with	NULL
a	NULL
CEM	NULL
nuclear	NULL
extract	NULL
.	NULL

Complex	NULL
D	NULL
(	NULL
bound	NULL
)	NULL
and	NULL
free	NULL
probe	NULL
were	NULL
isolated	NULL
.	NULL

After	NULL
gel	NULL
purification	NULL
,	NULL
DNA	NULL
was	NULL
chemically	NULL
cleaved	NULL
with	NULL
piperidine	NULL
.	NULL

The	NULL
cleavage	NULL
products	NULL
were	NULL
separated	NULL
on	NULL
a	NULL
15	NULL
%	NULL
denaturing	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

Guanine	NULL
residues	NULL
at	NULL
positions	NULL
where	NULL
methylation	NULL
interfered	NULL
with	NULL
binding	NULL
are	NULL
marked	NULL
by	NULL
arrows	NULL
.	NULL

The	NULL
asterisk	NULL
indicates	NULL
a	NULL
site	NULL
of	NULL
increased	NULL
sensitivity	NULL
to	NULL
piperidine	NULL
cleavage	NULL
.	NULL

At	NULL
the	NULL
bottom	NULL
,	NULL
the	NULL
sequence	NULL
of	NULL
site	NULL
D	NULL
is	NULL
shown	NULL
along	NULL
with	NULL
a	NULL
summary	NULL
of	NULL
the	NULL
methylation	NULL
interference	NULL
data	NULL
.	NULL

Numbers	NULL
above	NULL
the	NULL
DNA	NULL
sequence	NULL
represent	NULL
the	NULL
positions	NULL
of	NULL
the	NULL
nucleotides	NULL
in	NULL
the	NULL
HIV-1yy	NULL
;	NULL
genome	NULL
.	NULL

ment	NULL
associated	NULL
with	NULL
a	NULL
DNase	NULL
I-hypersensitive	NULL
site	NULL
present	NULL
in	NULL
the	NULL
pol	NULL
!	NULL

gene	NULL
of	NULL
HIV-1	NULL
.	NULL

High-resolution	NULL
mapping	NULL
of	NULL
the	NULL
pol-hypersensitive	NULL
region	NULL
in	NULL
U1	NULL
cells	NULL
identified	NULL
two	NULL
hypersensitive	NULL
sites	NULL
after	NULL
both	NULL
DNase	NULL
I	NULL
and	NULL
micrococcal	NULL
nuclease	NULL
digestion	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
;	NULL
summarized	NULL
in	NULL
Fig	NULL
.	NULL

10	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
a	NULL
region	NULL
centered	NULL
around	NULL
nt	NULL
4490	NULL
to	NULL
4766	NULL
is	NULL
nucleosome	NULL
free	NULL
in	NULL
vivo	NULL
.	NULL

A	NULL
500-bp	NULL
fragment	NULL
encompassing	NULL
this	NULL
hypersensitive	NULL
region	NULL
positively	NULL
regulated	NULL
transcription	NULL
from	NULL
the	NULL
HIV-1	NULL
LTR	NULL
in	NULL
tran	NULL
Spl	NULL
binding	NULL
.	NULL

(	NULL
C	NULL
)	NULL
The	NULL
nucleotide	NULL
sequences	NULL
of	NULL
the	NULL
coding	NULL
and	NULL
noncoding	NULL
strands	NULL
within	NULL
the	NULL
Sp1	NULL
region	NULL
are	NULL
shown	NULL
.	NULL

Sites	NULL
of	NULL
increased	NULL
DNase	NULL
I	NULL
sensitivity	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
.	NULL

Bars	NULL
above	NULL
and	NULL
below	NULL
the	NULL
sequence	NULL
indicate	NULL
Spl-protected	NULL
areas	NULL
of	NULL
the	NULL
coding	NULL
and	NULL
noncoding	NULL
strands	NULL
,	NULL
respectively	NULL
.	NULL

Numbers	NULL
above	NULL
the	NULL
DNA	NULL
sequence	NULL
represent	NULL
the	NULL
positions	NULL
of	NULL
the	NULL
nucleotides	NULL
in	NULL
the	NULL
HIV-1yy	NULL
,	NULL
genome	NULL
.	NULL

sient	NULL
transfection	NULL
assays	NULL
.	NULL

Several	NULL
sequence	NULL
motifs	NULL
within	NULL
the	NULL
viral	NULL
regulatory	NULL
region	NULL
which	NULL
interact	NULL
specifically	NULL
with	NULL
nuclear	NULL
factors	NULL
in	NULL
vitro	NULL
were	NULL
defined	NULL
physically	NULL
by	NULL
in	NULL
vitro	NULL
DNase	NULL
I	NULL
footprinting	NULL
,	NULL
EMSAs	NULL
,	NULL
and	NULL
methylation	NULL
interference	NULL
experiments	NULL
(	NULL
summarized	NULL
in	NULL
Fig	NULL
.	NULL

10	NULL
)	NULL
.	NULL

DNA-binding	NULL
motifs	NULL
of	NULL
the	NULL
intragenic	NULL
regulatory	NULL
region	NULL
.	NULL

(	NULL
i	NULL
)	NULL
Site	NULL
B	NULL
.	NULL

Site	NULL
B	NULL
displays	NULL
a	NULL
high	NULL
degree	NULL
of	NULL
sequence	NULL
polymor-phism	NULL
;	NULL
however	NULL
,	NULL
this	NULL
polymorphism	NULL
does	NULL
not	NULL
generate	NULL
considerable	NULL
variations	NULL
of	NULL
binding	NULL
specificities	NULL
.	NULL

Four	NULL
nuclear	NULL
protein-DNA	NULL
complexes	NULL
(	NULL
B1	NULL
,	NULL
B2	NULL
,	NULL
B3	NULL
,	NULL
and	NULL
B4	NULL
)	NULL
were	NULL
detected	NULL
in	NULL
EMSAs	NULL
with	NULL
U1	NULL
site	NULL
B	NULL
as	NULL
a	NULL
probe	NULL
.	NULL

Complex	NULL
B4	NULL
was	NULL
demonstrated	NULL
to	NULL
contain	NULL
a	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
related	NULL
to	NULL
the	NULL
transcription	NULL
factor	NULL
PU.1/Spi-1	NULL
.	NULL

This	NULL
PU.1/Spi-1	NULL
proto-oncogene-encoded	NULL
factor	NULL
is	NULL
an	NULL
ets	NULL
gene	NULL
family	NULL
member	NULL
which	NULL
has	NULL
been	NULL
previously	NULL
cloned	NULL
by	NULL
different	NULL
methodologies	NULL
(	NULL
33	NULL
,	NULL
45	NULL
,	NULL
56	NULL
,	NULL
63	NULL
)	NULL
.	NULL

PU.1/Spi-1	NULL
is	NULL
expressed	NULL
in	NULL
erythroid	NULL
cells	NULL
,	NULL
B	NULL
cells	NULL
,	NULL
myelomonocytes	NULL
,	NULL
and	NULL
2644	NULL
VAN	NULL
LINT	NULL
ET	NULL
AL	NULL
.	NULL

DNase	NULL
I	NULL
WWL	NULL
Kink	NULL
Site	NULL
A	NULL
Sp	NULL
)	NULL
Site	NULL
C	NULL
Site	NULL
D	NULL
{	NULL
_	NULL
}	NULL
--	NULL
-m-	NULL
x	NULL
HMH	NULL
_	NULL
H	NULL
micrococcal	NULL
nuclease	NULL
HUA	NULL
Spi	NULL
Bite	NULL
C	NULL
Site	NULL
b	NULL
4982	NULL
corrtar	NULL
u	NULL
|	NULL
-3	NULL
FIG	NULL
.	NULL

10	NULL
.	NULL

Summary	NULL
of	NULL
protein	NULL
binding	NULL
sites	NULL
within	NULL
the	NULL
po	NULL
!	NULL

regulatory	NULL
region	NULL
of	NULL
HIV-1	NULL
.	NULL

The	NULL
results	NULL
from	NULL
nuclease	NULL
digestion	NULL
of	NULL
the	NULL
po	NULL
!	NULL

gene	NULL
are	NULL
combined	NULL
with	NULL
the	NULL
identified	NULL
nuclear	NULL
factor	NULL
binding	NULL
sites	NULL
.	NULL

The	NULL
nuclease-hypersensitive	NULL
sites	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
the	NULL
Ul-hypersensitive	NULL
site	NULL
is	NULL
shown	NULL
,	NULL
with	NULL
bold	NULL
overrules	NULL
indicating	NULL
the	NULL
binding	NULL
sites	NULL
that	NULL
were	NULL
identified	NULL
.	NULL

The	NULL
Ets1	NULL
site	NULL
present	NULL
in	NULL
some	NULL
HIV-1	NULL
isolates	NULL
is	NULL
indicated	NULL
.	NULL

mast	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
nonhematopoietic	NULL
cell	NULL
types	NULL
(	NULL
30	NULL
,	NULL
45	NULL
,	NULL
68	NULL
)	NULL
.	NULL

DNA-binding	NULL
studies	NULL
have	NULL
identified	NULL
the	NULL
consensus	NULL
sequence	NULL
for	NULL
PU.1	NULL
binding	NULL
as	NULL
purine-rich	NULL
segments	NULL
containing	NULL
a	NULL
5-GGAA-3	NULL
'	NULL
core	NULL
sequence	NULL
(	NULL
42	NULL
)	NULL
.	NULL

PU.1/Spi-1	NULL
binding	NULL
sites	NULL
are	NULL
present	NULL
in	NULL
a	NULL
large	NULL
number	NULL
of	NULL
B-lymphoid-	NULL
,	NULL
myeloid-	NULL
,	NULL
and	NULL
erythroid	NULL
cell-specific	NULL
transcriptional	NULL
elements	NULL
,	NULL
such	NULL
as	NULL
the	NULL
enhancers	NULL
of	NULL
two	NULL
SV40	NULL
variants	NULL
(	NULL
66	NULL
)	NULL
,	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
II	NULL
gene	NULL
I-AfB	NULL
(	NULL
20	NULL
)	NULL
,	NULL
the	NULL
mouse	NULL
immunoglobulin	NULL
k3	NULL
'	NULL
enhancer	NULL
(	NULL
67	NULL
)	NULL
,	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
human	NULL
myeloid	NULL
cell-specific	NULL
CD11b	NULL
gene	NULL
(	NULL
62	NULL
)	NULL
,	NULL
the	NULL
lymphotropic	NULL
papovavirus	NULL
enhancer	NULL
(	NULL
23	NULL
)	NULL
,	NULL
and	NULL
the	NULL
B-cell-specific	NULL
immunoglobulin	NULL
u	NULL
heavy-chain	NULL
gene	NULL
enhancer	NULL
(	NULL
58	NULL
)	NULL
.	NULL

In	NULL
many	NULL
of	NULL
these	NULL
systems	NULL
,	NULL
the	NULL
PU.1	NULL
sites	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
crucial	NULL
for	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
regulatory	NULL
element	NULL
.	NULL

Importantly	NULL
,	NULL
a	NULL
PU.1	NULL
binding	NULL
site	NULL
has	NULL
recently	NULL
been	NULL
identified	NULL
in	NULL
the	NULL
LTR	NULL
of	NULL
equine	NULL
infectious	NULL
anemia	NULL
virus	NULL
(	NULL
EIAV	NULL
)	NULL
,	NULL
a	NULL
lentivirus	NULL
related	NULL
to	NULL
HIV-1	NULL
(	NULL
12	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
this	NULL
site	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
the	NULL
primary	NULL
determinant	NULL
for	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
EIAV	NULL
promoter	NULL
in	NULL
monocytes	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Our	NULL
results	NULL
demonstrate	NULL
that	NULL
the	NULL
PU	NULL
box	NULL
of	NULL
U1	NULL
site	NULL
B	NULL
and	NULL
the	NULL
Ets1	NULL
site	NULL
identified	NULL
just	NULL
upstream	NULL
of	NULL
site	NULL
B	NULL
in	NULL
several	NULL
HIV-1	NULL
isolates	NULL
are	NULL
specific	NULL
for	NULL
binding	NULL
of	NULL
their	NULL
respective	NULL
factors	NULL
,	NULL
PU.1/Spi-1	NULL
and	NULL
Ets1	NULL
.	NULL

Nevertheless	NULL
,	NULL
because	NULL
proteins	NULL
that	NULL
bind	NULL
DNA	NULL
by	NULL
means	NULL
of	NULL
an	NULL
ETS	NULL
domain	NULL
share	NULL
DNA	NULL
recognition	NULL
properties	NULL
(	NULL
74	NULL
,	NULL
85	NULL
,	NULL
86	NULL
)	NULL
,	NULL
we	NULL
can	NULL
not	NULL
rule	NULL
out	NULL
the	NULL
possibility	NULL
that	NULL
other	NULL
ets	NULL
family	NULL
members	NULL
also	NULL
bind	NULL
to	NULL
these	NULL
sites	NULL
.	NULL

It	NULL
is	NULL
also	NULL
worth	NULL
noting	NULL
that	NULL
the	NULL
Ets1	NULL
binding	NULL
site	NULL
is	NULL
absent	NULL
in	NULL
U1	NULL
cells	NULL
and	NULL
present	NULL
in	NULL
the	NULL
T-cell-tropic	NULL
isolates	NULL
HXB2	NULL
,	NULL
LAI	NULL
,	NULL
and	NULL
SF2	NULL
,	NULL
which	NULL
do	NULL
not	NULL
contain	NULL
the	NULL
PU.1	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

The	NULL
PU	NULL
box	NULL
is	NULL
detected	NULL
in	NULL
a	NULL
minority	NULL
of	NULL
HIV-1	NULL
isolates	NULL
(	NULL
NYS	NULL
and	NULL
U1	NULL
)	NULL
,	NULL
and	NULL
most	NULL
isolates	NULL
sequenced	NULL
to	NULL
date	NULL
contain	NULL
a	NULL
site	NULL
for	NULL
other	NULL
ets	NULL
family	NULL
members	NULL
such	NULL
as	NULL
Ets1	NULL
.	NULL

However	NULL
,	NULL
most	NULL
laboratory	NULL
isolates	NULL
of	NULL
HIV-1	NULL
have	NULL
been	NULL
selected	NULL
in	NULL
vitro	NULL
for	NULL
their	NULL
ability	NULL
to	NULL
replicate	NULL
in	NULL
T-cell	NULL
lines	NULL
and	NULL
are	NULL
known	NULL
not	NULL
to	NULL
be	NULL
truly	NULL
J	NULL
.	NULL

Vigor	NULL
.	NULL

representative	NULL
of	NULL
viral	NULL
strains	NULL
found	NULL
in	NULL
vivo	NULL
,	NULL
since	NULL
sequence	NULL
changes	NULL
occur	NULL
during	NULL
passage	NULL
of	NULL
virus	NULL
in	NULL
vitro	NULL
in	NULL
tissue	NULL
culture	NULL
(	NULL
47	NULL
,	NULL
53	NULL
)	NULL
.	NULL

This	NULL
selection	NULL
in	NULL
T	NULL
cells	NULL
might	NULL
have	NULL
caused	NULL
the	NULL
loss	NULL
of	NULL
the	NULL
binding	NULL
site	NULL
for	NULL
PU.1/Spi-1	NULL
,	NULL
a	NULL
factor	NULL
absent	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
its	NULL
replacement	NULL
by	NULL
a	NULL
binding	NULL
site	NULL
for	NULL
other	NULL
ets	NULL
family	NULL
members	NULL
such	NULL
as	NULL
Ets1	NULL
.	NULL

A	NULL
potential	NULL
role	NULL
of	NULL
the	NULL
PU	NULL
box	NULL
for	NULL
HIV-1	NULL
regulation	NULL
in	NULL
infected	NULL
monocytes/macrophages	NULL
is	NULL
further	NULL
suggested	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
potential	NULL
PU.1/Spi-1	NULL
binding	NULL
site	NULL
in	NULL
site	NULL
B	NULL
of	NULL
the	NULL
monocytotropic	NULL
isolates	NULL
JRCSF	NULL
and	NULL
JRFL	NULL
.	NULL

Indeed	NULL
,	NULL
this	NULL
site	NULL
(	NULL
5'-	NULL
[	NULL
nt	NULL
4536	NULL
]	NULL
-TTAAGAGAAAGT	NULL
(	NULL
nt	NULL
4525	NULL
]	NULL
-3	NULL
'	NULL
)	NULL
matches	NULL
by	NULL
11	NULL
bp	NULL
the	NULL
12-bp	NULL
Spi-1/PU.1	NULL
consensus	NULL
sequence	NULL
recently	NULL
derived	NULL
by	NULL
Galson	NULL
et	NULL
al	NULL
.	NULL

(	NULL
30	NULL
)	NULL
from	NULL
several	NULL
characterized	NULL
PU	NULL
boxes	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
the	NULL
pol	NULL
gene	NULL
PU.1/Spi-1	NULL
binding	NULL
site	NULL
described	NULL
here	NULL
for	NULL
U1	NULL
cells	NULL
of	NULL
monocytic	NULL
origin	NULL
and	NULL
potentially	NULL
for	NULL
monocytotropic	NULL
isolates	NULL
is	NULL
suggestive	NULL
of	NULL
a	NULL
role	NULL
of	NULL
PU.1/Spi-1	NULL
in	NULL
HIV-1-infected	NULL
cells	NULL
of	NULL
the	NULL
monocyte/	NULL
macrophage	NULL
lineage	NULL
(	NULL
see	NULL
below	NULL
)	NULL
.	NULL

(	NULL
ii	NULL
)	NULL
Site	NULL
C.	NULL
Site	NULL
C	NULL
is	NULL
highly	NULL
conserved	NULL
among	NULL
divergent	NULL
isolates	NULL
,	NULL
suggesting	NULL
an	NULL
important	NULL
regulatory	NULL
function	NULL
.	NULL

Three	NULL
protein-DNA	NULL
complexes	NULL
(	NULL
C1	NULL
,	NULL
C2	NULL
,	NULL
and	NULL
C3	NULL
)	NULL
were	NULL
formed	NULL
at	NULL
site	NULL
C	NULL
in	NULL
EMSAs	NULL
with	NULL
the	NULL
different	NULL
nuclear	NULL
extracts	NULL
.	NULL

The	NULL
multiplicity	NULL
of	NULL
the	NULL
complexes	NULL
observed	NULL
with	NULL
the	NULL
23-bp	NULL
site	NULL
C	NULL
oligonucleotide	NULL
suggests	NULL
the	NULL
presence	NULL
of	NULL
overlapping	NULL
binding	NULL
sites	NULL
,	NULL
a	NULL
hypothesis	NULL
which	NULL
was	NULL
confirmed	NULL
by	NULL
the	NULL
identification	NULL
of	NULL
the	NULL
same	NULL
contacting	NULL
guanine	NULL
residue	NULL
in	NULL
the	NULL
three	NULL
complexes	NULL
.	NULL

This	NULL
observation	NULL
raises	NULL
the	NULL
possibility	NULL
of	NULL
in	NULL
vivo	NULL
competition	NULL
among	NULL
factors	NULL
at	NULL
overlapping	NULL
recognition	NULL
sites	NULL
.	NULL

In	NULL
vivo	NULL
competition	NULL
among	NULL
factors	NULL
provides	NULL
a	NULL
potentially	NULL
sensitive	NULL
mechanism	NULL
for	NULL
regulating	NULL
gene	NULL
expression	NULL
in	NULL
different	NULL
cell	NULL
types	NULL
or	NULL
tissues	NULL
in	NULL
response	NULL
to	NULL
modest	NULL
differences	NULL
in	NULL
relative	NULL
levels	NULL
of	NULL
participating	NULL
factors	NULL
.	NULL

Another	NULL
alternative	NULL
is	NULL
the	NULL
simultaneous	NULL
interaction	NULL
of	NULL
a	NULL
protein	NULL
with	NULL
the	NULL
major	NULL
groove	NULL
and	NULL
of	NULL
a	NULL
second	NULL
protein	NULL
with	NULL
the	NULL
minor	NULL
groove	NULL
of	NULL
the	NULL
DNA	NULL
double	NULL
helix	NULL
.	NULL

This	NULL
is	NULL
unlikely	NULL
in	NULL
this	NULL
case	NULL
,	NULL
since	NULL
dimethyl	NULL
sulfate	NULL
methylates	NULL
guanine	NULL
residues	NULL
at	NULL
the	NULL
N-7	NULL
position	NULL
in	NULL
the	NULL
major	NULL
groove	NULL
.	NULL

It	NULL
is	NULL
also	NULL
possible	NULL
that	NULL
the	NULL
different	NULL
binding	NULL
factors	NULL
do	NULL
not	NULL
all	NULL
interact	NULL
with	NULL
the	NULL
DNA	NULL
at	NULL
the	NULL
same	NULL
time	NULL
,	NULL
depending	NULL
on	NULL
the	NULL
cellular	NULL
conditions	NULL
.	NULL

Our	NULL
competition	NULL
experiments	NULL
demonstrate	NULL
that	NULL
the	NULL
factors	NULL
present	NULL
in	NULL
complexes	NULL
C1	NULL
,	NULL
C2	NULL
,	NULL
and	NULL
C3	NULL
have	NULL
a	NULL
DNA-binding	NULL
specificity	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
factors	NULL
B1	NULL
,	NULL
B2	NULL
,	NULL
and	NULL
B3	NULL
,	NULL
respectively	NULL
,	NULL
identified	NULL
within	NULL
site	NULL
B	NULL
.	NULL

Sites	NULL
B	NULL
and	NULL
C	NULL
contain	NULL
a	NULL
sequence	NULL
homologous	NULL
to	NULL
the	NULL
TCF-1	NULL
consensus	NULL
sequence	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

The	NULL
results	NULL
of	NULL
our	NULL
EMSA	NULL
experiments	NULL
showed	NULL
that	NULL
site	NULL
B	NULL
and	NULL
site	NULL
C	NULL
contain	NULL
a	NULL
low-affinity	NULL
TCF-1	NULL
binding	NULL
site	NULL
,	NULL
since	NULL
they	NULL
were	NULL
able	NULL
to	NULL
compete	NULL
for	NULL
TCF-1	NULL
binding	NULL
to	NULL
the	NULL
TCF-1a	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

7C	NULL
)	NULL
.	NULL

Site	NULL
B	NULL
competed	NULL
more	NULL
efficiently	NULL
for	NULL
binding	NULL
than	NULL
site	NULL
C	NULL
,	NULL
presumably	NULL
because	NULL
the	NULL
latter	NULL
matches	NULL
the	NULL
TCF-1	NULL
consensus	NULL
sequence	NULL
less	NULL
well	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

However	NULL
,	NULL
sites	NULL
B	NULL
and	NULL
C	NULL
bind	NULL
with	NULL
a	NULL
much	NULL
higher	NULL
affinity	NULL
a	NULL
T-cell-specific	NULL
factor	NULL
(	NULL
complexes	NULL
B3	NULL
and	NULL
C3	NULL
)	NULL
distinct	NULL
from	NULL
TCF-1/TCF-1	NULL
«	NULL
.	NULL

Our	NULL
results	NULL
do	NULL
not	NULL
exclude	NULL
the	NULL
possibility	NULL
that	NULL
this	NULL
T-cell	NULL
factor	NULL
is	NULL
a	NULL
member	NULL
of	NULL
the	NULL
TCF-1	NULL
family	NULL
.	NULL

Further	NULL
purification	NULL
and	NULL
isolation	NULL
of	NULL
a	NULL
cDNA	NULL
clone	NULL
encoding	NULL
this	NULL
T-cell	NULL
factor	NULL
will	NULL
clarify	NULL
the	NULL
answer	NULL
to	NULL
this	NULL
question	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
the	NULL
potential	NULL
TCF-1	NULL
binding	NULL
site	NULL
,	NULL
sites	NULL
B	NULL
and	NULL
site	NULL
C	NULL
share	NULL
another	NULL
sequence	NULL
homology	NULL
,	NULL
from	NULL
which	NULL
we	NULL
derived	NULL
the	NULL
consensus	NULL
sequence	NULL
5'-CATANWTYY-3	NULL
'	NULL
(	NULL
see	NULL
below	NULL
)	NULL
,	NULL
in	NULL
which	NULL
N	NULL
represents	NULL
any	NULL
nucleotide	NULL
,	NULL
W	NULL
represents	NULL
T	NULL
or	NULL
A	NULL
,	NULL
and	NULL
Y	NULL
represents	NULL
C	NULL
or	NULL
T.	NULL
This	NULL
sequence	NULL
could	NULL
constitute	NULL
the	NULL
DNA-binding	NULL
site	NULL
of	NULL
the	NULL
nuclear	NULL
factors	NULL
binding	NULL
to	NULL
both	NULL
site	NULL
B	NULL
and	NULL
site	NULL
C.	NULL
A	NULL
data	NULL
base	NULL
search	NULL
indicated	NULL
that	NULL
this	NULL
consensus	NULL
sequence	NULL
is	NULL
present	NULL
in	NULL
several	NULL
cellular	NULL
and	NULL
viral	NULL
genes	NULL
,	NULL
including	NULL
the	NULL
LTR	NULL
of	NULL
Gardner-Arnstein	NULL
feline	NULL
leukemia	NULL
virus	NULL
,	NULL
the	NULL
mouse	NULL
immunoglobulin	NULL
«	NULL
gene	NULL
,	NULL
the	NULL
human	NULL
interferon	NULL
a	NULL
gene	NULL
,	NULL
the	NULL
chicken	NULL
c-myc	NULL
gene	NULL
,	NULL
the	NULL
rat	NULL
interleukin	NULL
3	NULL
gene	NULL
,	NULL
and	NULL
in	NULL
the	NULL
genomes	NULL
of	NULL
human	NULL
papillomavirus	NULL
type	NULL
18	NULL
,	NULL
Vou	NULL
.	NULL

68	NULL
,	NULL
1994	NULL
SV40	NULL
,	NULL
human	NULL
Epstein-Barr	NULL
virus	NULL
,	NULL
human	NULL
herpes	NULL
simplex	NULL
virus	NULL
type	NULL
1	NULL
,	NULL
and	NULL
human	NULL
hepatitis	NULL
B	NULL
virus	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Site	NULL
C	NULL
,	NULL
CATAGATTC	NULL
LAI	NULL
site	NULL
B	NULL
,	NULL
CATACTTTC	NULL
SF2	NULL
site	NULL
B	NULL
,	NULL
CATAATTTT	NULL
U1	NULL
site	NULL
B	NULL
,	NULL
CATACTTCC	NULL
HXB2	NULL
site	NULL
B	NULL
CATATTTTC	NULL
consensus	NULL
sequence	NULL
,	NULL
CATANWTYY	NULL
(	NULL
iii	NULL
)	NULL
Spl	NULL
site	NULL
.	NULL

The	NULL
po	NULL
!	NULL

regulatory	NULL
element	NULL
contains	NULL
a	NULL
binding	NULL
site	NULL
for	NULL
Spl	NULL
,	NULL
a	NULL
ubiquitous	NULL
transcription	NULL
factor	NULL
that	NULL
binds	NULL
to	NULL
GC-rich	NULL
sequence	NULL
elements	NULL
in	NULL
a	NULL
wide	NULL
variety	NULL
of	NULL
viral	NULL
and	NULL
cellular	NULL
promoters	NULL
(	NULL
22	NULL
,	NULL
41	NULL
)	NULL
.	NULL

Spl	NULL
can	NULL
mediate	NULL
the	NULL
formation	NULL
of	NULL
a	NULL
DNA	NULL
loop	NULL
in	NULL
vitro	NULL
by	NULL
self-association	NULL
of	NULL
DNA-bound	NULL
Sp1	NULL
molecules	NULL
joining	NULL
together	NULL
distant	NULL
DNA	NULL
fragments	NULL
(	NULL
50	NULL
,	NULL
77	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
in	NULL
vivo	NULL
,	NULL
a	NULL
functional	NULL
interaction	NULL
between	NULL
upstream	NULL
and	NULL
downstream	NULL
Spl	NULL
binding	NULL
sites	NULL
results	NULL
in	NULL
a	NULL
marked	NULL
synergistic	NULL
activation	NULL
of	NULL
transcription	NULL
of	NULL
the	NULL
modified	NULL
thymidine	NULL
kinase	NULL
promoter	NULL
(	NULL
16	NULL
)	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
three	NULL
tandemly	NULL
arranged	NULL
Sp1	NULL
sites	NULL
in	NULL
the	NULL
HIV-1	NULL
5'-LTR	NULL
and	NULL
of	NULL
one	NULL
Spl	NULL
site	NULL
in	NULL
the	NULL
pol	NULL
nuclease-hypersensitive	NULL
site	NULL
suggests	NULL
a	NULL
putative	NULL
interaction	NULL
between	NULL
these	NULL
elements	NULL
.	NULL

Such	NULL
an	NULL
association	NULL
could	NULL
bring	NULL
in	NULL
close	NULL
proximity	NULL
other	NULL
factors	NULL
bound	NULL
to	NULL
the	NULL
5-LTR	NULL
and	NULL
to	NULL
the	NULL
pol	NULL
regulatory	NULL
element	NULL
,	NULL
and	NULL
this	NULL
arrangement	NULL
could	NULL
play	NULL
a	NULL
role	NULL
in	NULL
transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
HIV-1	NULL
promoter	NULL
.	NULL

(	NULL
iv	NULL
)	NULL
Site	NULL
D.	NULL
A	NULL
ubiquitously	NULL
expressed	NULL
factor	NULL
interacts	NULL
specifically	NULL
with	NULL
the	NULL
site	NULL
D	NULL
sequence	NULL
,	NULL
which	NULL
is	NULL
well	NULL
conserved	NULL
among	NULL
many	NULL
HIV-1	NULL
isolates	NULL
.	NULL

The	NULL
relative	NULL
intensity	NULL
of	NULL
complex	NULL
D	NULL
varied	NULL
among	NULL
cell	NULL
lines	NULL
,	NULL
suggesting	NULL
quantitative	NULL
differences	NULL
of	NULL
the	NULL
factor	NULL
,	NULL
although	NULL
other	NULL
parameters	NULL
such	NULL
as	NULL
contamination	NULL
of	NULL
the	NULL
nuclear	NULL
contents	NULL
with	NULL
cytoplasm	NULL
may	NULL
alter	NULL
relative	NULL
factor	NULL
concentrations	NULL
.	NULL

Computer	NULL
analysis	NULL
revealed	NULL
no	NULL
homology	NULL
between	NULL
this	NULL
binding	NULL
site	NULL
and	NULL
the	NULL
recognition	NULL
sequences	NULL
of	NULL
known	NULL
transcription	NULL
factors	NULL
.	NULL

DNA	NULL
regulatory	NULL
regions	NULL
in	NULL
eukaryotic	NULL
genomes	NULL
frequently	NULL
adopt	NULL
a	NULL
nuclease-hypersensitive	NULL
configuration	NULL
(	NULL
36	NULL
)	NULL
.	NULL

This	NULL
hypersensitivity	NULL
is	NULL
thought	NULL
to	NULL
result	NULL
from	NULL
the	NULL
disruption	NULL
of	NULL
the	NULL
packaging	NULL
of	NULL
DNA	NULL
into	NULL
nucleosomes	NULL
by	NULL
DNA-bound	NULL
regulatory	NULL
proteins	NULL
(	NULL
26	NULL
,	NULL
46	NULL
,	NULL
91	NULL
)	NULL
.	NULL

The	NULL
absence	NULL
of	NULL
a	NULL
hypersensitive	NULL
site	NULL
in	NULL
the	NULL
pol	NULL
gene	NULL
of	NULL
HIV-1	NULL
integrated	NULL
in	NULL
two	NULL
chronically	NULL
infected	NULL
T-cell	NULL
lines	NULL
could	NULL
be	NULL
due	NULL
to	NULL
differences	NULL
in	NULL
nucleotide	NULL
sequence	NULL
among	NULL
HIV-1	NULL
isolates	NULL
or	NULL
to	NULL
the	NULL
presence	NULL
of	NULL
different	NULL
regulatory	NULL
factors	NULL
in	NULL
different	NULL
cell	NULL
types	NULL
(	NULL
lymphoid	NULL
versus	NULL
monocyte/	NULL
macrophage	NULL
cells	NULL
)	NULL
.	NULL

It	NULL
is	NULL
also	NULL
possible	NULL
that	NULL
the	NULL
po	NULL
!	NULL

region	NULL
is	NULL
nucleosome	NULL
free	NULL
in	NULL
ACH2	NULL
and	NULL
8E5S	NULL
cells	NULL
but	NULL
is	NULL
occupied	NULL
by	NULL
bound	NULL
factors	NULL
in	NULL
such	NULL
a	NULL
way	NULL
as	NULL
to	NULL
adopt	NULL
a	NULL
configuration	NULL
resistant	NULL
to	NULL
nuclease	NULL
digestion	NULL
.	NULL

In	NULL
vivo	NULL
footprinting	NULL
of	NULL
the	NULL
protein-DNA	NULL
interactions	NULL
occurring	NULL
in	NULL
intact	NULL
U1	NULL
,	NULL
ACH2	NULL
,	NULL
and	NULL
8E5	NULL
cells	NULL
will	NULL
provide	NULL
additional	NULL
information	NULL
on	NULL
this	NULL
issue	NULL
.	NULL

An	NULL
apparent	NULL
contradiction	NULL
lies	NULL
in	NULL
the	NULL
observation	NULL
that	NULL
the	NULL
hypersensitive	NULL
site	NULL
is	NULL
observed	NULL
only	NULL
in	NULL
U1	NULL
cells	NULL
(	NULL
derived	NULL
from	NULL
U937	NULL
)	NULL
and	NULL
not	NULL
in	NULL
lymphoid	NULL
cells	NULL
(	NULL
ACH2	NULL
and	NULL
8E5	NULL
)	NULL
(	NULL
82	NULL
)	NULL
,	NULL
whereas	NULL
transient	NULL
functional	NULL
studies	NULL
presented	NULL
here	NULL
show	NULL
the	NULL
fragment	NULL
to	NULL
be	NULL
equally	NULL
active	NULL
in	NULL
both	NULL
cell	NULL
types	NULL
.	NULL

However	NULL
,	NULL
the	NULL
regulation	NULL
of	NULL
transiently	NULL
transfected	NULL
DNA	NULL
may	NULL
not	NULL
completely	NULL
reflect	NULL
that	NULL
found	NULL
in	NULL
the	NULL
natural	NULL
chromosomal	NULL
context	NULL
,	NULL
since	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
the	NULL
bulk	NULL
of	NULL
DNA	NULL
is	NULL
not	NULL
assembled	NULL
into	NULL
chromatin	NULL
under	NULL
these	NULL
experimental	NULL
conditions	NULL
(	NULL
4	NULL
)	NULL
.	NULL

Recent	NULL
experiments	NULL
by	NULL
Kim	NULL
and	NULL
colleagues	NULL
(	NULL
44	NULL
)	NULL
support	NULL
this	NULL
latter	NULL
point	NULL
.	NULL

These	NULL
authors	NULL
studied	NULL
linker-scanning	NULL
mutations	NULL
in	NULL
the	NULL
LTR	NULL
of	NULL
HIV-1	NULL
and	NULL
compared	NULL
the	NULL
effects	NULL
of	NULL
each	NULL
of	NULL
these	NULL
mutations	NULL
in	NULL
vitro	NULL
(	NULL
transient	NULL
transfection	NULL
of	NULL
plasmid	NULL
constructs	NULL
)	NULL
and	NULL
in	NULL
vivo	NULL
(	NULL
effect	NULL
on	NULL
viral	NULL
growth	NULL
of	NULL
viral	NULL
mutants	NULL
)	NULL
.	NULL

Several	NULL
mutants	NULL
demonstrated	NULL
effects	NULL
on	NULL
viral	NULL
replication	NULL
that	NULL
were	NULL
more	NULL
severe	NULL
than	NULL
what	NULL
could	NULL
have	NULL
been	NULL
anticipated	NULL
from	NULL
the	NULL
effects	NULL
of	NULL
the	NULL
DNA-BINDING	NULL
MOTIFS	NULL
IN	NULL
THE	NULL
HIV-1	NULL
pol	NULL
GENE	NULL
2645	NULL
same	NULL
mutations	NULL
in	NULL
transient	NULL
transfection	NULL
assays	NULL
(	NULL
44	NULL
)	NULL
.	NULL

A	NULL
similar	NULL
paradox	NULL
has	NULL
been	NULL
observed	NULL
for	NULL
the	NULL
myoD	NULL
promoter/enhancer	NULL
element	NULL
;	NULL
in	NULL
transient	NULL
transfection	NULL
,	NULL
this	NULL
element	NULL
is	NULL
active	NULL
in	NULL
myogenic	NULL
as	NULL
well	NULL
as	NULL
in	NULL
many	NULL
nonmyogenic	NULL
cell	NULL
lines	NULL
,	NULL
whereas	NULL
in	NULL
transgenic	NULL
mice	NULL
its	NULL
activity	NULL
is	NULL
exclusively	NULL
restricted	NULL
to	NULL
the	NULL
skeletal	NULL
muscle	NULL
lineage	NULL
(	NULL
34	NULL
)	NULL
.	NULL

These	NULL
observations	NULL
suggest	NULL
that	NULL
despite	NULL
its	NULL
weak	NULL
activity	NULL
in	NULL
transient	NULL
transfection	NULL
assays	NULL
,	NULL
the	NULL
pol	NULL
gene	NULL
element	NULL
described	NULL
here	NULL
may	NULL
exert	NULL
a	NULL
more	NULL
important	NULL
effect	NULL
in	NULL
the	NULL
context	NULL
of	NULL
an	NULL
integrated	NULL
provirus	NULL
.	NULL

Experiments	NULL
with	NULL
viral	NULL
strains	NULL
containing	NULL
mutations	NULL
in	NULL
each	NULL
of	NULL
the	NULL
binding	NULL
sites	NULL
identified	NULL
in	NULL
this	NULL
report	NULL
will	NULL
be	NULL
necessary	NULL
to	NULL
assess	NULL
the	NULL
true	NULL
biological	NULL
significance	NULL
of	NULL
each	NULL
of	NULL
these	NULL
sites	NULL
for	NULL
HIV-1	NULL
replication	NULL
.	NULL

The	NULL
positive	NULL
regulatory	NULL
element	NULL
identified	NULL
here	NULL
could	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
macrophage	NULL
tropism	NULL
of	NULL
HIV-1	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
HIV-1	NULL
macrophage	NULL
tropism	NULL
is	NULL
primarily	NULL
determined	NULL
at	NULL
the	NULL
level	NULL
of	NULL
the	NULL
entry	NULL
,	NULL
by	NULL
regions	NULL
of	NULL
the	NULL
surface	NULL
envelope	NULL
glycoprotein	NULL
gp120	NULL
,	NULL
including	NULL
the	NULL
V3	NULL
loop	NULL
region	NULL
(	NULL
14	NULL
,	NULL
37	NULL
,	NULL
61	NULL
,	NULL
75	NULL
,	NULL
89	NULL
,	NULL
90	NULL
,	NULL
93	NULL
)	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
also	NULL
clear	NULL
that	NULL
other	NULL
determinants	NULL
of	NULL
tropism	NULL
may	NULL
manifest	NULL
themselves	NULL
after	NULL
viral	NULL
entry	NULL
,	NULL
as	NULL
illustrated	NULL
by	NULL
the	NULL
vpr	NULL
and	NULL
vpu	NULL
genes	NULL
,	NULL
which	NULL
are	NULL
required	NULL
for	NULL
efficient	NULL
viral	NULL
replication	NULL
in	NULL
primary	NULL
monocytes/macrophages	NULL
(	NULL
7	NULL
,	NULL
89	NULL
)	NULL
.	NULL

The	NULL
presence	NULL
in	NULL
the	NULL
pol	NULL
gene	NULL
of	NULL
HIV-1	NULL
of	NULL
a	NULL
regulatory	NULL
region	NULL
containing	NULL
a	NULL
PU.1	NULL
site	NULL
and	NULL
associated	NULL
with	NULL
a	NULL
monocyte-specific	NULL
DNase	NULL
I-hypersensitive	NULL
site	NULL
suggests	NULL
that	NULL
an	NULL
additional	NULL
determinant	NULL
of	NULL
macrophage	NULL
tropism	NULL
might	NULL
be	NULL
present	NULL
at	NULL
the	NULL
level	NULL
of	NULL
transcription	NULL
.	NULL

Whereas	NULL
a	NULL
large	NULL
number	NULL
of	NULL
studies	NULL
have	NULL
examined	NULL
the	NULL
lymphoid	NULL
specificity	NULL
of	NULL
the	NULL
HIV	NULL
promoter	NULL
(	NULL
for	NULL
reviews	NULL
,	NULL
see	NULL
references	NULL
18	NULL
,	NULL
31	NULL
,	NULL
35	NULL
,	NULL
40	NULL
,	NULL
64	NULL
,	NULL
and	NULL
79	NULL
)	NULL
,	NULL
little	NULL
is	NULL
known	NULL
regarding	NULL
its	NULL
monocyte/macrophage	NULL
specificity	NULL
or	NULL
other	NULL
cis-acting	NULL
elements	NULL
responsible	NULL
for	NULL
this	NULL
specificity	NULL
.	NULL

The	NULL
tropism	NULL
of	NULL
other	NULL
viruses	NULL
for	NULL
their	NULL
target	NULL
tissues	NULL
is	NULL
determined	NULL
in	NULL
part	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
.	NULL

In	NULL
murine	NULL
leukemia	NULL
viruses	NULL
,	NULL
a	NULL
switch	NULL
in	NULL
tropism	NULL
to	NULL
T	NULL
cells	NULL
was	NULL
found	NULL
to	NULL
be	NULL
caused	NULL
by	NULL
alterations	NULL
in	NULL
the	NULL
U3	NULL
region	NULL
of	NULL
the	NULL
LTR	NULL
(	NULL
13	NULL
)	NULL
.	NULL

The	NULL
enhancer	NULL
element	NULL
of	NULL
lymphotropic	NULL
papovavirus	NULL
,	NULL
which	NULL
contains	NULL
a	NULL
PU	NULL
box	NULL
required	NULL
for	NULL
its	NULL
activity	NULL
,	NULL
contributes	NULL
to	NULL
the	NULL
restricted	NULL
tropism	NULL
of	NULL
the	NULL
virus	NULL
for	NULL
primate	NULL
B	NULL
lymphocytes	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Importantly	NULL
,	NULL
the	NULL
PU.1/Spi-1	NULL
binding	NULL
site	NULL
situated	NULL
in	NULL
the	NULL
EIAV	NULL
LTR	NULL
is	NULL
a	NULL
primary	NULL
determinant	NULL
of	NULL
promoter	NULL
activity	NULL
in	NULL
transfected	NULL
monocyte	NULL
cell	NULL
lines	NULL
,	NULL
suggesting	NULL
that	NULL
it	NULL
may	NULL
be	NULL
relevant	NULL
to	NULL
the	NULL
macrophage	NULL
tropism	NULL
of	NULL
the	NULL
lentivirus	NULL
EIAV	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Most	NULL
studies	NULL
of	NULL
transcriptional	NULL
regulatory	NULL
mechanisms	NULL
of	NULL
retroviruses	NULL
have	NULL
focused	NULL
on	NULL
the	NULL
5'-LTR	NULL
.	NULL

However	NULL
,	NULL
studies	NULL
by	NULL
several	NULL
groups	NULL
have	NULL
identified	NULL
elements	NULL
located	NULL
outside	NULL
the	NULL
LTR	NULL
that	NULL
play	NULL
a	NULL
significant	NULL
role	NULL
in	NULL
determining	NULL
the	NULL
transcriptional	NULL
rate	NULL
and	NULL
tissue	NULL
specificity	NULL
of	NULL
retroviral	NULL
promoters	NULL
(	NULL
5	NULL
,	NULL
54	NULL
,	NULL
65	NULL
,	NULL
70	NULL
)	NULL
.	NULL

The	NULL
element	NULL
described	NULL
here	NULL
in	NULL
the	NULL
po	NULL
?	NULL

gene	NULL
of	NULL
HIV-1	NULL
offers	NULL
another	NULL
example	NULL
of	NULL
this	NULL
concept	NULL
.	NULL

The	NULL
novel	NULL
regulatory	NULL
element	NULL
reported	NULL
here	NULL
is	NULL
located	NULL
between	NULL
the	NULL
two	NULL
functional	NULL
domains	NULL
of	NULL
the	NULL
intragenic	NULL
enhancer	NULL
previously	NULL
identified	NULL
in	NULL
HeLa	NULL
cells	NULL
(	NULL
83	NULL
)	NULL
.	NULL

Although	NULL
each	NULL
of	NULL
these	NULL
subdomains	NULL
is	NULL
not	NULL
active	NULL
in	NULL
T-lymphoid	NULL
and	NULL
monocytoid	NULL
cell	NULL
lines	NULL
when	NULL
isolated	NULL
(	NULL
8	NULL
)	NULL
,	NULL
each	NULL
might	NULL
nevertheless	NULL
contribute	NULL
to	NULL
the	NULL
regulatory	NULL
activity	NULL
of	NULL
the	NULL
pol-hypersensitive	NULL
region	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
the	NULL
complete	NULL
functional	NULL
unit	NULL
of	NULL
the	NULL
HIV-1	NULL
intragenic	NULL
regulatory	NULL
region	NULL
is	NULL
constituted	NULL
of	NULL
these	NULL
three	NULL
elements	NULL
:	NULL
the	NULL
regulatory	NULL
region	NULL
described	NULL
here	NULL
and	NULL
the	NULL
two	NULL
domains	NULL
described	NULL
previously	NULL
(	NULL
83	NULL
)	NULL
.	NULL

Such	NULL
a	NULL
situation	NULL
has	NULL
been	NULL
reported	NULL
for	NULL
the	NULL
SV40	NULL
enhancer	NULL
,	NULL
which	NULL
can	NULL
be	NULL
dissected	NULL
into	NULL
multiple	NULL
segments	NULL
,	NULL
each	NULL
with	NULL
a	NULL
characteristic	NULL
cell	NULL
type	NULL
specificity	NULL
and	NULL
distinct	NULL
in	NULL
some	NULL
cases	NULL
from	NULL
that	NULL
of	NULL
the	NULL
complete	NULL
enhancer	NULL
(	NULL
73	NULL
)	NULL
.	NULL

Specific	NULL
expression	NULL
of	NULL
immunoglobulin	NULL
heavy-chain	NULL
genes	NULL
in	NULL
B	NULL
cells	NULL
is	NULL
transcriptionally	NULL
controlled	NULL
by	NULL
a	NULL
core	NULL
enhancer	NULL
that	NULL
is	NULL
equally	NULL
active	NULL
in	NULL
both	NULL
lymphoid	NULL
and	NULL
nonlymphoid	NULL
cells	NULL
and	NULL
a	NULL
flanking	NULL
region	NULL
upstream	NULL
of	NULL
this	NULL
core	NULL
which	NULL
2646	NULL
VAN	NULL
LINT	NULL
ET	NULL
AL	NULL
.	NULL

increases	NULL
immunoglobulin	NULL
heavy-chain	NULL
enhancer	NULL
activity	NULL
in	NULL
B	NULL
cells	NULL
but	NULL
represses	NULL
this	NULL
activity	NULL
in	NULL
nonlymphoid	NULL
cells	NULL
(	NULL
38	NULL
)	NULL
.	NULL

The	NULL
potential	NULL
importance	NULL
of	NULL
the	NULL
two	NULL
previously	NULL
identified	NULL
subdomains	NULL
is	NULL
suggested	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
three	NULL
functional	NULL
AP-1	NULL
binding	NULL
sites	NULL
in	NULL
one	NULL
of	NULL
the	NULL
fragments	NULL
(	NULL
81	NULL
)	NULL
and	NULL
the	NULL
recent	NULL
identification	NULL
in	NULL
the	NULL
other	NULL
fragment	NULL
of	NULL
a	NULL
functional	NULL
glucocorticoid	NULL
response	NULL
element	NULL
(	NULL
76	NULL
)	NULL
.	NULL

The	NULL
observations	NULL
reported	NULL
here	NULL
identify	NULL
a	NULL
novel	NULL
regulatory	NULL
element	NULL
associated	NULL
with	NULL
the	NULL
pol	NULL
gene	NULL
of	NULL
HIV-1	NULL
and	NULL
putative	NULL
cis-acting	NULL
elements	NULL
contributing	NULL
to	NULL
its	NULL
transcriptional	NULL
activity	NULL
.	NULL

Further	NULL
work	NULL
will	NULL
be	NULL
necessary	NULL
to	NULL
determine	NULL
the	NULL
biological	NULL
significance	NULL
of	NULL
the	NULL
pol-hypersensitive	NULL
region	NULL
in	NULL
the	NULL
virus	NULL
life	NULL
cycle	NULL
,	NULL
with	NULL
a	NULL
special	NULL
emphasis	NULL
on	NULL
the	NULL
potential	NULL
role	NULL
of	NULL
this	NULL
region	NULL
in	NULL
macrophage	NULL
tropism	NULL
.	NULL

Site-directed	NULL
mutations	NULL
of	NULL
the	NULL
protein	NULL
binding	NULL
sites	NULL
identified	NULL
will	NULL
be	NULL
examined	NULL
in	NULL
the	NULL
context	NULL
of	NULL
an	NULL
infectious	NULL
HIV-1	NULL
provirus	NULL
for	NULL
their	NULL
potential	NULL
effects	NULL
on	NULL
virus	NULL
expression	NULL
and	NULL
replication	NULL
.	NULL

Studying	NULL
the	NULL
molecular	NULL
events	NULL
that	NULL
regulate	NULL
HIV-1	NULL
transcription	NULL
should	NULL
lead	NULL
to	NULL
a	NULL
better	NULL
understanding	NULL
of	NULL
AIDS	NULL
pathogenesis	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
thank	NULL
Monique	NULL
Dubois-Dalcq	NULL
for	NULL
support	NULL
,	NULL
encouragement	NULL
,	NULL
and	NULL
suggestions	NULL
during	NULL
the	NULL
course	NULL
of	NULL
this	NULL
work	NULL
.	NULL

We	NULL
thank	NULL
Aboubaker	NULL
El	NULL
Kharroubi	NULL
for	NULL
nuclear	NULL
extracts	NULL
samples	NULL
and	NULL
Anthony	NULL
Fauci	NULL
,	NULL
Tom	NULL
Folks	NULL
,	NULL
and	NULL
Guido	NULL
Poli	NULL
for	NULL
making	NULL
their	NULL
cell	NULL
lines	NULL
available	NULL
through	NULL
the	NULL
AIDS	NULL
Research	NULL
and	NULL
Reference	NULL
Reagent	NULL
Program	NULL
(	NULL
Division	NULL
of	NULL
AIDS	NULL
,	NULL
NIAID	NULL
,	NULL
NIH	NULL
)	NULL
.	NULL

We	NULL
are	NULL
grateful	NULL
to	NULL
Monique	NULL
Dubois-Dalcq	NULL
,	NULL
Jin	NULL
Kim	NULL
,	NULL
Louis	NULL
Droogmans	NULL
,	NULL
and	NULL
Richard	NULL
Currie	NULL
for	NULL
critical	NULL
reading	NULL
and	NULL
discussion	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

C.V.L	NULL
.	NULL

is	NULL
an	NULL
aspirant	NULL
of	NULL
the	NULL
Fonds	NULL
National	NULL
de	NULL
la	NULL
Recherche	NULL
Scientifique	NULL
(	NULL
Brussels	NULL
,	NULL
Belgium	NULL
)	NULL
and	NULL
was	NULL
on	NULL
leave	NULL
from	NULL
the	NULL
Free	NULL
University	NULL
of	NULL
Brussels	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Adachi	NULL
,	NULL
A.	NULL
,	NULL
H.	NULL
E.	NULL
Gendelman	NULL
,	NULL
S.	NULL
Koenig	NULL
,	NULL
T.	NULL
Folks	NULL
,	NULL
R.	NULL
Willey	NULL
,	NULL
A.	NULL
Rabson	NULL
,	NULL
and	NULL
M.	NULL
A.	NULL
Martin	NULL
.	NULL

1986	NULL
.	NULL

Production	NULL
of	NULL
acquired	NULL
immunodeficiency	NULL
syndrome-associated	NULL
retrovirus	NULL
in	NULL
human	NULL
and	NULL
nonhuman	NULL
cells	NULL
transfected	NULL
with	NULL
an	NULL
infectious	NULL
molecular	NULL
clone	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

59:284-291	NULL
.	NULL

2	NULL
.	NULL

Amemiya	NULL
,	NULL
K.	NULL
,	NULL
R.	NULL
Traub	NULL
,	NULL
L.	NULL
Durham	NULL
,	NULL
and	NULL
E.	NULL
O	NULL
.	NULL

Major	NULL
.	NULL

1992	NULL
.	NULL

Adjacent	NULL
nuclear	NULL
factor-1	NULL
and	NULL
activator	NULL
protein	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
enhancer	NULL
of	NULL
the	NULL
neurotropic	NULL
JC	NULL
virus	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267:14204-14211	NULL
.	NULL

3	NULL
.	NULL

Angel	NULL
,	NULL
P.	NULL
,	NULL
I.	NULL
Baumann	NULL
,	NULL
B.	NULL
Stein	NULL
,	NULL
H.	NULL
Delius	NULL
,	NULL
H.	NULL
J.	NULL
Rhamsdorf	NULL
,	NULL
and	NULL
P.	NULL
Herrlich	NULL
,	NULL
1987	NULL
.	NULL

12-O-Tetradecanoyl-phorbol-13-acetate	NULL
induction	NULL
of	NULL
the	NULL
human	NULL
collagenase	NULL
gene	NULL
is	NULL
mediated	NULL
by	NULL
an	NULL
inducible	NULL
enhancer	NULL
element	NULL
located	NULL
in	NULL
the	NULL
5'-flanking	NULL
region	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

7:2256-2266	NULL
.	NULL

4	NULL
.	NULL

Archer	NULL
,	NULL
T.	NULL
K.	NULL
,	NULL
P.	NULL
Lefebvre	NULL
,	NULL
R.	NULL
G.	NULL
Wolford	NULL
,	NULL
and	NULL
G.	NULL
L.	NULL
Hager	NULL
.	NULL

1992	NULL
.	NULL

Transcription	NULL
factor	NULL
loading	NULL
on	NULL
the	NULL
MMTV	NULL
promoter	NULL
:	NULL
a	NULL
bimodal	NULL
mechanism	NULL
for	NULL
promoter	NULL
activation	NULL
.	NULL

Science	NULL
255:1573-1576	NULL
.	NULL

5	NULL
.	NULL

Arrigo	NULL
,	NULL
S.	NULL
,	NULL
M.	NULL
Yun	NULL
,	NULL
and	NULL
K.	NULL
Beemon	NULL
.	NULL

1987.	NULL
cis-acting	NULL
regulatory	NULL
elements	NULL
within	NULL
gag	NULL
genes	NULL
of	NULL
avian	NULL
retroviruses	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

7:388-397	NULL
.	NULL

6	NULL
.	NULL

Ausubel	NULL
,	NULL
F.	NULL
M.	NULL
,	NULL
R.	NULL
Brent	NULL
,	NULL
R.	NULL
E.	NULL
Kingston	NULL
,	NULL
D.	NULL
D.	NULL
Moore	NULL
,	NULL
J.	NULL
G.	NULL
Seidman	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Smith	NULL
,	NULL
and	NULL
K.	NULL
Striihl	NULL
.	NULL

1987	NULL
.	NULL

Current	NULL
protocols	NULL
in	NULL
molecular	NULL
biology	NULL
.	NULL

Wiley	NULL
,	NULL
New	NULL
York	NULL
.	NULL

7	NULL
.	NULL

Balotta	NULL
,	NULL
C.	NULL
,	NULL
P.	NULL
Lusso	NULL
,	NULL
R.	NULL
Crowley	NULL
,	NULL
R.	NULL
C.	NULL
Gallo	NULL
,	NULL
and	NULL
G.	NULL
Franchini	NULL
.	NULL

1993	NULL
.	NULL

Antisense	NULL
phosphorothioate	NULL
oligodeoxynucleotides	NULL
targeted	NULL
to	NULL
the	NULL
vpr	NULL
gene	NULL
inhibit	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
replication	NULL
in	NULL
primary	NULL
human	NULL
macrophages	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

67:4409-4414	NULL
.	NULL

8	NULL
.	NULL

Becker	NULL
,	NULL
N.	NULL
,	NULL
A.	NULL
Burny	NULL
,	NULL
and	NULL
E.	NULL
Verdin	NULL
.	NULL

Unpublished	NULL
observation	NULL
.	NULL

8a.Bhat	NULL
,	NULL
N.	NULL
K.	NULL
,	NULL
R.	NULL
J.	NULL
Fisher	NULL
,	NULL
S.	NULL
Fujiwara	NULL
,	NULL
R.	NULL
Ascione	NULL
,	NULL
and	NULL
T.	NULL
S.	NULL
Papas	NULL
.	NULL

1987	NULL
.	NULL

Temporal	NULL
and	NULL
tissue-specific	NULL
expression	NULL
of	NULL
mouse	NULL
ets	NULL
genes	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
84:3161-3165	NULL
.	NULL

9	NULL
.	NULL

Bosselut	NULL
,	NULL
R.	NULL
,	NULL
J.	NULL
F.	NULL
Duvall	NULL
,	NULL
A.	NULL
Gégonne	NULL
,	NULL
M.	NULL
Bailly	NULL
,	NULL
A.	NULL
Hémar	NULL
,	NULL
J.	NULL
Brady	NULL
,	NULL
and	NULL
J.	NULL
Ghysdael	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
product	NULL
of	NULL
the	NULL
c-ets-1	NULL
proto-oncogene	NULL
and	NULL
the	NULL
related	NULL
Ets2	NULL
protein	NULL
act	NULL
as	NULL
transcriptional	NULL
activators	NULL
of	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
of	NULL
human	NULL
T	NULL
cell	NULL
leukemia	NULL
10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

J.	NULL
Viror	NULL
.	NULL

virus	NULL
HTLV-1	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

9:3137-3144	NULL
.	NULL

Bradford	NULL
,	NULL
M.	NULL
M.	NULL
1976	NULL
.	NULL

A	NULL
rapid	NULL
and	NULL
sensitive	NULL
method	NULL
for	NULL
the	NULL
quantitation	NULL
of	NULL
microgram	NULL
quantities	NULL
of	NULL
protein	NULL
utilizing	NULL
the	NULL
principle	NULL
of	NULL
protein-dye	NULL
binding	NULL
.	NULL

Anal	NULL
.	NULL

Biochem	NULL
.	NULL

72:248-254	NULL
.	NULL

Brown	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
McKnight	NULL
.	NULL

1992	NULL
.	NULL

Specificities	NULL
of	NULL
protein-protein	NULL
and	NULL
protein-DNA	NULL
interaction	NULL
of	NULL
GABPa	NULL
and	NULL
two	NULL
newly	NULL
defined	NULL
ets-related	NULL
proteins	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

6:2502-2512	NULL
.	NULL

Carvalho	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
D.	NULL
Derse	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
PU.1/Spi-1	NULL
proto-oncogene	NULL
is	NULL
a	NULL
transcriptional	NULL
regulator	NULL
of	NULL
a	NULL
lentivirus	NULL
promoter	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

67:3885-3890	NULL
.	NULL

Celander	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
W.	NULL
Haseltine	NULL
.	NULL

1984	NULL
.	NULL

Tissue-specific	NULL
transcription	NULL
preference	NULL
as	NULL
a	NULL
determinant	NULL
of	NULL
cell	NULL
tropism	NULL
and	NULL
leukaemogenic	NULL
potential	NULL
of	NULL
murine	NULL
retroviruses	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
312:159-162	NULL
.	NULL

Cheng-Mayer	NULL
,	NULL
C.	NULL
,	NULL
M.	NULL
Quiroga	NULL
,	NULL
J.	NULL
W.	NULL
Tung	NULL
,	NULL
D.	NULL
Dina	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A	NULL
.	NULL

Levy	NULL
.	NULL

1990	NULL
.	NULL

Viral	NULL
determinants	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
T-cell	NULL
or	NULL
macrophage	NULL
tropism	NULL
,	NULL
cytopathogenicity	NULL
,	NULL
and	NULL
CD4	NULL
antigen	NULL
modulation	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

64:4390-4398	NULL
.	NULL

Clouse	NULL
,	NULL
K.	NULL
A.	NULL
,	NULL
D.	NULL
Powell	NULL
,	NULL
I.	NULL
Washington	NULL
,	NULL
G.	NULL
Poli	NULL
,	NULL
K.	NULL
Strebel	NULL
,	NULL
W.	NULL
Farrar	NULL
,	NULL
P.	NULL
Barstad	NULL
,	NULL
J.	NULL
Kovacs	NULL
,	NULL
A.	NULL
S.	NULL
Fauci	NULL
,	NULL
and	NULL
T.	NULL
M.	NULL
Folks	NULL
.	NULL

1989	NULL
.	NULL

Monokine	NULL
regulation	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
expression	NULL
in	NULL
a	NULL
chronically	NULL
infected	NULL
human	NULL
T	NULL
cell	NULL
clone	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

142:431-438	NULL
.	NULL

Courey	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
D.	NULL
A.	NULL
Holtzman	NULL
,	NULL
S.	NULL
P.	NULL
Jackson	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1989	NULL
.	NULL

Synergistic	NULL
activation	NULL
by	NULL
the	NULL
glutamine-rich	NULL
domains	NULL
of	NULL
human	NULL
transcription	NULL
factor	NULL
Sp1	NULL
.	NULL

Cell	NULL
59:827-836	NULL
.	NULL

Cullen	NULL
,	NULL
B.	NULL
R.	NULL
1990	NULL
.	NULL

The	NULL
HIV-1	NULL
Tat	NULL
protein	NULL
:	NULL
an	NULL
RNA	NULL
sequence-specific	NULL
processivity	NULL
factor	NULL
?	NULL

Cell	NULL
63:655-657	NULL
.	NULL

Cullen	NULL
,	NULL
B.	NULL
R.	NULL
1991	NULL
.	NULL

Regulation	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
replication	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Microbiol	NULL
.	NULL

45:219-250	NULL
.	NULL

Dignam	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
R.	NULL
M.	NULL
Lebovitz	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1983	NULL
.	NULL

Accurate	NULL
transcription	NULL
initiation	NULL
by	NULL
RNA	NULL
polymerase	NULL
II	NULL
in	NULL
a	NULL
soluble	NULL
extract	NULL
from	NULL
isolated	NULL
mammalian	NULL
nuclei	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

11:1475-1489	NULL
.	NULL

Dorn	NULL
,	NULL
A.	NULL
,	NULL
H.	NULL
J.	NULL
Fehling	NULL
,	NULL
W.	NULL
Koch	NULL
,	NULL
M.	NULL
Le	NULL
Meur	NULL
,	NULL
P.	NULL
Gerlinger	NULL
,	NULL
C.	NULL
Benoist	NULL
,	NULL
and	NULL
D.	NULL
Mathis	NULL
.	NULL

1988	NULL
.	NULL

B-cell	NULL
control	NULL
region	NULL
at	NULL
the	NULL
5	NULL
'	NULL
end	NULL
of	NULL
a	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
II	NULL
gene	NULL
:	NULL
sequences	NULL
and	NULL
factors	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8:3975-3987	NULL
.	NULL

Dynan	NULL
,	NULL
W.	NULL
S.	NULL
1987	NULL
.	NULL

DNase	NULL
I	NULL
footprinting	NULL
as	NULL
an	NULL
assay	NULL
for	NULL
mammalian	NULL
gene	NULL
regulatory	NULL
proteins	NULL
,	NULL
p.	NULL
75-87	NULL
.	NULL

In	NULL
J.	NULL
K.	NULL
Setlow	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
Genetic	NULL
engineering	NULL
principles	NULL
and	NULL
methods	NULL
,	NULL
vol	NULL
.	NULL

9	NULL
.	NULL

Plenum	NULL
Publishing	NULL
Corp.	NULL
,	NULL
New	NULL
York	NULL
.	NULL

Dynan	NULL
,	NULL
W.	NULL
S.	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1983	NULL
.	NULL

The	NULL
promoter-specific	NULL
transcription	NULL
factor	NULL
Spl	NULL
binds	NULL
to	NULL
upstream	NULL
sequences	NULL
in	NULL
the	NULL
SV40	NULL
early	NULL
promoter	NULL
.	NULL

Cell	NULL
35:79-87.	NULL
.	NULL

Erselius	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
B.	NULL
Jostes	NULL
,	NULL
A.	NULL
K.	NULL
Hatzopoulos	NULL
,	NULL
L.	NULL
Mosthaf	NULL
,	NULL
and	NULL
P.	NULL
Gruss	NULL
.	NULL

1990	NULL
.	NULL

Cell-type-specific	NULL
control	NULL
elements	NULL
of	NULL
the	NULL
lymphotropic	NULL
papovavirus	NULL
enhancer	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

64:1657-1666	NULL
.	NULL

Fauci	NULL
,	NULL
A.	NULL
S.	NULL
1988	NULL
.	NULL

The	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
:	NULL
infectivity	NULL
and	NULL
mechanisms	NULL
of	NULL
pathogenesis	NULL
.	NULL

Science	NULL
239:617-622	NULL
.	NULL

Feinberg	NULL
,	NULL
A.	NULL
P.	NULL
,	NULL
and	NULL
B.	NULL
Vogelstein	NULL
.	NULL

1983	NULL
.	NULL

A	NULL
technique	NULL
for	NULL
radiola-beling	NULL
DNA	NULL
restriction	NULL
endonuclease	NULL
fragments	NULL
to	NULL
high	NULL
specific	NULL
activity	NULL
.	NULL

Anal	NULL
.	NULL

Biochem	NULL
.	NULL

132:6-13	NULL
.	NULL

Felsenfeld	NULL
,	NULL
G.	NULL
1992	NULL
.	NULL

Chromatin	NULL
as	NULL
an	NULL
essential	NULL
part	NULL
of	NULL
the	NULL
transcriptional	NULL
mechanism	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
355:219-224	NULL
.	NULL

Folks	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
J.	NULL
Justement	NULL
,	NULL
A.	NULL
Kinter	NULL
,	NULL
S.	NULL
Schnittman	NULL
,	NULL
J.	NULL
Orenstein	NULL
,	NULL
G.	NULL
Poli	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Fauci	NULL
.	NULL

1988	NULL
.	NULL

Characterization	NULL
of	NULL
a	NULL
promonocytic	NULL
clone	NULL
chronically	NULL
infected	NULL
with	NULL
HIV	NULL
and	NULL
induction	NULL
by	NULL
13-phorbol-12-myristate	NULL
acetate	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

140:1117-1122	NULL
.	NULL

Folks	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
D.	NULL
Powell	NULL
,	NULL
M.	NULL
Lightfoote	NULL
,	NULL
S.	NULL
Koenig	NULL
,	NULL
A.	NULL
S.	NULL
Fauci	NULL
,	NULL
S.	NULL
Benn	NULL
,	NULL
A.	NULL
Rabson	NULL
,	NULL
D.	NULL
Daugherty	NULL
,	NULL
H.	NULL
E.	NULL
Gendelman	NULL
,	NULL
M.	NULL
D.	NULL
Hoggan	NULL
,	NULL
S.	NULL
Venkatesan	NULL
,	NULL
and	NULL
M.	NULL
A.	NULL
Martin	NULL
.	NULL

1986	NULL
.	NULL

Biological	NULL
and	NULL
biochemical	NULL
characterization	NULL
of	NULL
a	NULL
cloned	NULL
leu-3~	NULL
cell	NULL
surviving	NULL
infection	NULL
with	NULL
the	NULL
acquired	NULL
immune	NULL
deficiency	NULL
syndrome	NULL
retrovirus	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

164:280-290	NULL
.	NULL

Frankel	NULL
,	NULL
A.	NULL
D.	NULL
1992	NULL
.	NULL

Activation	NULL
of	NULL
HIV	NULL
transcription	NULL
by	NULL
Tat	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Genet	NULL
.	NULL

Dev	NULL
.	NULL

2:293-298	NULL
.	NULL

Galson	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
J.	NULL
O.	NULL
Hensold	NULL
,	NULL
T.	NULL
R.	NULL
Bishop	NULL
,	NULL
M.	NULL
Schalling	NULL
,	NULL
A.	NULL
D.	NULL
D'Andrea	NULL
,	NULL
C.	NULL
Jones	NULL
,	NULL
P.	NULL
E.	NULL
Auron	NULL
,	NULL
and	NULL
D.	NULL
E.	NULL
Housman	NULL
.	NULL

1993	NULL
.	NULL

Mouse	NULL
-globin	NULL
DNA-binding	NULL
protein	NULL
B1	NULL
is	NULL
identical	NULL
to	NULL
a	NULL
proto-oncogene	NULL
,	NULL
the	NULL
transcription	NULL
factor	NULL
Spi-Z/PU.1	NULL
,	NULL
and	NULL
is	NULL
restricted	NULL
in	NULL
expression	NULL
to	NULL
hematopoietic	NULL
cells	NULL
and	NULL
the	NULL
testis	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:2929-2941	NULL
.	NULL

Gaynor	NULL
,	NULL
R.	NULL
1992	NULL
.	NULL

Cellular	NULL
transcription	NULL
factors	NULL
involved	NULL
in	NULL
the	NULL
Vor	NULL
.	NULL

68	NULL
,	NULL
1994	NULL
39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

55.	NULL
regulation	NULL
of	NULL
HIV-1	NULL
gene	NULL
expression	NULL
.	NULL

AIDS	NULL
6:347-363.	NULL
.	NULL

Gégonne	NULL
,	NULL
A.	NULL
,	NULL
B.	NULL
Punyammalee	NULL
,	NULL
B.	NULL
Rabault	NULL
,	NULL
R.	NULL
Bosselut	NULL
,	NULL
S.	NULL
Seneca	NULL
,	NULL
M.	NULL
Crabeel	NULL
,	NULL
and	NULL
J.	NULL
Ghysdael	NULL
.	NULL

1992	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
DNA	NULL
binding	NULL
and	NULL
transcriptional	NULL
activation	NULL
properties	NULL
of	NULL
the	NULL
Ets	NULL
!	NULL

oncoprotein	NULL
.	NULL

New	NULL
Biol	NULL
.	NULL

4512-519.	NULL
.	NULL

Goebl	NULL
,	NULL
M.	NULL
G.	NULL
1990	NULL
.	NULL

The	NULL
PU.1	NULL
transcription	NULL
factor	NULL
is	NULL
the	NULL
product	NULL
of	NULL
the	NULL
putative	NULL
oncogene	NULL
Spi-1	NULL
.	NULL

Cell	NULL
61:1165-1166.	NULL
.	NULL

Goldhamer	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
A.	NULL
Faerman	NULL
,	NULL
M.	NULL
Shani	NULL
,	NULL
and	NULL
C.	NULL
P.	NULL
Emerson	NULL
,	NULL
Jr.	NULL
1992	NULL
.	NULL

Regulatory	NULL
elements	NULL
that	NULL
control	NULL
the	NULL
lineage-specific	NULL
expression	NULL
of	NULL
myoD	NULL
.	NULL

Science	NULL
256:538-542.	NULL
.	NULL

Greene	NULL
,	NULL
W.	NULL
C.	NULL
1990	NULL
.	NULL

Regulation	NULL
of	NULL
HIV-1	NULL
gene	NULL
expression	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

8:453-475.	NULL
.	NULL

Gross	NULL
,	NULL
D.	NULL
S.	NULL
,	NULL
and	NULL
W.	NULL
T.	NULL
Garrard	NULL
.	NULL

1988	NULL
.	NULL

Nuclease	NULL
hypersensitive	NULL
sites	NULL
in	NULL
chromatin	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

57:159-197.	NULL
.	NULL

Hwang	NULL
,	NULL
S.	NULL
S.	NULL
,	NULL
T.	NULL
J.	NULL
Boyle	NULL
,	NULL
H.	NULL
K.	NULL
Lyerly	NULL
,	NULL
and	NULL
B.	NULL
R.	NULL
Cullen	NULL
,	NULL
1991	NULL
.	NULL

Identification	NULL
of	NULL
the	NULL
envelope	NULL
V3	NULL
loop	NULL
as	NULL
the	NULL
primary	NULL
determinant	NULL
of	NULL
cell	NULL
tropism	NULL
in	NULL
HIV-1	NULL
.	NULL

Science	NULL
253:71-74.	NULL
.	NULL

Imler	NULL
,	NULL
J.-L.	NULL
,	NULL
C.	NULL
Lemaire	NULL
,	NULL
C.	NULL
Wasylyk	NULL
,	NULL
and	NULL
B.	NULL
Wasylyk	NULL
.	NULL

1987	NULL
.	NULL

Negative	NULL
regulation	NULL
contributes	NULL
to	NULL
tissue	NULL
specificity	NULL
of	NULL
the	NULL
immunoglobulin	NULL
heavy-chain	NULL
enhancer	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

7:2558-2567	NULL
.	NULL

Johnson	NULL
,	NULL
P.	NULL
F.	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
McKnight	NULL
.	NULL

1989	NULL
.	NULL

Eukaryotic	NULL
transcriptional	NULL
regulatory	NULL
proteins	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

58:799-839	NULL
.	NULL

Jones	NULL
,	NULL
K.	NULL
A	NULL
.	NULL

1989	NULL
.	NULL

HIV	NULL
trans-activation	NULL
and	NULL
transcription	NULL
control	NULL
mechanisms	NULL
.	NULL

New	NULL
Biol	NULL
.	NULL

1:127-135	NULL
.	NULL

Kadonaga	NULL
,	NULL
J.	NULL
T.	NULL
,	NULL
K.	NULL
R.	NULL
Carner	NULL
,	NULL
F.	NULL
R.	NULL
Masiarz	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1987	NULL
.	NULL

Isolation	NULL
of	NULL
cDNA	NULL
encoding	NULL
transcription	NULL
factor	NULL
Spl	NULL
and	NULL
functional	NULL
analysis	NULL
of	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
.	NULL

Cell	NULL
51:1079-1090	NULL
.	NULL

Karim	NULL
,	NULL
F.	NULL
D.	NULL
,	NULL
L.	NULL
D.	NULL
Urness	NULL
,	NULL
C.	NULL
S.	NULL
Thummel	NULL
,	NULL
M.	NULL
J.	NULL
Klemsz	NULL
,	NULL
S.	NULL
R.	NULL
McKercher	NULL
,	NULL
A.	NULL
Celada	NULL
,	NULL
C.	NULL
Van	NULL
Beveren	NULL
,	NULL
R.	NULL
A.	NULL
Maki	NULL
,	NULL
C.	NULL
V.	NULL
Gunther	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Nye	NULL
,	NULL
and	NULL
B.	NULL
J.	NULL
Graves	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
ETS-domain	NULL
:	NULL
a	NULL
new	NULL
DNA-binding	NULL
motif	NULL
that	NULL
recognizes	NULL
a	NULL
purine-rich	NULL
core	NULL
DNA	NULL
sequence	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

41451-1453	NULL
.	NULL

Karn	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
M.	NULL
A.	NULL
Graeble	NULL
.	NULL

1992	NULL
.	NULL

New	NULL
insights	NULL
into	NULL
the	NULL
mechanism	NULL
of	NULL
HIV-1	NULL
transactivation	NULL
.	NULL

Trends	NULL
Genet	NULL
.	NULL

8:365-368	NULL
.	NULL

Kim	NULL
,	NULL
J.	NULL
Y.	NULL
H.	NULL
,	NULL
F.	NULL
Gonzales-Scarano	NULL
,	NULL
S.	NULL
L.	NULL
Zeichner	NULL
,	NULL
and	NULL
J.	NULL
C.	NULL
Alwine	NULL
.	NULL

1993	NULL
.	NULL

Replication	NULL
of	NULL
type	NULL
1	NULL
human	NULL
immunodeficiency	NULL
viruses	NULL
containing	NULL
linker	NULL
substitution	NULL
mutations	NULL
in	NULL
the	NULL
-201	NULL
to	NULL
-	NULL
130	NULL
region	NULL
of	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

67:1658-1662	NULL
.	NULL

Klemsz	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
S.	NULL
R.	NULL
McKercher	NULL
,	NULL
A.	NULL
Celada	NULL
,	NULL
C.	NULL
Van	NULL
Beveren	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Maki	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
macrophage	NULL
and	NULL
B	NULL
cell-specific	NULL
transcription	NULL
factor	NULL
PU.1	NULL
is	NULL
related	NULL
to	NULL
the	NULL
ets	NULL
oncogene	NULL
.	NULL

Cell	NULL
61:113-124	NULL
.	NULL

Kornberg	NULL
,	NULL
R.	NULL
D.	NULL
,	NULL
and	NULL
Y.	NULL
Lorch	NULL
.	NULL

1992	NULL
.	NULL

Chromatin	NULL
structure	NULL
and	NULL
transcription	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

8:563-587	NULL
.	NULL

Kusumi	NULL
,	NULL
K.	NULL
,	NULL
B.	NULL
Conway	NULL
,	NULL
S.	NULL
Cunningham	NULL
,	NULL
A.	NULL
Berson	NULL
,	NULL
C.	NULL
Evans	NULL
,	NULL
A.	NULL
K.	NULL
N.	NULL
Iversen	NULL
,	NULL
D.	NULL
Colvin	NULL
,	NULL
M.	NULL
V.	NULL
Gallo	NULL
,	NULL
S.	NULL
Coutre	NULL
,	NULL
E.	NULL
G.	NULL
Shpaer	NULL
,	NULL
D.	NULL
V.	NULL
Faulkner	NULL
,	NULL
A.	NULL
de	NULL
Ronde	NULL
,	NULL
S.	NULL
Volkman	NULL
,	NULL
C.	NULL
Williams	NULL
,	NULL
M.	NULL
S.	NULL
Hirsch	NULL
,	NULL
and	NULL
J.	NULL
I.	NULL
Mullins	NULL
.	NULL

1992	NULL
.	NULL

Human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
envelope	NULL
gene	NULL
structure	NULL
and	NULL
diversity	NULL
in	NULL
vivo	NULL
and	NULL
after	NULL
cocultivation	NULL
in	NULL
vitro	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

66:875-885	NULL
.	NULL

Leiden	NULL
,	NULL
J.	NULL
M.	NULL
1992	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
during	NULL
T-cell	NULL
devel-opment	NULL
:	NULL
the	NULL
«	NULL
TCR	NULL
gene	NULL
as	NULL
a	NULL
molecular	NULL
model	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
13:22-30	NULL
.	NULL

Lenardo	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1989	NULL
.	NULL

NF-kB	NULL
:	NULL
a	NULL
pleiotropic	NULL
mediator	NULL
of	NULL
inducible	NULL
and	NULL
tissue-specific	NULL
gene	NULL
control	NULL
.	NULL

Cell	NULL
58	NULL
:	NULL
227-229	NULL
.	NULL

Mastrangelo	NULL
,	NULL
I	NULL
.	NULL

A.	NULL
,	NULL
A.	NULL
J.	NULL
Courey	NULL
,	NULL
J.	NULL
S.	NULL
Wall	NULL
,	NULL
S.	NULL
P.	NULL
Jackson	NULL
,	NULL
and	NULL
P.	NULL
V.	NULL
C.	NULL
Hough	NULL
.	NULL

1991	NULL
.	NULL

DNA	NULL
looping	NULL
and	NULL
Spl	NULL
multimer	NULL
links	NULL
:	NULL
a	NULL
mechanism	NULL
for	NULL
transcriptional	NULL
synergism	NULL
and	NULL
enhancement	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:5670-5674	NULL
.	NULL

Maxam	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
and	NULL
W.	NULL
Gilbert	NULL
.	NULL

1980	NULL
.	NULL

Sequencing	NULL
end-labeled	NULL
DNA	NULL
with	NULL
base-specific	NULL
chemical	NULL
cleavages	NULL
.	NULL

Methods	NULL
Enzymol	NULL
.	NULL

65:499-560.	NULL
.	NULL

McCune	NULL
,	NULL
J.	NULL
M.	NULL
1991	NULL
.	NULL

HIV-1	NULL
:	NULL
the	NULL
infective	NULL
process	NULL
in	NULL
vivo	NULL
.	NULL

Cell	NULL
64:351-363.	NULL
.	NULL

Meyerhans	NULL
,	NULL
A.	NULL
,	NULL
R.	NULL
Cheynier	NULL
,	NULL
J.	NULL
Albert	NULL
,	NULL
M.	NULL
Seth	NULL
,	NULL
S.	NULL
Kwok	NULL
,	NULL
J.	NULL
Sninsky	NULL
,	NULL
L.	NULL
Morfeldt-MaAnson	NULL
,	NULL
B.	NULL
Asjo	NULL
,	NULL
and	NULL
S.	NULL
Wain-Hobson	NULL
.	NULL

1989	NULL
.	NULL

Temporal	NULL
fluctuations	NULL
in	NULL
HIV	NULL
quasispecies	NULL
in	NULL
vivo	NULL
are	NULL
not	NULL
reflected	NULL
by	NULL
sequential	NULL
HIV	NULL
isolations	NULL
.	NULL

Cell	NULL
58:901-910.	NULL
.	NULL

Miller	NULL
,	NULL
C.	NULL
L.	NULL
,	NULL
R.	NULL
Garner	NULL
,	NULL
and	NULL
V.	NULL
Paetkau	NULL
.	NULL

1992	NULL
.	NULL

An	NULL
activation	NULL
dependent	NULL
,	NULL
T-lymphocyte-specific	NULL
transcriptional	NULL
activator	NULL
in	NULL
the	NULL
mouse	NULL
mammary	NULL
tumor	NULL
virus	NULL
env	NULL
gene	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:3262-3272	NULL
.	NULL

Mitchell	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1989	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
in	NULL
56	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

64	NULL
.	NULL

65	NULL
.	NULL

66	NULL
.	NULL

67	NULL
.	NULL

68	NULL
.	NULL

69	NULL
.	NULL

70	NULL
.	NULL

71	NULL
.	NULL

72	NULL
.	NULL

74	NULL
.	NULL

DNA-BINDING	NULL
MOTIFS	NULL
IN	NULL
THE	NULL
HIV-1	NULL
po	NULL
!	NULL

GENE	NULL
2647	NULL
mammalian	NULL
cells	NULL
by	NULL
sequence-specific	NULL
DNA-binding	NULL
proteins	NULL
.	NULL

Science	NULL
245:371-378	NULL
.	NULL

Moreau-Gachelin	NULL
,	NULL
F.	NULL
,	NULL
D.	NULL
Ray	NULL
,	NULL
M.-G.	NULL
Mattei	NULL
,	NULL
P.	NULL
Tambourin	NULL
,	NULL
and	NULL
A.	NULL
Tavitian	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
putative	NULL
oncogene	NULL
Spi-1	NULL
:	NULL
murine	NULL
chromosomal	NULL
localization	NULL
and	NULL
transcriptional	NULL
activation	NULL
in	NULL
murine	NULL
acute	NULL
erythroleukemias	NULL
.	NULL

Oncogene	NULL
4:1449-1456.	NULL
.	NULL

Myers	NULL
,	NULL
G.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Berzofsky	NULL
,	NULL
B.	NULL
Korber	NULL
,	NULL
R.	NULL
F.	NULL
Smith	NULL
,	NULL
and	NULL
G.	NULL
N.	NULL
Pavlakis	NULL
.	NULL

1992	NULL
.	NULL

Human	NULL
retroviruses	NULL
and	NULL
AIDS	NULL
.	NULL

A	NULL
compilation	NULL
and	NULL
analysis	NULL
of	NULL
nucleic	NULL
acid	NULL
and	NULL
amino	NULL
acid	NULL
sequences	NULL
.	NULL

Theoretical	NULL
Biology	NULL
and	NULL
Biophysics	NULL
,	NULL
Los	NULL
Alamos	NULL
National	NULL
Laboratory	NULL
,	NULL
Los	NULL
Alamos	NULL
,	NULL
N.	NULL
Mex	NULL
.	NULL

Nelsen	NULL
,	NULL
B.	NULL
,	NULL
G.	NULL
Tian	NULL
,	NULL
B.	NULL
Erman	NULL
,	NULL
J.	NULL
Gregoire	NULL
,	NULL
R.	NULL
Maki	NULL
,	NULL
B.	NULL
Graves	NULL
,	NULL
and	NULL
R.	NULL
Sen.	NULL
1993	NULL
.	NULL

Regulation	NULL
of	NULL
lymphoid-specific	NULL
immunoglobulin	NULL
u	NULL
heavy	NULL
chain	NULL
gene	NULL
enhancer	NULL
by	NULL
ETS-domain	NULL
proteins	NULL
.	NULL

Science	NULL
261:82-86	NULL
.	NULL

Neumann	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
C.	NULL
A.	NULL
Morency	NULL
,	NULL
and	NULL
K.	NULL
O.	NULL
Russian	NULL
.	NULL

1987	NULL
.	NULL

A	NULL
novel	NULL
rapid	NULL
assay	NULL
for	NULL
chloramphenicol	NULL
acetyltransferase	NULL
gene	NULL
expression	NULL
.	NULL

BioTechniques	NULL
5:444-447	NULL
.	NULL

Nye	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
J.	NULL
M.	NULL
Petersen	NULL
,	NULL
C.	NULL
V.	NULL
Gunther	NULL
,	NULL
M.	NULL
D.	NULL
Jonsen	NULL
,	NULL
and	NULL
B.	NULL
J.	NULL
Graves	NULL
.	NULL

1992	NULL
.	NULL

Interaction	NULL
of	NULL
murine	NULL
Ets1	NULL
with	NULL
GGA-binding	NULL
sites	NULL
establishes	NULL
the	NULL
ETS	NULL
domain	NULL
as	NULL
a	NULL
new	NULL
DNA-binding	NULL
motif	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

6:975-990	NULL
.	NULL

O'Brien	NULL
,	NULL
W.	NULL
A.	NULL
,	NULL
Y.	NULL
Koyanagi	NULL
,	NULL
A.	NULL
Namazie	NULL
,	NULL
J.-Q	NULL
.	NULL

Zhao	NULL
,	NULL
A.	NULL
Diagne	NULL
,	NULL
K.	NULL
Idler	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Zack	NULL
,	NULL
and	NULL
I.	NULL
S.	NULL
Y.	NULL
Chen	NULL
.	NULL

1990	NULL
.	NULL

HIV-1	NULL
tropism	NULL
for	NULL
mononuclear	NULL
phagocytes	NULL
can	NULL
be	NULL
determined	NULL
by	NULL
regions	NULL
of	NULL
gp120	NULL
outside	NULL
the	NULL
CD4-binding	NULL
domain	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
348:69-73	NULL
.	NULL

Pahl	NULL
,	NULL
H.	NULL
L.	NULL
,	NULL
R.	NULL
J.	NULL
Scheibe	NULL
,	NULL
D.-E.	NULL
Zhang	NULL
,	NULL
H.-M.	NULL
Chen	NULL
,	NULL
D.	NULL
L.	NULL
Galson	NULL
,	NULL
R.	NULL
A.	NULL
Maki	NULL
,	NULL
and	NULL
D.	NULL
G.	NULL
Tenen	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
proto-oncogene	NULL
PU.1	NULL
regulates	NULL
expression	NULL
of	NULL
the	NULL
myeloid-specific	NULL
CD11b	NULL
promoter	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:5014-5020.	NULL
.	NULL

Paul	NULL
,	NULL
R.	NULL
,	NULL
S.	NULL
Schuetze	NULL
,	NULL
S.	NULL
L.	NULL
Kozak	NULL
,	NULL
C.	NULL
A.	NULL
Kozak	NULL
,	NULL
and	NULL
D.	NULL
Kabat	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
Sfpi-1	NULL
proviral	NULL
integration	NULL
site	NULL
of	NULL
Friend	NULL
erythroleuke-mia	NULL
encodes	NULL
the	NULL
efs-related	NULL
transcription	NULL
factor	NULL
PU.1	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

65:464-467	NULL
.	NULL

Paviakis	NULL
,	NULL
G.	NULL
N.	NULL
,	NULL
and	NULL
B.	NULL
K.	NULL
Felber	NULL
.	NULL

1990	NULL
.	NULL

Regulation	NULL
of	NULL
expression	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
.	NULL

New	NULL
Biol	NULL
.	NULL

2:20-31	NULL
.	NULL

Payvar	NULL
,	NULL
F.	NULL
,	NULL
D.	NULL
DeFranco	NULL
,	NULL
G.	NULL
L.	NULL
Firestone	NULL
,	NULL
B.	NULL
Edgar	NULL
,	NULL
O.	NULL
Wrange	NULL
,	NULL
S.	NULL
Okret	NULL
,	NULL
J.-A	NULL
.	NULL

Gustafsson	NULL
,	NULL
and	NULL
K.	NULL
R.	NULL
Yamamoto	NULL
.	NULL

1983	NULL
.	NULL

Sequence-specific	NULL
binding	NULL
of	NULL
glucocorticoid	NULL
receptor	NULL
to	NULL
MTV	NULL
DNA	NULL
at	NULL
sites	NULL
within	NULL
and	NULL
upstream	NULL
of	NULL
the	NULL
transcribed	NULL
region	NULL
.	NULL

Cell	NULL
35:38	NULL
1-392	NULL
.	NULL

Pettersson	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
W.	NULL
Schaffner	NULL
.	NULL

1987	NULL
.	NULL

A	NULL
purine-rich	NULL
DNA	NULL
sequence	NULL
motif	NULL
present	NULL
in	NULL
SV40	NULL
and	NULL
lymphotropic	NULL
papovavirus	NULL
binds	NULL
a	NULL
lymphoid-specific	NULL
factor	NULL
and	NULL
contributes	NULL
to	NULL
enhancer	NULL
activity	NULL
in	NULL
lymphoid	NULL
cells	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

1:962-972	NULL
.	NULL

Pongubala	NULL
,	NULL
J.	NULL
M.	NULL
R.	NULL
,	NULL
S.	NULL
Nagulapalli	NULL
,	NULL
M.	NULL
J.	NULL
Klemsz	NULL
,	NULL
S.	NULL
R.	NULL
McKercher	NULL
,	NULL
R.	NULL
A.	NULL
Maki	NULL
,	NULL
and	NULL
M.	NULL
L.	NULL
Atchison	NULL
.	NULL

1992	NULL
.	NULL

PU.1	NULL
recruits	NULL
a	NULL
second	NULL
nuclear	NULL
factor	NULL
to	NULL
a	NULL
site	NULL
important	NULL
for	NULL
immunoglobulin	NULL
«	NULL
3	NULL
'	NULL
enhancer	NULL
activity	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:368-378	NULL
.	NULL

Ray	NULL
,	NULL
D.	NULL
,	NULL
R.	NULL
Bosselut	NULL
,	NULL
J.	NULL
Ghysdael	NULL
,	NULL
M.-G.	NULL
Mattei	NULL
,	NULL
A.	NULL
Tavitian	NULL
,	NULL
and	NULL
F.	NULL
Moreau-Gachelin	NULL
.	NULL

1992	NULL
.	NULL

Characterization	NULL
of	NULL
Spi-B	NULL
,	NULL
a	NULL
transcription	NULL
factor	NULL
related	NULL
to	NULL
the	NULL
putative	NULL
oncoprotein	NULL
Spi-1/PU.1	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:4297-4304	NULL
.	NULL

Rosen	NULL
,	NULL
C.	NULL
A	NULL
.	NULL

1991	NULL
.	NULL

Regulation	NULL
of	NULL
HIV	NULL
gene	NULL
expression	NULL
by	NULL
RNA-protein	NULL
interactions	NULL
.	NULL

Trends	NULL
Genet	NULL
.	NULL

7:9-14	NULL
.	NULL

Ryden	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
M.	NULL
de	NULL
Mars	NULL
,	NULL
and	NULL
K.	NULL
Beemon	NULL
.	NULL

1993	NULL
.	NULL

Mutation	NULL
of	NULL
the	NULL
C/EBP	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
Rous	NULL
sarcoma	NULL
virus	NULL
long	NULL
terminal	NULL
repeat	NULL
and	NULL
gag	NULL
enhancers	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

67:2862-2870	NULL
.	NULL

Sambrook	NULL
,	NULL
J.	NULL
,	NULL
E.	NULL
F.	NULL
Fritsch	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1982	NULL
.	NULL

Molecular	NULL
cloning	NULL
:	NULL
a	NULL
laboratory	NULL
manual	NULL
,	NULL
2nd	NULL
ed	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
N.Y.	NULL
Sanger	NULL
,	NULL
F.	NULL
,	NULL
S.	NULL
Nicklen	NULL
,	NULL
and	NULL
A.	NULL
R.	NULL
Coulson	NULL
.	NULL

1977	NULL
.	NULL

DNA	NULL
sequencing	NULL
with	NULL
chain-terminating	NULL
inhibitors	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
74:5463-5467.	NULL
.	NULL

Schirm	NULL
,	NULL
S.	NULL
,	NULL
J.	NULL
Jirieny	NULL
,	NULL
and	NULL
W.	NULL
Schaffner	NULL
.	NULL

1987	NULL
.	NULL

The	NULL
SV40	NULL
enhancer	NULL
can	NULL
be	NULL
dissected	NULL
into	NULL
multiple	NULL
segments	NULL
,	NULL
each	NULL
with	NULL
a	NULL
different	NULL
cell	NULL
type	NULL
specificity	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

1:65-74	NULL
.	NULL

Seth	NULL
,	NULL
A.	NULL
,	NULL
R.	NULL
Ascione	NULL
,	NULL
R.	NULL
J.	NULL
Fisher	NULL
,	NULL
G.	NULL
J.	NULL
Mavrothalassitis	NULL
,	NULL
N.	NULL
K.	NULL
Bhat	NULL
,	NULL
and	NULL
T.	NULL
S.	NULL
Papas	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
ets	NULL
gene	NULL
family	NULL
.	NULL

Cell	NULL
Growth	NULL
Differ	NULL
.	NULL

3:327-334.	NULL
.	NULL

Shioda	NULL
,	NULL
T.	NULL
,	NULL
J	NULL
.	NULL

A	NULL
.	NULL

Levy	NULL
,	NULL
and	NULL
C.	NULL
Cheng-Mayer	NULL
.	NULL

1991	NULL
.	NULL

Macrophage	NULL
and	NULL
T-cell	NULL
line	NULL
tropisms	NULL
of	NULL
HIV-1	NULL
are	NULL
determined	NULL
by	NULL
specific	NULL
regions	NULL
of	NULL
the	NULL
envelope	NULL
gp120	NULL
gene	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
349:167-169	NULL
.	NULL

2648	NULL
76	NULL
.	NULL

77	NULL
.	NULL

78	NULL
.	NULL

79	NULL
.	NULL

80	NULL
.	NULL

81	NULL
.	NULL

82	NULL
.	NULL

83	NULL
.	NULL

84	NULL
.	NULL

VAN	NULL
LINT	NULL
ET	NULL
AL	NULL
.	NULL

Soudeyns	NULL
,	NULL
H.	NULL
,	NULL
R.	NULL
Geleziunas	NULL
,	NULL
G.	NULL
Shyamala	NULL
,	NULL
J.	NULL
Hiscott	NULL
,	NULL
and	NULL
M.	NULL
A.	NULL
Wainberg	NULL
.	NULL

1993	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
novel	NULL
glucocorticoid	NULL
response	NULL
element	NULL
within	NULL
the	NULL
genome	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
.	NULL

Virology	NULL
194:758-768	NULL
.	NULL

Su	NULL
,	NULL
W.	NULL
,	NULL
S.	NULL
Jackson	NULL
,	NULL
R.	NULL
Tjian	NULL
,	NULL
and	NULL
H.	NULL
Echols	NULL
.	NULL

1991	NULL
.	NULL

DNA	NULL
looping	NULL
between	NULL
sites	NULL
for	NULL
transcriptional	NULL
activation	NULL
:	NULL
self-association	NULL
of	NULL
DNA-bound	NULL
Sp1	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

5:820-826	NULL
.	NULL

Tesmer	NULL
,	NULL
V.	NULL
M.	NULL
,	NULL
A.	NULL
Rajadhyaksha	NULL
,	NULL
J.	NULL
Babin	NULL
,	NULL
and	NULL
M.	NULL
Bina	NULL
.	NULL

1993	NULL
.	NULL

NF-IL6-mediated	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:7298-7302	NULL
.	NULL

Vaishnav	NULL
,	NULL
Y.	NULL
N.	NULL
,	NULL
and	NULL
F.	NULL
Wong-Staal	NULL
,	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
biochemistry	NULL
of	NULL
AIDS	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

60:577-630.	NULL
van	NULL
de	NULL
Wetering	NULL
,	NULL
M.	NULL
,	NULL
M.	NULL
Oosterwegel	NULL
,	NULL
D.	NULL
Dooijes	NULL
,	NULL
and	NULL
H.	NULL
Clevers	NULL
.	NULL

1991	NULL
.	NULL

Identification	NULL
and	NULL
cloning	NULL
of	NULL
TCF-1	NULL
,	NULL
a	NULL
T	NULL
lymphocyte-specific	NULL
transcription	NULL
factor	NULL
containing	NULL
a	NULL
sequence-specific	NULL
HMG	NULL
box	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

10:123-132	NULL
.	NULL

Van	NULL
Lint	NULL
,	NULL
C.	NULL
,	NULL
A.	NULL
Burny	NULL
,	NULL
and	NULL
E.	NULL
Verdin	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
intragenic	NULL
enhancer	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
contains	NULL
functional	NULL
AP-1	NULL
binding	NULL
sites	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

65:7066-7072	NULL
.	NULL

Verdin	NULL
,	NULL
E.	NULL
1991	NULL
.	NULL

DNase	NULL
I-hypersensitive	NULL
sites	NULL
are	NULL
associated	NULL
with	NULL
both	NULL
long	NULL
terminal	NULL
repeats	NULL
and	NULL
with	NULL
the	NULL
intragenic	NULL
enhancer	NULL
of	NULL
integrated	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

65	NULL
:	NULL
6790-6799	NULL
.	NULL

Verdin	NULL
,	NULL
E.	NULL
,	NULL
N.	NULL
Becker	NULL
,	NULL
F.	NULL
Bex	NULL
,	NULL
L.	NULL
Droogmans	NULL
,	NULL
and	NULL
A.	NULL
Burny	NULL
.	NULL

1990	NULL
.	NULL

Identification	NULL
and	NULL
characterization	NULL
of	NULL
an	NULL
enhancer	NULL
in	NULL
the	NULL
coding	NULL
region	NULL
of	NULL
the	NULL
genome	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87:4874-4878	NULL
.	NULL

Verdin	NULL
,	NULL
E.	NULL
,	NULL
P.	NULL
Paras	NULL
,	NULL
Jr.	NULL
,	NULL
and	NULL
C.	NULL
Van	NULL
Lint	NULL
.	NULL

1993	NULL
.	NULL

Chromatin	NULL
disruption	NULL
in	NULL
the	NULL
promoter	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
during	NULL
transcriptional	NULL
activation	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12:3249-3259	NULL
.	NULL

85	NULL
.	NULL

86	NULL
.	NULL

87	NULL
.	NULL

88	NULL
.	NULL

89	NULL
.	NULL

90	NULL
.	NULL

91	NULL
.	NULL

92	NULL
.	NULL

93	NULL
.	NULL

J.	NULL
Viror	NULL
.	NULL

Wang	NULL
,	NULL
C.-Y	NULL
.	NULL

,	NULL
B.	NULL
Petryniak	NULL
,	NULL
I.-C.	NULL
Ho	NULL
,	NULL
C.	NULL
B.	NULL
Thompson	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Leiden	NULL
.	NULL

1992	NULL
.	NULL

Evolutionarily	NULL
conserved	NULL
ets	NULL
family	NULL
members	NULL
display	NULL
distinct	NULL
DNA	NULL
binding	NULL
specificities	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

175:1391-1399	NULL
.	NULL

Wasylyk	NULL
,	NULL
B.	NULL
,	NULL
S.	NULL
L.	NULL
Hahn	NULL
,	NULL
and	NULL
A.	NULL
Giovane	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
Ets	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Biochem	NULL
.	NULL

211:7-18	NULL
.	NULL

Waterman	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
and	NULL
K.	NULL
A.	NULL
Jones	NULL
.	NULL

1990	NULL
.	NULL

Purification	NULL
of	NULL
TCF-la	NULL
,	NULL
a	NULL
T-cell-specific	NULL
transcription	NULL
factor	NULL
that	NULL
activates	NULL
the	NULL
T-cell	NULL
receptor	NULL
Ca	NULL
gene	NULL
enhancer	NULL
in	NULL
a	NULL
context-dependent	NULL
manner	NULL
.	NULL

New	NULL
Biol	NULL
.	NULL

2:621-636	NULL
.	NULL

Westervelt	NULL
,	NULL
P.	NULL
,	NULL
H.	NULL
E.	NULL
Gendelman	NULL
,	NULL
and	NULL
L.	NULL
Ratner	NULL
.	NULL

1991	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
determinant	NULL
within	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
surface	NULL
envelope	NULL
glycoprotein	NULL
critical	NULL
for	NULL
productive	NULL
infection	NULL
of	NULL
primary	NULL
monocytes	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
$	NULL
8:3097-3101	NULL
.	NULL

Westervelt	NULL
,	NULL
P.	NULL
,	NULL
T.	NULL
Henkel	NULL
,	NULL
D.	NULL
B.	NULL
Trowbridge	NULL
,	NULL
J.	NULL
Orenstein	NULL
,	NULL
J.	NULL
Heuser	NULL
,	NULL
H.	NULL
E.	NULL
Gendelman	NULL
,	NULL
and	NULL
L.	NULL
Ratner	NULL
.	NULL

1992	NULL
.	NULL

Dual	NULL
regulation	NULL
of	NULL
silent	NULL
and	NULL
productive	NULL
infection	NULL
in	NULL
monocytes	NULL
by	NULL
distinct	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
determinants	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

66:3925-3931	NULL
.	NULL

Westervelt	NULL
,	NULL
P.	NULL
,	NULL
D.	NULL
B.	NULL
Trowbridge	NULL
,	NULL
L.	NULL
G.	NULL
Epstein	NULL
,	NULL
B.	NULL
M.	NULL
Blumberg	NULL
,	NULL
Y.	NULL
Li	NULL
,	NULL
B.	NULL
H.	NULL
Hahn	NULL
,	NULL
G.	NULL
M.	NULL
Shaw	NULL
,	NULL
R.	NULL
W.	NULL
Price	NULL
,	NULL
and	NULL
L.	NULL
Ratner	NULL
.	NULL

1992	NULL
.	NULL

Macrophage	NULL
tropism	NULL
determinants	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
in	NULL
vivo	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

66:2577-2582	NULL
.	NULL

Wolffe	NULL
,	NULL
A	NULL
.	NULL

1992	NULL
.	NULL

Chromatin	NULL
,	NULL
structure	NULL
and	NULL
function	NULL
.	NULL

Academic	NULL
Press	NULL
,	NULL
Inc.	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
Calif.	NULL
Wu	NULL
,	NULL
C.	NULL
1989	NULL
.	NULL

Analysis	NULL
of	NULL
hypersensitive	NULL
sites	NULL
in	NULL
chromatin	NULL
.	NULL

Methods	NULL
Enzymol	NULL
.	NULL

170:269-289	NULL
.	NULL

York-Higgins	NULL
,	NULL
D.	NULL
,	NULL
C.	NULL
Cheng-Mayer	NULL
,	NULL
D.	NULL
Bauer	NULL
,	NULL
J	NULL
.	NULL

A	NULL
.	NULL

Levy	NULL
,	NULL
and	NULL
D.	NULL
Dina	NULL
.	NULL

1990	NULL
.	NULL

Human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
cellular	NULL
host	NULL
range	NULL
,	NULL
replication	NULL
,	NULL
and	NULL
cytopathicity	NULL
are	NULL
linked	NULL
to	NULL
the	NULL
envelope	NULL
region	NULL
of	NULL
the	NULL
viral	NULL
genome	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

64:4016-4020	NULL
.	NULL

